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Abstract
The B cell antigen receptor (BCR) can be expressed in a number of molecular forms 
during B cell development, and provides context-dependent signals that lead to a variety of 
cellular outcomes. Isotype switching during an immune response represents a key, 
irreversible molecular change in BCR structure, where naive BCR isotypes (IgM and IgD) 
are replaced by switched isotypes (IgG, IgA, IgE) that become markers of antigen 
experience. Attempts to study isotype-specific BCR signalling in vivo have been 
hampered, however, by the changes in BCR affinity, location, cell surface phenotype, 
activation requirements and lifespan that also accompany antigen priming.
To address the role of isotype-switched BCR expression during an immune response, 
homogeneous populations of naive B cells derived from anti-lysozyme immunoglobulin 
transgenic mice were seeded into a T-dependent immune response to lysozyme in vivo. 
Comparisons were made between transgenic B cells expressing IgM and IgD BCRs and B 
cells expressing full length IgG or the unique IgG membrane tail domain.
It was found that naive transgenic B cells expressing the IgG membrane tail domain 
make a more robust response to antigen compared to naive transgenic B cells bearing IgM, 
both in terms of net clonal expansion and in the production of antibody-forming cells. 
Transgenic B cells expressing the IgG membrane tail were not activated more efficiently, 
nor did they have a greater rate of cell division compared to IgM transgenic B cells. 
Rather, the IgG membrane tail protected B cells from cell death during the process of clonal 
expansion.
This experimental strategy was verified by showing that B cell developmental 
differences in the bone marrow, as well as phenotypic variations in the marginal zone and 
follicular B cell subsets of the various transgenic lines did not account for their responses to 
antigen in vivo. The only apparent determinant of reactivity to antigen in this system was 
BCR isotype and the expression of the IgG membrane tail domain.
This study has identified BCR isotype as a regulator of B cell responses to antigen 
during an immune response in vivo. It also shows that the IgG membrane tail is the key 
molecular determinant of the protective effect of IgG expression, leading to increased cell 
survival during the process of clonal expansion. Isotype switching to IgG may therefore 
represent a critical component of B cell priming, allowing greater magnitude expansion of 
memory B cells during a memory response.
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Chapter 1. Introduction
2 Chapter 1
Section 1.1. Preamble
The immune system is a complex interconnected series of cell types and proteins that 
has evolved to protect the body from infection. The innate arm consists of physical and 
antimicrobial chemical barriers to infection as well as series of cells bearing receptors that 
recognise common conserved patterns amongst pathogens (Hoffmann, 1999). This is found 
in most forms of multicellular life and represents a complex but evolutionarily primitive 
form of immune system. By contrast, some form of adaptive immune system is shared by 
higher vertebrates and consists of cells that use recombined receptors to recognise a vast 
array of potential pathogen signatures. The hallmarks of adaptive immunity include a 
pathogen-specific response to clear infection and in many cases a state of immunological 
“memory” that provides long-term protective immunity against reinfection.
While an appreciation of the ability of the innate immune system to initiate immune 
responses and to regulate the other arms of the immune system has been relatively recent 
(Fearon, 1996), the adaptive arm of the immune system has been studied experimentally for 
over 100 years (Silverstein, 1989). The phenomenon of immune memory, especially with 
respect to antibody production by B lymphocytes, is well known and yet the underlying 
cellular mechanisms remain obscure. We know that a first encounter with a pathogen 
“primes” the immune system so that secondary, or memory immune responses have distinct 
qualitative and quantitative differences (Ahmed, 1996). Specific antibody is of higher 
affinity, is produced more rapidly and in much higher quantities compared to a primary 
response. In addition the antibody isotype profile changes, with switched isotypes such as 
IgG and IgA dominating. These complex, inter-connected changes make the phenomenon 
of “memory” very difficult to dissect, and it is still unclear what factors are responsible for 
the maintenance of the memory state versus the memory response itself.
For example, the role of isotype-switched B cell antigen receptor (BCR) expression 
on many memory B cells is unknown. At most other stages of B cell development it is well 
documented that signals through different molecular forms of the BCR influence B cell 
responses. During B cell production in the bone marrow, pre-BCR mediated signalling is 
crucial for developmental progression, while immature B cells respond to BCR 
crosslinking with clonal deletion, clonal anergy and a reduced life span. In the same way 
mature naive B cells expressing IgM and IgD respond to protein antigen presented in the 
correct co-stimulatory context with clonal expansion, however in the absence of T cell help 
make an abortive response unless the antigen is highly multivalent or linked to a B cell 
mitogen. After a T-dependent immune response many isotype-switched memory B cells 
persist and are recruited into secondary antibody responses, however the contribution of
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antigen-dependent signalling through isotype-switched receptors to the subsequent memory 
response has yet to be determined.
This introduction will review the role of BCR isotype in shaping B cell development, 
and outline the features of T-dependent immune responses. The unique qualities of the 
memory response and memory cells will be discussed, as well as current theories to explain 
the persistence of the memory state and the features of the memory response. Finally, 
evidence for isotype-specific signalling, both in vitro and in vivo will be reviewed and 
placed in context with the current study.
Section 1.2. B cell development and differentiation
B cell development from stem cells in the fetal liver and adult bone through to mature 
peripheral B cells can be thought of as a series of checkpoints where B cell antigen receptor 
(BCR) expression and signalling at each stage in B cell development plays an important 
role in shaping the eventual repertoire (reviewed in Rolink, 1993; Goodnow, 1995; 
Melchers, 1999; Pillai, 1999; Meffre, 2000; Monroe, 2000). B cell subsets in the bone 
marrow are shown in Figure 1-1, and peripheral B cell subsets in Figure 1-2.
1.2 (a) Stem cells and B lineage commitment
B lymphopoiesis in the mouse starts in the fetal yolk sac and moves to the fetal liver 
around day 14 of gestation. B lymphopoiesis is then established in the bone marrow in the 
first weeks after birth and continues for the life of the animal. In the bone marrow self- 
renewing hematopoietic stem cells give rise to common lymphoid progenitors that under 
normal conditions produce T, B and NK cells (Kondo, 1997). The stem cells and 
progenitor cells that give rise to lymphoid lineages are thought to express multiple different 
lineage determinants at low levels. In fact bone marrow-derived stem cells show 
remarkable plasticity and under the right conditions can contribute to a wide range of 
tissues including heart, brain, skeletal muscle and liver (Blau, 2001). Lineage 
“commitment” seems to involve the emergence of a more stable pattem of gene expression 
that reinforces lineage-specific gene expression and actively represses other possible cell 
fates (Nutt, 1999b; Akashi, 2000; Busslinger, 2000). In the case of B lymphopoiesis in the 
bone marrow, knockout studies have determined genes important for the development of B 
cells (Scott, 1994; Zhuang, 1994; Lin, 1995; Schilham, 1996; Wang, 1996). The 
transcription factor Pax-5 (also known as BSAP: B cell-specific activator protein) is the 
only factor shown so far to be required for B lineage commitment rather than
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developmental progression. It is expressed from the earliest commited B cell stage, and 
while Pax-5'7' B cells appear to arrest at the early pro-B stage, they remain multipotent and 
able to form T cells, NK cells, osteoclasts, macrophages, dendritic cells and granulocytes in 
vitro (Nutt, 1999a) and in some cases in vivo (Rolink, 1999).
1.2 (b) B cell development in the adult bone marrow
The earliest stage of committed B cell precursors express the surface markers AA4.1, 
B220 and CD43 and are referred to as pre-pro-B cells (Hardy’s Fraction Ao, Aj and A2) 
(Hardy, 1991; Li, 1993; Allman, 1999). These retain immunoglobulin loci in a germline 
configuration, express low levels of recombinase activator (RAG) genes and lack 
expression of components of the BCR, such as Igocß, suggesting initial B cell commitment 
is not driven by antigen receptor signals (Allman, 1999).
By contrast, pro-B cells (Hardy’s fraction B and C) are the first B lineage stage to 
express a potentially functional precursor version of the BCR (the pro-BCR). This stage is 
distinguished by the expression of various additional surface markers such as CD24 (HSA)
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and BP-1 (Hardy, 1991). During the pro-B cell stage sequential induction of heavy chain 
immunoglobulin Dh —» Jh and Vh —> DhJh rearrangements occurs. Non-productive 
truncated forms of mlgji (Djli) are counter-selected at this stage leading to developmental 
arrest at the pro-B stage (Meffre, 2000). Pro-B cells express the Iga, Igß, VpreB and A.5 
components of the pre-BCR (Karasuyama, 1993; Meffre, 1996), and recent evidence 
suggests that a complex exists between calnexin and Igocß on the surface of pro-B cells 
(Nagata, 1997). Interestingly, crosslinking of Igß in vivo in RAG-deficient mice allowed 
the pro-B cells to display some features of pre-B cells as if the Igaß complex on pro-B cells 
delivers a signal for developmental progression (Nagata, 1997). Further evidence that 
signalling via the calnexin/Igaß complex may be important for pro-B cell progression 
comes from analysis of Igß'7' (Gong, 1996) and (xMT mice (Ehlich, 1993). In the absence 
of Igß there are no pre-B cells, but in the pro-B subset Vh —> DhJh rearrangements are 
decreased compared to Dh —> Jh joins. By contrast, in the absence of membrane-bound jll 
(and therefore a functional pre-BCR) there are a normal number of VH —> DhJh 
rearrangements, suggesting that Igß plays a role in signalling even in the absence of the 
pre-BCR. This observation fits with a model in which constant checks are imposed on 
developing B cells to ensure the correct expression of the components of a functional BCR.
After a period of clonal expansion, pre-B cells become small and resting (Hardy’s 
fraction D). This is the stage of most light chain immunoglobulin gene Vl —» Jl 
rearrangement, with a productively rearranged K or X light chain replacing surrogate light 
chain to form a complete BCR.
When a surface IgM isotype BCR is expressed, the B cell is considered “immature” 
(Hardy’s fraction E). Immature B cells lose expression of IL-7R and have lower BP-1 
expression (Hardy, 1991). The expression of a functional IgM BCR signals a cessation of 
Ig light chain gene rearrangement, the degradation of RAG proteins, and a loss of mRNA 
for RAG and pre-BCR components. Immature B cells exit from the bone marrow via the 
blood and mature further phenotypically in the spleen, eventually contributing to the 
mature, long-lived recirculating pool.
A fraction of bone marrow B cells are derived from the mature, recirculating pool that 
home back to this site. They are distinguished from the other bone marrow subsets by 
expression of mature B cell markers and are CD23+, B220hl, HSA10 IgM10 IgD+ (Hardy’s 
Fraction F) (Hardy, 1991).
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1.2 (c) Selection shapes the mature B cell repertoire
Evidence for selection
Selection shapes the peripheral B cell repertoire during the transition from immature 
to mature B cells in the periphery, and also during the formation of specialised mature 
subsets in the splenic marginal zone and the peritoneal and pleural cavities. The fact that 
selection occurs at these points seems clear, however the relative importance of “negative” 
selection to self-antigens, foreign-antigen driven “clonal” selection or “positive” selection 
to undefined ligands for this process is still in doubt.
Only a small fraction of bone marrow-derived immature B cells are ever incorporated 
into the long-lived recirculating mature B cell pool (MacLennan, 1986). The exact site of 
cell loss has been difficult to determine and is probably a combination of apoptosis in the 
bone marrow and the spleen. Unlike the production of thymus-derived lymphocytes, which 
occurs in a defined organ and whose rate of emigration can be accurately estimated 
(Scollay, 1980), the actual rate of emigration of newly formed B cells from the bone 
marrow to the periphery is still uncertain. Estimates originally suggested a turnover rate of 
2-5 x 107 IgM+ B cells in the mouse bone marrow compartment daily (Opstelten, 1983; 
Osmond, 1986). While this may reflect the rate of cell production, it is likely to be a gross 
overestimate of the number of immature B cells that leave the bone marrow as many 
tolerance mechanisms operate at that site that lead to clonal deletion (Nemazee, 1989; 
Hartley, 1993). Also, because of the rapid clearance of apoptotic bodies in the bone 
marrow the rate of B cell apoptosis is difficult to determine. Recently the emigration rate 
of B cells from murine BM has been revised to 9xl06 IgM+ cells per day by taking into 
account the rate of apoptosis (Lu, 1997, 2000).
After entry into the spleen, there is evidence for two B cell populations, one with a 
very short turnover rate of a few days (Allman, 1993), and one with a half-life of several 
months (Gray, 1988; Forster, 1990; Allman, 1993; Hao, 2001). The prevailing view is that 
the short-lived subset represents immature B cells and that a very small fraction (1-10 %) of 
these enter the long-lived pool (Ron, 1985; Lortan, 1987; Gray, 1988; Forster, 1990; Chan, 
1993), although the use of BrdU and other labels that mark proliferating cells rest on the 
assumption that immature B cells are the only cells derived from proliferating precursors.
A subset of mature B cells are also likely to be proliferating by mechanisms such as clonal 
expansion due to encounter with both T-dependent and T-independent antigens 
(MacLennan, 1986; Chan, 1993), making the interpretation of labelling data difficult. The 
loss of the majority of recent bone marrow emigrant B cells that reach the spleen is 
probably due to their inability to enter B cell follicles and receive survival signals.
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Certainly the “space” available for new B cells in the follicle niches is a critical, 
presumably neutral mediator of entry into the long-lived pool, as demonstrated by studies 
showing the rapid “re-filling” of those areas after depletion (Bazin, 1985b, 1985a). This 
“clonal competition” (MacLennan, 1986; Lortan, 1987) is also regulated by negative 
selection forces that affect the ability of self-reactive B cells to compete for follicle entry 
(Cyster, 1994).
The second piece of evidence for selection shaping peripheral B cell subsets comes 
from the restricted pattern of J558 Vh gene useage in mature splenic B cells compared to 
bone marrow derived immature B cells (Gu, 1991). In addition, the B-l subset is enriched 
for B cells specific for numerous self and foreign antigens (Wortis, 2001) and recent 
analyses in rats (Dammers, 1999a) and several transgenic mouse models (Martin, 2000a) 
show that the splenic marginal zone compartment can be enriched for certain specificities.
Negative selection
Negative selection is a major force in determining the nature of the mature B cell 
repertoire. The nature and timing of self-antigen exposure leads to a number of negative 
selection responses in B cells. This process has been most carefully studied in transgenic 
models that allow the regulated expression of autoantigens (Goodnow, 1992; Goodnow, 
1995; Nemazee, 2000).
In the bone marrow, the binding of high avidity self antigen to self-reactive BCRs on 
immature bone marrow B cells can lead to autoreactive cell deletion (Nemazee, 1989). Self 
antigen binding to high avidity autoantigens causes developmental arrest at the immature B 
cell stage, which is separate from subsequent apoptotic loss (Hartley, 1993). It seems that 
strongly self-reactive immature B cells can alter their antigen receptors by secondary Ig 
gene rearrangements during developmental arrest, a process termed “receptor editing” 
(Radic, 1993; Tiegs, 1993). Subsequent expression of a non-autoreactive BCR then allows 
immature B cells to “escape” the developmental block, although this mechanism still 
produces an effective “clonal deletion” of the original self-reactive BCR. This process has 
been modelled in the 3-83 anti-H-2k b transgenic system. On a RAG+/+ background,
“edited” mature B cells carrying endogenous Lc accumulate in the periphery, while on the 
RAG 7' background B cells fail to populate peripheral lymphoid organs (Spanopoulou, 
1994).
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Figure 1-1. B cell development in the bone marrow
This diagram outlines the major steps in B cell lymphopoiesis in the bone marrow, from 
hematopoietic stem cell precursors through pre-pro-B cells, pro-B cells, pre-B cells and 
immature B cells. The expression of relevant cell surface and intracellular markers is 
indicated by bars underneath each cell subset. Also, the nomenclature for each subset 
according to Hardy (Hardy, 1991; Li, 1993) is indicated A ^E . Calnexin is shown in green 
in a putative receptor complex with Igaß (yellow) on pro-B cells. Rearranged heavy chain 
is shown in outline, either in complex with \|/L (red) on pre-B cells or in complex with 
rearranged light chain (blue) on immature B cells. Molecules involved in the transitions 
between the subsets are shown at the relevant points, where x'1' means the phenotype 
observed in the knockout of molecule jc.
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The importance of receptor editing versus cell death as a mechanism to ensure 
tolerance against high avidity, abundantly expressed self-antigens is unclear. While one 
report suggested that evidence of receptor editing is common amongst IgM+̂ + peripheral B 
cells in normal mice (Retter, 1998), most light chain gene rearrangements are to JkI (Nishi, 
1985), suggesting receptor editing is not a common occurrence, at least for k+ cells.
For the systemic membrane-bound anti-MHC system, as well as the anti-HEL system 
where HEL is expressed as a membrane-bound array, the major pathway of tolerance in the 
bone marrow is developmental arrest, followed by receptor editing or clonal deletion. By 
contrast, when a lower avidity soluble form of HEL is used, clonal deletion gives way to 
clonal anergy, in which many self-reactive B cells mature and fill the periphery but are 
functionally impaired (Goodnow, 1988; Goodnow, 1989; Goodnow, 1995; Goodnow,
1996). Anergic B cells in this system have been shown to have a reduced lifespan due to 
peripheral follicular exclusion (Cyster, 1994), are unable to up-regulate co-stimulatory 
molecules (Ho, 1994), and are actively killed via the Fas/FasL pathway by antigen-specific 
T cells (Rathmell, 1995; Rathmell, 1996). They express lower levels of BCR, flux calcium 
poorly in response to receptor crosslinking and only generate a subset of the transcriptional 
responses usually associated with full B cell activation (Glynne, 2000). Sufficiently low 
avidity systemic autoantigen can actually be ignored by the developing B cell, as in the case 
where a secreted form of H-2Kb was expressed in mice carrying the 3-83 anti-H-2k,b He and 
Lc genes (Nemazee, 1991). Clonal ignorance has also been observed in anti-HEL double 
transgenic mice expressing sufficiently low concentrations of circulating HEL (Goodnow, 
1989; Cyster, 1994).
Tolerance induction is not simply limited to the encounter of systemic autoantigen in 
the bone marrow. For example, restricted expression of membrane-bound H-2k in the liver 
led to the deletion of anti-H-2k,b 3-83 transgenic B cells after exit from the bone marrow, 
probably in the spleen during the transition to the mature cell compartment (Russell, 1991). 
To model negative selection in fully mature, peripheral B cells the Cre/loxP inducible gene- 
inversion system was used to switch BCR He expression on mature B cells from an 
innocuous specificity to recognise anti-H-2k b (Lam, 1998). This sudden exposure of 
mature 3-83+ B cells to membrane-bound H-2b molecules led to very rapid elimination of 
those cells, indicating that sufficiently strong tolerising signals can negatively select even 
phenotypically mature B cells. In a similar way, the peritoneal cavity microenvironment of 
anti-erythrocyte transgenic mice allows auto-reactive B-l cells to accumulate (Murakami, 
1992), while B-2 cells are efficiently deleted. Injection of erythrocytes into the peritoneal 
cavity leads to B-l cell deletion, again showing that mature B cells can be efficiently 
tolerised if auto-antigen exposure is sufficiently strong. Finally, the anti-TNP transgenic
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system was used to model the effect of sudden antigen encounter on peripheral B cell 
subsets (Carsetti, 1993, 1995). It was found that the major B cell subset affected by 
antigen encounter were “transitional” cells in the bone marrow and spleen, leading the 
authors to speculate that immature “transitional” B cells in the bone marrow and spleen are 
sensitive to apoptosis and are primary targets for negative selection in the periphery.
At present it is unclear why immature B cells often respond to antigen binding with a 
tolerance response while mature B cells often respond to antigen binding with activation 
(Monroe, 2000). Extrinsic factors that lead to B cell tolerance must include a lack of 
appropriate T cell help and co-stimulatory signals during self-antigen binding. Also, the 
extrinsic microenvironmental differences between bone marrow and peripheral lymphoid 
tissue may play a role in determining whether immature B cells respond with 
developmental arrest (Melamed, 1998) or apoptosis (Carsetti, 1995). For example, the 
culture of immature B cells with unfractionated bone marrow protects immature cells from 
apoptosis due to BCR crosslinking (Sandel, 1999; Sandel, 2001). Intrinsic factors may also 
affect B cell responses to antigen. For example, antigen receptor crosslinking in an 
immature B cell line and in thymocytes does not induce antigen receptor movement into 
lipid microdomains (Ebert, 2000; Sproul, 2000), which is an important early event in full 
antigen receptor signalling in mature B and T cells (Ebert, 2000; Sproul, 2000). In a 
similar way, pro-apoptotic and anti-apoptotic members of the Bcl-2 family alter their 
expression levels during the immature to mature B cell transition, with Bcl-2 most highly 
expressed in pro-B and mature B cells, but poorly expressed in immature B cells (Li, 1993). 
Bcl-xL is expressed most highly in pre-B cells but is nearly absent from mature B cells 
(Choi, 1996). A1 expression is low in immature and transitional cells but is highly 
expressed in mature B cells (Tomayko, 1998). There is evidence that the relative levels of 
these anti-apoptotic members may make immature B cells more sensitive to cell death 
compared to mature B cells. Over-expression of Bcl-2 and Bcl-xL, for example, lead to the 
impaired deletion of autoreactive immature B cells in the bone marrow (Hartley, 1993; 
Fang, 1998).
Antigen-driven selection
Superimposed upon negative selection during B cell development is the process of 
antigen-driven selection by active immune responses that lead to antigen-specific B cell 
clonal expansion. This process, coupled with the culling of self-reactive clones by negative 
selection may be sufficient to explain the makeup of the mature B cell repertoire. In 
particular, the role of antigen-driven selection in promoting B cell entry into the marginal 
zone and B-l peripheral subsets will be dealt with later.
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Some researchers invoke a third process, termed “positive” or “ligand” selection, to 
explain observations such as Vh gene useage and clonal enrichment in certain B cell 
subsets (Gu, 1991; Martin, 1999; Pillai, 1999). In this model they envisage that B cells are 
selected and maintained on the basis of their specificity in the pre-immune repertoire by 
contact with some self or foreign antigen. It is certainly clear that peripheral B cell survival 
requires functional BCR expression, as conditional ablation of BCR expression leads to 
rapid mature B cell death (Lam, 1997). Also, survival signals can be transmitted through 
the BCR, for example when B cell survival in CD45'* mice was rescued by binding self 
antigen (Cyster, 1996). However, in contrast to CD4+ (Takeda, 1996; Kirberg, 1997) and 
CD8+ (Tanchot, 1997) T cells, which require MHC contact for survival, there is no way at 
present to distinguish whether a BCR must contact some specific ligand or whether “tonic” 
BCR signalling is sufficient for survival. For B cells, which lack obvious common ligands 
and which could potentially interact with a vast array of different molecules with varying 
avidity, only one case has been reported in which the development of a peripheral B cell 
clone is dependent on the presence of a specific ligand (Hayakawa, 1999). In that study, 
the formation of anti-Thy-1 B-la B cells was shown to be dependent on the presence of the 
Thy-1 antigen. While that study showed that expression of CD5 on a given B cell clone 
required the presence of the cognate antigen it failed to determine whether that interaction 
was a true positive selection signal or simply an antigen-driven phenotypic change.
In summary, it is unclear whether true positively selecting ligands act to shape the B 
cell repertoire. It seems the term “positive” selection is currently used loosely in B cell 
biology to include not only ligands that are absolutely required for the simple maintenance 
of mature lymphocytes (as in T cell biology), but also for the antigen-driven process of 
clonal expansion. Currently a combination of the processes of negative selection and 
antigen (self or foreign)-driven clonal expansion seems a simpler explanation for the 
patterns of selection observed in the B cell repertoire. It may be that genuine, pre-immune, 
positively selecting ligands, such as those operating on peripheral T cells may not operate 
in B cell biology.
1.2(d) B cell subsets in the periphery
The formation of mature B cell subsets
After exit from the bone marrow, immature B cells move rapidly via the blood to the 
spleen (Osmond, 1986), where most are excluded from follicular entry (Lortan, 1987). 
Rather than automatically entering the mature peripheral pool, immature B cells undergo 
further maturation steps (called “transitional” stages) (Figure 1-2).
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During these transitional stages IgD expression gradually increases, from IgDlo/' 
through to IgDhl. In some studies this transition is divided into HSAhl B220io IgM+ IgD' 
immature and HSA10 B220hl IgM+ IgD+ mature subsets (Brink, 1992; Allman, 1993). Other 
studies use more comprehensive markers to define transitional type 1 (IgD10, IgMhl, C D 2l’°, 
CD23', CD62L'), transitional type 2 (IgD10, IgMhi, CD21hi, CD23+, CD62L') and mature B 
cell subsets (follicular: IgDhi, IgM10, CD21int, CD23+, CD62L+ and marginal zone: IgDlo/', 
IgMhl, CD21hl, CD23') (Carsetti, 1995; Loder, 1999). T1 and T2 subsets are absent from 
lymph nodes and the T2 phenotype is seen only in the spleen, consistent with the immature 
to mature B cell transition occurring almost exclusively in this location (Loder, 1999). T1 
cells appear first during ontogeny, followed by T2, mature follicular and finally marginal 
zone cells. On the basis of cell transfer experiments, T1 cells give rise to T2 cells that are 
then capable of forming mature B cells (Loder, 1999).
The origin o f the marginal zone subset is less clear. Some marginal zone B cells are 
memory cells, derived presumably from mature follicular B cells during T cell-dependent 
responses (MacLennan, 1990). As well, many naive marginal zone B cells are derived 
from mature, recirculating B cells. Marginal zone B cells appear after mature B cells 
during ontogeny (Loder, 1999), appear after follicular B cells during reconstitution o f hind 
limb shielded irradiated rats (Lane, 1986) and are rapidly repopulated by transfer of mature 
recirculating thoracic duct lymphocytes into marginal zone depleted rats (Kumararatne, 
1981b). Despite these findings, both CD45' '  and Bt/fld mice show severe defects in mature 
follicular phenotype B cells (IgM'° CD21med CD23"), and yet have phenotypically normal 
marginal zone subsets (IgMhl CD21hl CD23‘) (Loder, 1999). This raises the possibility that 
at some low level T1 or T2 cells can directly form marginal zone cells.
Mature, follicular B cells
Mature follicular (IgD+ IgM10 CD21med CD23+ CD62L+) B cells constantly recirculate 
through secondary lymphoid tissues, blood and afferent lymphatic vessels and rely on 
functional BCR expression for their survival (Lam, 1997). They continue this process until 
triggered by antigen, a process that will be described further in the next section. As a 
population they have a half-life o f the order of several months, based on BrdU labelling 
(Forster, 1990), disruption o f IL-7 signalling (Grabstein, 1993; Sudo, 1993), and more 
recently gene-targeting experiments (Hao, 2001).
Marginal zone B cells
The marginal zone (MZ) of the spleen forms a boundary between the red pulp and the 
white pulp, consisting o f the arteriole-draining marginal sinus with marginal zone
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metallophilic macrophages on the follicular face and a ring of marginal zone B cells, 
dendritic cells and marginal zone macrophages as an outer boundary (Cyster, 2000; Vos, 
2000). Blood constantly percolates through the MZ via the marginal sinus and outward 
into the red pulp and this close proximity to blood-borne antigens is thought to allow rapid 
MZ B cell activation during T-independent type 2 and memory B cell responses.
In normal mice, marginal zone B cells consist approximately 5-10 % of splenic B 
cells and are phenotypically distinct from other peripheral B cell subsets. They have been 
characterised as CD21hl, CD23', IgMhl, IgDlo/' (Gray, 1984b; Loder, 1999; Martin, 2000b) 
and CDld+ (Amano, 1998; Roark, 1998). In the mouse, marginal zone B cells may express 
higher levels of CD38, CD40 (Oliver, 1997a) and the co-stimulatory molecules B7.1 and 
B7.2 (Oliver, 1999) compared to follicular B cells. In addition, marginal zone B cells are 
non-dividing (Liu, 1988), enlarged (Oliver, 1997a) and non-recirculating (Kumararatne, 
1981a; Kumararatne, 1981b).
The marginal zone B cell population of the spleen has been associated with two 
functions. Firstly, marginal zone B cells are involved in responses against T-independent 
type 2 antigens such as bacterial polysaccharides from encapsulated bacteria. Blood-bome 
versions of these antigens localise very rapidly to the area of the marginal sinus, trapped by 
resident macrophages (Humphrey, 1981; Gray, 1984a; Matsuno, 1989; Peset Llopis, 1996; 
Martin, 2000a). The key role of the marginal zone in allowing immune responses against 
these antigens is underlined by the fact that splenectomised patients and children under the 
age of 2 years, are unable to mount effective immune responses to encapsulated bacteria 
(Mond, 1995).
Because marginal zone B cells are able to form in the absence of T cells (Dammers, 
1999a) and exposure to exogenous antigens (Kumararatne, 1981a), at least part of this 
subset can be considered naive. However, B cells bearing evidence of somatic 
hypermutation also accumulate in the marginal zone compartment. In rats immunised with 
a T-dependent form of the hapten dinitrophenyl (DNP), hapten-binding memory B cells 
primarily localised to the marginal zone (Liu, 1991) and were rapidly mobilised from that 
site upon in an antigen-specific manner. In humans also, many marginal zone B cells show 
signs of a germinal centre origin by the presence of somatic mutation (Dunn-Walters, 1995; 
Tierens, 1999) and by the expression of cell surface markers such as CD27 which are 
associated with memory cells (Tangye, 1998). By contrast, when B cells from the spleen of 
inimmunised rats were analysed, only 20 % of cells were found to carry somatic mutations 
(Dammers, 1999b; Dammers, 2000). The difference in the extent of memory cells in the 
MZ of human and rodent spleen is difficult to interpret, as they are poorly matched 
comparisons.
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The nature of the signals that lead to selection and maintenance of B cells in the 
follicular and marginal zone compartments is poorly understood. Memory B cells localise 
to the marginal zone, and the phenotypic changes that allow this have not been elucidated. 
As well, it has recently been shown that the pre-immune marginal zone repertoire is not 
random and may be subject to selective pressures. In one study by Dammers and 
colleagues, it was estimated that only 0.03 % of mature recirculating follicular B cells were 
used to replenish the marginal zone B cell pool in the rat per day (Dammers, 1999b). 
Evidence for the selection of B cell clones in this process came from an analysis of PC7183 
family Vh genes in unimmunised rats (Dammers, 2000). Despite 80 % of B cells carrying 
germline-encoded sequences, it was found that the PC-1 and PC-4 family members were 
enriched in the follicular B cell compartment, and gene sequences from marginal zone B 
cells showed a shorter CDR3 region length compared to the other subsets tested. This 
correlation of short CDR3 length with marginal zone occupancy fits with the proposal of 
Martin and Kearney that the marginal zone is enriched by some form of “positive selection” 
for B cell clones with “polyreactive” antigen receptors (Martin, 2000a). They have shown 
using transgenic mice that extreme enrichment of certain clones into the marginal zone 
compartment can be obtained and requires intact antigen receptor signalling. The 8lx 
heavy chain transgenic mouse carries a Vh81x gene derived from a multireactive mouse 
fetal liver B cell clone (Martin, 1997). The transgenic heavy chain preferentially associates 
with the Vk 1C/Jk5 light chain in surviving peripheral B cells expressing the 8lx He (Chen, 
1997) and the resulting 35-1 idiotype+ B cells constitute 94 % of the marginal zone subset 
and just 5 % of the follicular subset (Martin, 2000b). This enrichment process has also 
been shown in the M l67 anti-phosphorylcholine Hc-only transgenic where M l67 idiotype+ 
B cells make up 83 % of the marginal zone subset and only 14 % of the follicular subset 
(Martin, 2000b). By contrast, the MD2 anti-HEL heavy-chain only line (Martin, 2000b) 
produces HEL-binding clones with a predominantly follicular phenotype.
Despite the striking accumulation of these clones in the marginal zone, the relative 
importance of negative and positive and their relevance for physiological selection in 
normal, diverse B cell repertoires is difficult to assess. There is evidence that 
Vh8 lx/endogenous Lc combinations other than Vk1C/Jk5 are the target of negative 
selection in the 8lx transgenic model, including strong competitive exclusion in a diverse 
repertoire and a lack of transgene-encoded serum antibody or plasma cells (Martin, 1997). 
This negative selection may be offset in the case of “polyreactive” 81x/Vk1C,Jk5 clones by 
contact with some antigen such as bacterial products from commensal organisms, leading 
to the observed clonal enrichment through each stage of B cell development (Martin, 
2000b). Certainly a lack of clonal enrichment in the absence of functional Btk suggests
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some sort of positive signal via the BCR is required for the preferential accumulation of the 
35-1 Id+ cells in the marginal zone.
Despite the profound levels of selection shown in this transgenic model, clonal 
competition is also important for entry into the marginal zone pool. In bone marrow 
chimeras of 1:1 81x-Tg and non-Tg mixtures, only a tiny fraction of marginal zone cells (3 
%) were derived from transgenic donor cells compared to nearly 100 % in normal 8lx 
transgenic mice (Martin, 1997). Therefore it is possible that the extreme enrichment of 
clones into the marginal zone in the 8lx Tg model is a transgenic artefact. The strong 
selection of 35-1 Id+ cells in 8 lx transgenic mice may be due to negative selection of many 
8lx Hc/endogenous Lc combinations, allowing the 8lx/ Vk1C,Jk5 bearing clones to enter 
and enrich the MZ subset by default. Under more normal conditions in the polyclonal, 
diverse B cell repertoire of the competition bone marrow chimeras, the selective forces that 
allow 35-1 Id+ cell enrichment are swamped. This important competition effect is also seen 
in the anti-HEL system, where it has been noticed that in the presence of “competing” B 
cells of other specificities, the MD2 Hc-only anti-HEL line produces few HEL-binding 
marginal zone cells. By contrast, in the absence of B cells bearing enodogenous 
specificities, the MD4 Hc+Lc anti-HEL line produces a large number of HEL-binding 
marginal zone cells (Mason, 1992; Martin, 2000b).
Several signalling pathways have been implicated in the formation, selection and 
maintenance of the marginal zone B cell subset. The co-receptor CD 19 seems to be 
essential for the production of marginal zone B cells (Martin, 2000b; Cariappa, 2001). By 
contrast, while expression of CD21 is important for the localisation of TI-2 antigens to the 
marginal zone (Guinamard, 2000), it is not required for the production of marginal zone B 
cells (Cariappa, 2000). The tyrosine kinase Btk (Bruton’s agammaglobulinemia tyrosine 
kinase) has been implicated in the enrichment process by which certain specificities in the 
8lx and M l67 transgenic lines accumulate in the marginal zone. Even though a marginal 
zone B cells can develop in Btk*ld animals, the enrichment process in 8 lx and M l67 
transgenic mice does not occur on a Btk?ld background (Martin, 2000b), suggesting that 
enrichment requires a certain level of BCR signalling. Cariappa and colleagues have 
presented a contrasting model in which “weaker” BCR-derived signals lead to more 
marginal zone B cells while “stronger” BCR-derived signals lead to an increased number of 
follicular B cells (Cariappa, 2001). In their view, the fact that Btk*7' mice show an greater 
ratio of marginal zone relative to follicular B cells suggests that marginal zone B cells 
develop to a greater extent when BCR signalling has been decreased. They also argue that 
marginal zone B cells are absent from Aiolos" mice, due to the fact that a negative 
regulator of BCR signalling has been lost so follicular B cell formation is favoured. The
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importance of signalling through BCR-associated mechanisms for recruitment into the 
marginal zone is also suggested by the finding that in anergic MD4 x ML5 mice, anti-HEL 
transgenic B cells constantly exposed to a self antigen are depleted from the marginal zone. 
By contrast, in the naive MD4 line anti-HEL transgenic B cells form a normal marginal 
zone subset (Mason, 1992). In this case decreased BCR signalling through the anergic 
BCR leads to fewer anti-HEL marginal zone B cells.
Other signalling pathways that are important for the formation and maintenance of 
marginal zone B cells involve the tyrosine kinase Pyk2, the GTP exchange factor (GEF) 
Lsc, trophic signals via BAFF receptors (BCMA, TACI and BAFF-R) and signals via 
NFkB.
The tyrosine kinase RAFTK/Pyk2 is related to Focal Adhesion Kinase and has been 
implicated in signalling by chemokine receptors, integrins, antigen receptors and ion 
channels (Avraham, 2000). In the absence of Pyk2, peripheral B cells show an intrinsic 
defect in marginal zone formation and fail to undergo chemotaxis to chemokines, 
suggesting Pyk2 may be part of the pathway that directs marginal zone B cells to or retains 
marginal zone B cells within their correct anatomical location. Connected to this is the 
finding that mice deficient for the GEF Lsc show reduced marginal zone B cells due to a 
lymphocyte-intrinsic defect (Girkontaite, 2001). This may be because normal marginal 
zone localisation requires the arrest of cell movement in response to blood-borne products, 
and Lsc1' mice show a defect in the serum-dependent inhibition of chemotaxis.
Marginal zone B cells are in close proximity with marginal zone macrophages and 
metalophilic macrophages, and the finding that the B cell survival factor BAFF (also 
known as BLyS, TALL, THANK, zTNF4) is expressed on monocytes, macrophages and 
dendritic cells (Moore, 1999; Schneider, 1999; Shu, 1999) raises the possibility that 
interactions with other cells is required for marginal zone B cell function. Interestingly, 
transgenic mice that over-express BAFF show B cell hyperplasia, particulary in the 
transitional type 2 and marginal zone compartments (Mackay, 1999; Batten, 2000). The 
signalling pathways responsible for the action of BAFF are not fully known, although 
reports suggest that BAFF is able to activate NF-kB and JNK (Do, 2000; Xia, 2000; Yan, 
2000). An absence of marginal zone B cells has been reported in NFicBp50' '  mice 
(Cariappa, 2000) and it may be that BAFF overexpression mediates its effects on marginal 
zone B cells via NFkB.
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B-1 B cells
The study of B-l phenotype B cells has been dominated by two competing theories. 
One, the “lineage” hypothesis, maintains that B-l cells represent a distinct lineage, 
abundant in fetal liver hematopoietic precursors but absent from adult bone marrow 
(Herzenberg, 2000). The alternative “instructive” theory maintains that the B-1 pool is 
derived from the same lineage as B-2 phenotype cells due to differences in antigen contact, 
selection and compensatory phenotypic changes (Wortis, 2001). Recent studies outlined 
below show the remarkable plasticity of phenotype choice among peripheral B cell clones 
in different situations, lending weight to the “instructive” hypothesis.
B-l B cells have a distinctive phenotype, they are self-renewing and are enriched in 
the pleural and peritoneal cavities of adult mice. They are CD5+ (B-l a only, B-lb cells are 
CD5'), IgMhi, IgD10, CD23lo/', CD43+, B220'° and CD1 lbhi (in the peritoneal cavity only) 
(Hayakawa, 1983). In contrast to B-2 follicular B cells, the B-l pool is enriched for B cell 
specificites directed against self antigens and bacterial antigens (Fagarasan, 2000b; Martin, 
2000a). These are directed against foreign antigens such as bacterial phosphorylcholine, or 
against self antigens such as phosphatidylcholine, immunoglobulin, DNA, and membrane 
proteins on erythrocytes and thymocytes (Fagarasan, 2000a; Herzenberg, 2000; Martin, 
2000a). B-l cells are thought to be important for the production of so-called “natural” IgM 
antibodies present in germ-free animals and for IgA production against commensal bacteria 
across intestinal mucosal surfaces (Macpherson, 2000), as well as T-independent responses 
to blood-borne antigens (Martin, 2001).
The B-l subset represents a more heavily selected subset than normal mature 
follicular B cells and selection of specific clones into the B-l subset is exquisitely sensitive 
to alterations in BCR signal transduction. For example, mutations in negative regulators of 
BCR signalling such as SHP-1 (Cyster, 1995) and CD72 (Pan, 1999) tend to increase the B- 
1 pool, while mutations in positive regulators of BCR signalling such as Btk (Khan, 1995), 
CD19 (Engel, 1995; Inaoki, 1997), Cr2 (Aheam, 1996), BLNK (Xu, 2000) and PLC-y2 
(Hashimoto, 2000) decrease the B-l pool. Among individual clones this effect is clearly 
seen. For example, the anti-HEL MD4 transgenic contains essentially no B-l antigen- 
specific cells. When BCR signalling is altered by the removal of the negative regulator 
SHP-1, many antigen-specific B-l cells appear in the peritoneal cavity (Cyster, 1995). The 
modulation of BCR signalling in converting B-l and B-2 B cells can work both ways. For 
example, transgenic mice expressing a rearranged Vh12 heavy chain generate 
predominantly B-l B cells. Decreasing the strength of BCR signalling by crossing onto a 
Bt\?'d background leads to most B cells adopting a B-2 phenotype (Clarke, 1998). The 
finding that certain transgenic clones can be manipulated to generate both B-l and B-2
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phenotypes and the finding that in vitro stimulation of B-2 cells can lead to upregulation of 
CD5 (Cong, 1991), suggests that antigen-driven selection is a major factor directing B cell 
entry into the B 1 subset. The importance of antigen contact for recruitment of anti­
thymocyte B-l cells into this pool was elegantly demonstrated by Hayakawa and colleagues 
using heavy chain transgenic animals crossed to Thy-1 deficient mice (Hayakawa, 1999).
In the absence of the selecting antigen, B-l a Thy-1 reactive cells were absent.
1.2 (e) Memory B cells
Memory B cells represent a poorly defined subset that are traditionally described as 
antigen-experienced B cells responsible for heightened “memory” or “recall” antibody 
responses to thymus-dependent (TD) antigens. The generation, maintenance and 
phenotypic and functional characteristics of memory B cells will be dealt elsewhere (see 
section 1.4 (b)). Recently the B-l and marginal zone B cell subsets have been termed 
“natural memory” cells, on account of these subsets being enriched for both self-reactive 
and foreign-reactive B cell clones (Martin, 2000a). This is an extension of an earlier idea 
the evolutionary pressure has maintained certain B cell specificities because of their ability 
to react to common pathogens (Decker, 1992; Klinman, 1998). As discussed previously in 
section 1.2 (d), there is good evidence that antigen exposure is responsible for the 
enrichment of self and foreign reactive cells in the B-l subset. Marginal zone B cells also 
have an activated phenotype, make a rapid response to blood-borne antigens and may be 
selected into that subset by prior antigen contact. Another traditional “memory” feature, 
that of long lifespan, may also be shared by B-l and marginal zone subsets. When the 
production of new B cells in the bone marrow is disrupted in adult mice by the conditional 
targeting of the RAG2 gene, both B-l and MZ subsets persist at stable levels (Hao, 2001). 
This may be due to continual cell homeostatic cell division rather than intrinsically long 
lifespans, but the effect is the same -  a pool of antigen-reactive cells poised to respond to 
infection.
1.2(f) Plasma cells
Plasma cells (PC) represent the terminally-differentiated effector stage of the B cell 
lineage. Phenotypically they are dedicated to the secretion of antibody and are B220*° 
(Smith, 1996), syndecan-l+ (Sanderson, 1989), CD38hl (human) (Arpin, 1997), CD38' 
(mouse) (Oliver, 1997b; Ridderstad, 1998), Class II MHC‘, J-chain+, surface-Iglo/‘ (Smith, 
1997) and immunoglobulin-secreting. PCs are formed by two major routes during immune 
responses. TI and TD antigens both induce the early formation of PCs in extrafollicular 
foci and the red pulp of the spleen or the lymph node medullary cords. The majority of
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these PCs are short lived (Ho, 1986), with most undergoing apoptosis in situ (Smith, 1996). 
In addition, TD antigens are also capable of driving the formation of germinal centres, 
which also lead to PC production and the subsequent production of high affinity antibody. 
Most PC derived from germinal centres home to the bone marrow, have a longer lifespan 
(Ho, 1986; Manz, 1997; Slifka, 1998b), and are thought to be critical for the maintenance 
of long-term protective immunity (Benner, 1981; Slifka, 1998a). The localisation of PC in 
extrafollicular sites in secondary lymphoid tissue as well as the bone marrow has recently 
been attributed to changes in chemokine responsiveness. PCs lose chemotactic responses 
to CXCL13, CCL19 and CCL21, while becoming more responsive to CXCL12, the 
CXCR4 ligand expressed in extrafollicular sites in the spleen and lymph node, as well as in 
the bone marrow (Hargreaves, 2001).
B cell terminal differentiation involves reciprocal regulation of the transcription 
factors Pax-5 and Blimp-1. Pax-5 is downregulated during terminal differentiation 
(Morrison, 1998) and over-expression of Pax-5 in vitro in B cell lines represses expression 
of syndecan-1 and high levels of Ig secretion (Usui, 1997). Blimp-1, by contrast, drives 
plasma cell differentiation, both in vitro (Turner, 1994) and in vivo (Angelin-Duclos, 2000), 
in part by repressing expression of c-myc (Lin, 1997). Plasma cell differentiation can be 
postponed in some circumstances, for example during the germinal centre reaction, where 
activated B cells undergo rounds of selection and hypermutation rather than terminal 
differentiation. It seems that Bcl-6, a transcription factor expressed highly in germinal 
centre cells (Shaffer, 2000; Shaffer, 2001) actively represses Blimp-1 expression, halting 
terminal differentiation (Reljic, 2000). This may be the mechanism behind observations 
that combinations of a variety of signals likely found in the germinal centre (BCR, CD40 
ligation, some cytokines) can inhibit terminal differentiation (Randall, 1998; Knodel,
2001). The extrapolation of these in vitro studies to the selection environment of the 
germinal centre is difficult, however, especially given the tightly regulated, transient 
expression of these selecting factors in vivo (Yellin, 1994; Casamayor-Palleja, 1995).
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Figure 1-2. B cell subsets in the periphery
This diagram shows the phenotype and putative relationships between the various B cell 
subsets of the periphery, from transitional type 1 recent emigrants to the mature follicular 
and marginal zone subsets. Signalling mutants in which the formation of these subsets is 
disrupted are indicated, as is the cell surface phenotype of each subset. Solid lines 
represent development pathways that are well understood, dashed lines represent less well 
characterised transitions.
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Section 1.3. B cells in primary immune responses
Naive mature B cells are capable of two main pathways of differentiation. During an 
immune response they are induced by a variety of signals to become either memory B cells, 
or to terminally differentiate into antibody-secreting plasma cells.
1.3 (a) T-independent immune responses
B cell responses to some antigens do not require thymus-derived MHC Class II- 
restricted aß T cells. The antigens that cause TI responses comprise polyclonal B cell 
activators such as LPS, and antigens such as bacterial polysaccharides composed of 
repeated antigenic epitopes thought to induce strong BCR cross-linking (Mond, 1995). 
These antigens do not normally induce classical B cell memory, but may induce isotype 
switching, predominantly producing IgM and IgG3. This thesis deals with a T-dependent 
system, so the rest of this introduction will describe properties of B cells associated with 
TD antigens.
1.3 (b) T-dependent immune responses
In contrast with TI antigens, T-dependent (TD) antigens are characterised by their 
ability to associate with MHC molecules on the surface of activated antigen-presenting 
cells to allow antigen-specific T cells to be recruited into an immune response. Through 
recruiting antigen-specific B cells, the TD response leads to immunological memory, 
protective immunity and high affinity antibody production through antigen-driven selection 
in germinal centres.
Activation of antigen-specific B and T lymphocytes
TD responses are initiated by antigen trafficking from sites of infection to secondary 
lymphoid tissue by dendritic cells (DCs) in peripheral tissues that take up antigen as they 
sample the local environment. Through “danger” signals associated with the infectious 
agents such as inflammatory chemokines and microbial products DCs are induced to 
mature functionally, upregulate co-stimulatory molecules and migrate to the T cell-rich 
areas of local lymphoid organs (Cyster, 1999). Migration of activated DCs to the T-cell 
rich paracortex of lymph nodes and the periarteriolar lymphoid sheath (PALS) of spleen 
facilitates antigen-mediated recruitment of CD4+ helper T cells into the response.
General Introduction 25
Antigen-specific helper T cells are primed by DCs via a lengthy specific engagement 
of T cell receptor with peptide bound to MHC Class II molecules on the surface of the DC 
(Grakoui, 1999; Bromley, 2001). T cell priming leads to increased responsiveness to the 
chemokine CXCL13 and decreased responsiveness to the chemokines CCL21 and CCL19 
(Ansel, 1999). This allows activated T cells to accumulate near the boundary of the B cell 
follicle and PALS at the site of initial contact with antigen-stimulated naive B cells (van 
den Eertwegh, 1993; Toellner, 1996; Garside, 1998). This change in chemokine 
responsiveness also allows the eventual accumulation and expansion of helper T cells in the 
follicle required to sustain germinal centres (Kearney, 1994; Gulbranson-Judge, 1996;
Ansel, 1999; Garcia de Vinuesa, 2000). Naive antigen-specific B cells, by contrast, are 
activated by exposure to soluble antigen picked up from the blood or afferent lymph, and 
also change their distribution pattern to home to the border of the B cell follicle and PALS, 
probably in response to chemokine gradients (Cyster, 1999). Antigen-specific B cells are 
able to trap and process antigen to helper T cells in a highly specific way (Lanzavecchia,
1985), but in the naive state are poor APCs, lacking co-stimulatory function and requiring 
primed T cell help (Parker, 1993).
As well as antigen-specific contacts, both T cell and B cell activation requires a 
variety of positive and negative “co-stimulatory” signals. These reinforce the 
collaborations made by DC, T and B cells and are essential for the normal spectrum of TD 
antibody responses by ensuring the full activation of antigen-specific cells. Positive “co­
stimulatory” pairs important for the priming phase of a TD antibody response include 
CD28/B7.1, B7.2 (Freeman, 1993a; Freeman, 1993b; Shahinian, 1993; Borriello, 1997), 
CD40/CD40L (Foy, 1993; Kawabe, 1994; Renshaw, 1994; Xu, 1994; Foy, 1996), 
OX40/OX40L (Murata, 2000) and ICOS/B7h (B7RP-1) (Swallow, 1999; Yoshinaga, 1999; 
Dong, 2001; McAdam, 2001; Tafuri, 2001). Co-stimulatory signalling also provides for 
negative regulation of immune responses via related molecules such as CTLA-4 (Tivol, 
1995; Waterhouse, 1995) and PD-1 (Nishimura, 1999). In addition, censoring mechanisms 
are active to stop the activation of overtly self-reactive cells. For example, anergic B cells 
are deficient in providing co-stimulatory signals to T helper cells (Ho, 1994), and so are 
unable to prevent apoptotic cell death via Fas ligation (Rathmell, 1995; Rathmell, 1996).
Extrafollicular antibody responses
The interaction of antigen-specific B cells with T cell help leads to two pathways of B 
cell differentiation. Extrafollicular foci of antigen-specific plasmablasts form relatively 
early during many responses near bridging channels (also known as “junction zones”) 
where the splenic marginal zone intersects the PALS (Jacob, 1991; Liu, 1991; Jacob, 1992;
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Sze, 2000). These foci differentiate into plasma cells over the next 2-6 days and produce 
unmutated, low affinity antibody (Smith, 1997), but most are lost from the spleen in a wave 
of apoptosis shortly afterward (Smith, 1996). A few plasma cells can persist in this site for 
several weeks (Ho, 1986; Sze, 2000). This early production of antibody is important for 
defence against infection, and for providing immune complexes to stimulate other arms of 
the immune system, allowing antigen to be trapped by follicular dendritic cell networks.
The signals that direct B cells to the extrafollicular differentiation pathway are poorly 
understood. In one study using polyclonal blocking antisera against 0X40 it was proposed 
that T cell 0X40 and B cell OX40L interaction was required for the development of 
extrafollicular foci but not for germinal centres (Stuber, 1996). Recently this study has 
been reinterpreted by Lane and colleagues, who believe that the blocking sera used in the 
previous work was engaging 0X40 on activated T cells and driving them into a follicular 
pathway of differentiation (Walker, 1999). It is tempting to speculate that even if 
OX40/OX40L signalling is not directing B cells to the extrafollicular reaction, the 
temporally regulated movement of most activated T cells into B cell follicles (Kearney, 
1994; Gulbranson-Judge, 1996; Ansel, 1999) sets a time limit for the recruitment of antigen 
specific B cells into the extrafollicular response. The other critical factor is probably the 
availability of free antigen that is complexed quickly by the first wave of antigen-specific 
antibody from the foci themselves (Liu, 1991).
Plasmablasts in extrafollicular foci do not associate with antigen-specific T cells 
(Jacob, 1991; Gulbranson-Judge, 1996) and the reaction does not require CD40 ligation for 
maintenance (Han, 1995a). Instead, myeloid-derived CD1 lchl “plasmablast-associated” 
dendritic cells (PDCs) have been co-localised with extrafollicular foci, and experimental 
manipulations that increase the number of these PDCs tend to increase the ability of the 
spleen to support plasma cells (Garcia de Vinuesa, 1999). This may have relevance to the 
extrinsic factor that places a ceiling on the capacity of the spleen to support plasma cells, at 
least in the response to the hapten NP (Sze, 2000).
Much of our knowledge about the extrafollicular focus reaction comes from the 
response of mice to the hapten NP. Other model systems, such as the primary anti-Ars 
response in A/J mice (Vora, 1998) or the anti-DNP primary response in rats (Liu, 1991) do 
not generate many foci. Also, many anti-protein primary responses do not generate 
significant antigen-specific IgM (Metzger, 1984; Nossal, 1989). The reasons behind this 
diversity probably include different antigen-specific precursor B cell frequencies in 
unimmunised mice (Press, 1974; Stashenko, 1980; Toellner, 1996), as well as varying 
grades of tolerance to protein and hapten antigens which may cross-react with self-antigens 
to some degree (Nossal, 1989; Nossal, 1990; Vora, 1998).
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Germinal centre reactions
Germinal centres (GCs) are critical for generating high-affinity memory B cells and 
long-lived plasma cells during TD responses (MacLennan, 1994; Kelsoe, 1995). They 
begin to form — 4 — 10 days after the immune response is initiated (Liu, 1991) when as few 
as 3-5 (Liu, 1991; Jacob, 1992) B cell blasts move from the boundary of the B/T cell zones 
into B cell follicles and begin a process of exponential expansion, with a cell division rate 
of ~6-7 hours (Zhang, 1988; Liu, 1991). The signal required for the initial nucleation of the 
GC is not understood, as the centroblast pool can form in the absence of T cell help (Garcia 
de Vinuesa, 2000) and functional GCs can form in the absence of detectable immune 
complex deposition (Hannum, 2000). Anatomically, mature GCs consist of a “dark zone” 
of centroblasts that undergo somatic hypermutation to generate the raw material upon 
which antigen-driven selection takes place. Centroblasts that exit cell cycle and re-express 
somatically mutated antigen receptors are known as centrocytes. These move into the 
“light zone” of the germinal centre that is filled with antigen-specific T cells, follicular 
dendritic cells and tingible body macrophages, where the processes of selection and affinity 
maturation take place (MacLennan, 1997).
The somatically mutated centrocytes are thought to compete for access to antigen 
depots on FDCs and then receive “rescue” signals from antigen-specific T cells, which 
make up 5-10 % of the GC (Gray, 1997) and are located toward the outer face of the “light 
zone” (Casamayor-Palleja, 1995). There is evidence that GC-resident T cells have special 
qualities, such as the ability to rapidly mobilise CD40L expression upon TCR engagement 
(Casamayor-Palleja, 1995), as well as distinct cytokine and co-stimulatory profiles 
(Breitfeld, 2000; Schaerli, 2000; Kim, 2001). The CD40/CD40L pathway has been 
implicated in this process, as in vivo blockade using mAh led to the rapid dissolution of 
established GCs (Han, 1995a). After interaction with antigen specific T cells three choices 
are available for the B cell. Some probably re-enter the centroblast pool to undergo further 
rounds of somatic mutation to sustain the germinal centre (Casamayor-Palleja, 1996; Garcia 
de Vinuesa, 2000). Alternatively, memory B cells or long-lived plasma cells secreting 
high-affinity antibody can be formed. The nature of the selective signals that determine 
memory cell versus plasma cell differentiation are poorly understood, however in vitro 
reports suggest that the relative engagement of CD40 on human GC B cells determines 
whether the memory or plasma cell pathway is induced (Arpin, 1995).
Apoptosis is the default pathway for B cells that have low affinity or overtly self­
reactive antigen receptors (Han, 1995b; Pulendran, 1995; Shokat, 1995). The signals 
leading to apoptosis of lower affinity and autoreactive B cells is obscure. An early report 
suggested that Fas-mediated apoptosis was not a factor, despite expression of Fas/FasL in
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the GC, as Faslpr mice still produced memory B cells and high affinity AFCs (Smith, 1995). 
A recent study has re-opened the possibility that Fas does play a part in selection, as 
memory B cells in Faslpr mice accumulate many more somatic mutations (Takahashi,
2001). The role of Bcl-2 in the selection process is also interesting, as Bcl-2 
overexpression increases the recruitment of lower-affinity memory B cells (Smith, 1994), 
but the selection of high-affinity bone marrow AFCs is not affected. This may point to 
different antigen-driven selection processes, one involving a “competitive” selection of 
memory cells that can be overcome by simply inhibiting apoptosis, and the other involving 
a “threshold” affinity selection of plasma cells (Smith, 2000).
Isotype switching: mechanism and signals
Isotype switching is the process by which antibody production is diversified to 
include a range of alternative effector functions as well as allowing expression of different 
molecular forms of the BCR. The switch of antibody isotype profile from IgM to IgGi 
especially is a hallmark of the TD response to protein and hapten antigens (Nossal, 1989; 
Toellner, 1996).
Switching involves the recombination of immunoglobulin heavy chain variable 
region gene segments upstream of alternative constant region genes, and is an irreversible 
differentiation step. In the mouse, the IgH locus on chromosome 12 is arranged with heavy 
chain constant region exons in the order 5’ p - 6 - y3 - yl - 72b - 72a - e - a  3’ (Coffman, 
1993). Switch regions consisting of GC-rich tandem repeats located upstream of every 
constant region section (except 5) provide the sites for recombination, which most 
commonly involves the excision of a DNA loop containing the heavy chain constant region 
genes between the donor and acceptor points. In this way secondary switch recombination 
to downstream constant region genes is possible but upstream gene segments are lost.
The specificity of switch recombination lies in the signals that regulate the production 
of germline transcripts from the various downstream contant regions. Many of these are 
derived from cytokines and have been studied extensively in vitro, for example, in murine 
B cells IL-4 promotes IgGl and IgE switching and IFN-y promotes IgG2a and IgG3 
switching (Snapper, 1987; Coffman, 1993; Stavnezer, 2000). In vivo evidence for the 
effect of these cytokines on switch recombination includes studes in knockout mice (Kuhn, 
1991) and the cytokine-mediated deviation of normal isotypes in model immune responses 
(Finkelman, 1988; Buchanan, 1995). Engagement of CD40 on B cells by CD40L on 
activated T helper cells is also required for isotype switching to isotypes produced during 
TD responses. This is highlighted by the absence of switched isotypes in humans (Allen,
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1993; Aruffo, 1993; DiSanto, 1993; Korthauer, 1993) and mice (Allen, 1993; Aruffo, 1993; 
DiSanto, 1993; Korthauer, 1993) with crippled CD40 signalling pathways.
There may be multiple sites of isotype switching during a normal TD immune 
response. An early report suggested that switching took place in the germinal centre, on the 
basis that the majority of germinal centre PNAhl cells were IgM+ in the primary response 
but IgG+ in the secondary response to heterologous red blood cells (Kraal, 1982). In 
keeping with this, analysis of sorted subsets of human tonsillar B cells suggested that 
germline transcripts were found most abundantly in germinal centre centrocytes (Liu,
1996b) and it was hypothesised that switching at this point reduces the risk of potentially 
self-reactive B cells acquiring new effector functions. The chronic immune response of the 
human tonsil is difficult to compare with response in experimental animals and data from 
mice immunised with hapten-carrier conjugates is more consistent with the induction of 
isotype switching prior to entry into germinal centres. Jacob et al. showed that isotype 
switching in extrafollicular foci was relatively synchronous in NP-CGG primary responses 
and all germinal centres were populated by IgG+ cells (Jacob, 1991). In a similar study, 
Toellner et al. showed that the induction of yl germline transcripts was a very rapid event 
that coincided with B/T collaboration in the outer PALS, at least for CGG-specific memory 
cells (Toellner, 1996). The earlier induction of switch recombination in this model is 
proposed to be a more effective way of producing IgG, as switch recombination occurs 
prior to major periods of clonal expansion at extrafollicular sites or germinal centres.
The remnants of an immune response -  memory B cells and long-lived 
plasma cells.
One of the most striking features of the adaptive immune system is the ability to 
provide protective immunity for many years after a primary immune response. This is a 
combination of the presence of antigen-specific “memory” cells and the high titres of 
antigen-specific antibody provided by long-lived plasma cells in the bone marrow, both of 
which will be considered in more detail in the next section.
Section 1.4. Memory cells and memory responses
Humankind has been familiar with the concept of immune memory for over 2000 
years and it has been frequently noted that those who survived a disease were often 
“exempt” (“immunatis”) from its effect during a second epidemic (Silverstein, 1989). 
Early scientific observations of long-term immunity include the famous case of two
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measles epidemics on the remote Faroe Islands. Ludwig Panum, a Danish physician 
observed that no-one affected by measles in the 1781 epidemic was afflicted with the 
disease during a second epidemic in 1846, 65 years later (Matzinger, 1994; Ahmed, 1996).
Despite the very real practical benefit of immune “memory” in the successful design 
of vaccines, a clear understanding of its cellular and molecular basis is still elusive. There 
is significant debate about the mechanisms of immune memory and the mechanisms for the 
persistence of the memory state.
1.4 (a) Early observations on the nature of immune memory
Memory responses to TD antigens are characterised by the rapid formation of high 
titres of high affinity isotype-switched antibody, and these features have been observed 
experimentally since the early 1900s (Glenny, 1931; Freund, 1953). In his writing on 
“Active Immunisation with Toxin”, Glenny states:
“The essential difference between primary and secondary stimulus response lies in the duration o f the 
latent period and in the amount of antitoxin produced.” (Glenny, 1931)
Experiments in a number of different animal models showed that secondary antibody 
responses were much more rapid than primary responses and led to much higher titres of 
antigen-specific antibodies (Burnet, 1949; Freund, 1953; Dixon, 1954; Burnet, 1959). In 
addition, the dominance of IgG over IgM in the secondary response was noted. Starch 
block electrophoresis (Tiselius, 1938) and analytical ultracentrifugation (Heidelberger, 
1936) of serum proteins showed pre-immune sera contained a predominant antibody 
species o f-180,000 Da (sedimentation coefficient 7S) and a minor antibody form of 
- lx l  06 Da (sedimentation coefficient 18S). The relative levels of these antibody species 
were found to vary during the course of an immune response and a switch from 18S (IgM) 
to 7S (IgG) antibody production was described using a number of protein (Bauer, 1961) 
and particulate antigens (Stelos, 1957; Uhr, 1962).
Early models viewed the changes during the secondary response as being due to the 
physical release of pre-synthesised antibody, rather than fresh antibody production 
(Pauling, 1940). An important conceptual change came from the views of Burnet and 
Fenner (Burnet, 1949) in which the logarithmic rise in antibody during a secondary 
response was interpreted as evidence for the multiplication of antibody-producing units in 
the body. This was further developed in Burnet’s “Clonal Selection Theory” of antibody 
formation (Burnet, 1959) in which clones of cells carrying antigen-reactive receptors were 
selected to participate in an immune response. Burnet provided a simple explanation for 
memory responses with the statement:
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“The primary stimulus finds only a few examples of the appropriate clones; by the time of the 
secondary stimulus many more individuals of the selected clones are accessible.” (Burnet,
1959)
This is an important theme in immune memory that is still debated, as it is still not 
clear to what extent memory responses can be explained by the increased clonal precursor 
frequency of reactive cells resulting from prior contact with antigen (Celada, 1971; Freer, 
1995; Ahmed, 1996). Some reports concluded that the rate of clonal expansion and 
antibody production on a per cell basis was equal during the primary and secondary 
immune responses (Uhr, 1961). Burnet hinted, however, that he did not accept this simple 
explanation, and described the primary response as a “tooling-up” event that alters the 
immune system in a more fundamental way to account for the special characteristics of the 
secondary response (Burnet, 1959).
After the discovery that the small lymphocyte was the carrier of immune memory 
(Gowans, 1966), cellular theories of memory antibody responses invoked the linear 
differentiation of naive lymphocytes into antigen-experienced cells (Sercarz, 1961; 
Makinodan, 1963; Sterzl, 1967; Celada, 1971). According to these models, re-encounter 
with antigen led to the terminal differentiation of antigen-experienced cells into antibody- 
secreting plasma cells. Importantly this focused attention on the changes induced in 
lymphocytes upon encounter with antigen that led to the propagation of memory.
It is now generally agreed that there are both phenotypic and functional differences 
between naive and “antigen-experienced” or “memory” B and T lymphocytes. Despite this, 
it has been difficult to address the importance of these changes versus the simple increase 
in reactive cell frequency. Both of these processes are tightly connected with antigen 
priming during the primary response.
1.4 (b) Current issues in the study of immune memory
The two most important questions in immune memory are difficult to separate. 
Firstly, it is unclear what mechanism allows for the long-term maintenance of the memory 
state. Secondly, it is not known which of the phenotypic and functional changes that 
accompany the memory state are important for the heightened responses seen upon re­
encounter with antigen.
Mechanisms for the persistence of the memory state
Various theories to account for the persistence of the memory state have been 
proposed and they can mostly be placed on a spectrum between the following two
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extremes. On one side, memory results from the increased frequency of special antigen- 
specific B and T lymphocytes that carry enhanced reactivity toward antigen and are 
maintained in the absence of antigenic stimulation because of an intrinsically long lifespan. 
At the other end of the spectrum, memory simply reflects an increased frequency of 
antigen-specific lymphocytes that are constantly or intermittently stimulated to become 
effectors by persistent pathogens, reinfection, depots of processed antigens, bystander 
effects due to other immune responses or interaction with cross-reactive self-antigens. 
Elements of both of these theories appear to be true, as memory cells themselves do not 
seem to require contact with specific or cross-reactive antigen to be maintained, however 
continual antigen contact may be critically important for protective serum antibody 
production (Benner, 1981; Ahmed, 1996; Slifka, 1998a; McHeyzer-Williams, 1999). This 
notion may fit with the idea of the memory “stem cell” (Fearon, 2001). Under this 
definition, memory cells responsible for the maintenance of the memory state would have 
stem cell properties and self-renew by some mechanism, while presumably producing 
effector cells in an asymmetric division process like hematopoietic stem cells in the bone 
marrow.
A number of viral infections are either chronic (e.g. herpes viruses) or subject to 
repeated re-exposure (e.g. influenza), providing a potential mechanism for the intermittent 
restimulation of memory cells. However, memory to non-replicating antigens such as 
proteins also exists. In the late 1960’s it was shown that small amounts of intact protein 
antigen could persist in lymphoid tissues for months after immunisation (Nossal, 1971; 
Tew, 1979). This was in the form of immune complex, which were hypothesised to allow 
for the continual stimulation of antigen-specific B (Tew, 1990) and helper T cells (Gray, 
1991a) to maintain a state of memory. Subsequent cell transfer experiments by Gray and 
Skarvall (Gray, 1988) and Gray and Matzinger (Gray, 1991b) showed that both functional 
B and T cell memory declined rapidly with a half-life of around three weeks in the apparent 
absence of antigen. However, other studies estimated the lifespan of memory cells and 
concluded that only ~10 % of the memory B cell population is in active cell division at any 
one time (Schittek, 1990). This is difficult to reconcile with the cell transfer experiments 
and is more consistent with memory B cells being relatively quiescent and stimulated into 
cell division infrequently. One possibility is that Gray and Skarvall measured the decline 
of primed effector B cells by sampling the thoracic duct lymph, as many memory cells are 
in fact non-recirculating and found in sites such as the splenic marginal zone (Liu, 1988; 
Liu, 1991).
The view that contact with specific antigen is not required for memory cell 
persistence has received recent support. For example, B cell memory can be maintained in 
follicular dendritic cell-deficient mice (Karrer, 2000) and in the absence of T cell help
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[Vieira, 1990 #18]. Also, in elegant recent experiments, Maruyama and colleagues used 
inducible gene targeting to switch the antigenic specificity of memory B cells in immunised 
mice to an antigen unrelated to the immunogen (Maruyama, 2000). They found that 
“memory” B cells expressing the new specificity were retained at constant levels for up to 9 
months after the specificity switch. This suggests that, in the complete absence of specific 
antigen, memory B cells can persist for very long periods. The only caveat to this 
experiment is that the decay of these cells over time was not compared to naive B cells 
expressing the same anti-PE specificity. As the half-life of mature recirculating naive B 
cells is of the order of months (Gray, 1988; Forster, 1990; Hao, 2001), the study should 
have ruled out the possibility that the new specificity had a long intrinsic lifespan unrelated 
to its priming status. A “News and Views” article describing this study is presented in 
Chapter 9 as an appendix. Finally, both CD4+ and CD8+ T cell memory has been shown to 
persist when memory T cells are transferred into MF1C-deficient recipient mice (Murali- 
Krishna, 1999; Swain, 1999), suggesting T cell memory can persist in the absence of 
specific or cross-reactive antigen.
As well as the maintenance of memory cells, the memory state includes “protective 
immunity” in the form of elevated titres of antigen-specific antibody (Black, 1961; Benner, 
1981; Simonsen, 1984; Ahmed, 1996). The half-life of bone marrow resident plasma cells 
is over 100 days (Manz, 1997; Slifka, 1998b). This places much less of a burden on the 
memory pool to constantly replenish plasma cells, and the finding that 10 % of memory B 
cells are engaged in cell division (Schittek, 1990) may allow sufficient differentiation to 
maintain the required numbers to sustain antibody production. In summary, while specific 
antigen persistence is not required for simple memory cell maintenance, it may be critically 
important for maintaining protective serum antibody levels. Much of the data concerning 
the maintenance of the memory state could then be reconciled by acknowledging the 
contributions of relatively quiescent “stem-cell like” memory cells as well as the continual 
low level production of long-lived plasma cells in response to persisting antigen.
Memory B cell phenotypes and locations
One of the phenotypic markers associated with a subset of memory B cells is the 
expression of switched isotype BCRs. This correlation was established by early cell 
transfer experiments demonstrating the enrichment of IgG+ antigen-specific B cells in 
primed lymphocyte mixtures and the importance of those cells for transferable memory 
(Black, 1977; Coffman, 1977; Yuan, 1977; Zan-Bar, 1977, Okomura, 1976 #253; 
Kanowith-Klein, 1979; Yefenof, 1985; Yefenof, 1986). For many years the expression of 
an isotype-switched BCR was the most unequivocal marker for memory B cells (Mackay,
34 Chapter 1
1993), and has been used in this capacity in several recent experiments (Hayakawa, 1987; 
Maruyama, 2000). Studies on human peripheral blood B cells, however, have broadened 
the definition of memory B cells with respect to BCR isotype. The presence of IgM* IgD' 
(Klein, 1997) and IgM4̂ IgD+ B cells (Klein, 1998) carrying somatic mutations and 
phenotypic markers such as CD27 shows that memory B cells do not have to carry 
switched isotype receptors. In rodents, some marginal zone-resident memory B cells also 
bear unswitched receptors (Liu, 1988), but most undergo switch recombination quickly 
during a secondary response (Toellner, 1996). The range of switched and non-switched 
isotypes expressed by somatically mutated B cells means the “gold standard” criterion for a 
memory B cell is now the expression of a somatically mutated BCR, showing signs of 
antigen-driven selection.
As well as BCR isotype, memory B cells have been ascribed other phenotypic 
markers, to the extent that there may be several phenotypic “subsets” of memory B cell, 
perhaps depending on their location. In humans, memory B cells have been described as 
CD27+ (Klein, 1998; Tangye, 1998), CD148+ (Tangye, 1998) and IgD' CD38' CD20+ 
CD39+ CD44+ (Bm5 tonsil subset) (Arpin, 1995; Liu, 1996a, Liu, 1995; Arpin, 1997). In 
addition human tonsil memory cells constitutively express CD80 and CD86 and can act as 
efficient APCs in vitro (Liu, 1995). A similar result has been reported for human 
peripheral blood memory B cells, where distinct CD27+ CD80' and CD27+ CD80+ subsets 
have been identified (Bar-Or, 2001).
In the mouse memory B cells lose CD38 expression (Oliver, 1997b; Ridderstad, 
1998). Interestingly, two recent studies in mouse have identified putative B220' memory B 
cells produced in response to immunisation with the hapten NP (McHeyzer-Williams,
2000; Driver, 2001). These have a B220', NP-binding, CD1 lb+, IgG+, CD24", CD 19" and 
CD22' phenotype and may be functionally distinct from B220+ memory B cells, forming 
plasma cells more rapidly upon in vitro culture.
The explosion of phenotypic definitions for memory B cells seems to reflect an 
underlying diversity in the memory B cell pool and may reflect a central theme in B and T 
cell memory. A similar diversity has recently been shown for memory T cells, with the 
description of CCR7+ “central” memory and CCR7' “effector” memory cells that show 
distinct patterns of activation and cytokine production (Sallusto, 1999).
The most radical phenotypic distinction attributed to memory B cells comes from 
Klinman and colleagues who reported that memory B cell precursors in the mouse are 
enriched within the J1 ID10 (CD2410) pre-immune B cell repertoire (Linton, 1989). They 
speculated that memory B cells and primary antibody-forming cells form distinct lineages
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(Ahmed, 1996; Klinman, 1997). Despite this, studies have shown a common clonal origin 
for plasma cells in extrafollicular splenic foci and germinal centre B cells, suggesting that a 
single B cell clone can seed both memory and AFC pathways (Jacob, 1992).
Memory B cells reside in a number of anatomical locations, including the blood 
(Klein, 1997; Klein, 1998; Bar-Or, 2001), the splenic marginal zone (Liu, 1988; Tierens, 
1999) and similar areas in the tonsil (Liu, 1995) and Peyer’s patch (Spencer, 1985). They 
have been termed “sessile” or non-recirculating (MacLennan, 2000) and seem to be absent 
from normal follicles (Küppers, 1993). Despite this, Strober reported that thoracic duct 
lymphocytes passaged through a secondary host could adoptively transfer memory to a 
third animal (Strober, 1975) and Bachmann and colleagues showed that memory cells to 
VSV can move to other areas of the animal (Bachmann, 1994).
Mechanisms for the features of the memory response
A number of interconnected changes that accompany antigen priming have been used 
to explain the unique features of the memory response.
The simplest explanation for the rapid memory response is that antigen-specific B 
and T cells are maintained at elevated frequencies compared to the pre-immune repertoire 
(Ahmed, 1996; Doherty, 1996). For B cells, several studies have shown elevated 
frequencies of anti gen-specific IgG+ memory cells of between 0.01-0.07 % of total 
splenocytes under various immunisation regimes (Hayakawa, 1987; Schittek, 1990; 
McHeyzer-Williams, 1991; Smith, 1994; Kaisho, 1997; Maruyama, 2000). Early 
objections to the idea that memory could be carried by IgG+ B cells (Zan-Bar, 1979) 
stemmed from their low frequency in normal animals where they seldom account for more 
than 1-2 % of lymphocytes (Gray, 1993). It was reasoned that large proportions of IgG+ B 
cells should accumulate over the lifetime of an animal if they were solely responsible for 
memory. To a large extent this problem has been solved by the observations that a large 
fraction of human peripheral blood B cells are non-switched memory cells (Klein, 1997; 
Klein, 1998) and many non-switched marginal zone memory cells rapidly switch isotype 
during a secondary response in mice (Toellner, 1996). It has also been proposed that 
memory B cells are poised to rapidly produce plasma cells and so are biased towards 
terminal differentiation, a mechanism that might stop “repertoire freezing” due to the 
accumulation of too many memory cells (Arpin, 1997). This finding may also explain the 
dominance of extrafollicular focus reactions over germinal centre formation during the 
secondary response, as memory cells are poised to differentiate into plasma cells rather than 
seed GCs (Liu, 1991; Arpin, 1997; Vora, 1998).
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As well as increased frequency, other phenotypic and functional changes play a role 
in the rapid initiation of memory responses. As discussed earlier, memory B cells localise 
to antigen-draining sites and are rapidly mobilised to migrate to the outer PALS upon 
antigen binding (Liu, 1991). This, coupled with the ability to drive the secondary response 
as APCs, by virtue of high affinity antigen receptors and the rapid up-regulate co­
stimulatory molecules (Liu, 1995; Bar-Or, 2001), means memory B cells play a more active 
role in initiating the secondary response. This may be one reason why immuno-stimulatory 
adjuvant is not usually required for the induction of a memory response (Liu, 1991; 
McHeyzer-Williams, 1991; Kaisho, 1997). In the same way, memory T helper cells show a 
number of phenotypic changes, including more efficient activation and cytokine secretion 
as well as a faster rate of cell division (Rogers, 2000).
The rapid initiation of memory responses is easy to envisage, given the qualitative 
and frequency differences of memory cells versus naive cells. However it is not so obvious 
how multiple logio increases in the amount of antibody can be produced during the 
secondary response, especially in light of recent evidence that there are extrinsic factors in 
the spleen that limit the survival of plasma cells (Sze, 2000). Also the effective antigen 
dose driving the response should be lower, due to the presence of high affinity neutralising 
antibody from the primary response and the rapid production of high affinity antibody from 
secondary plasma cells.
The dominance of isotype-switched antibody during TD secondary responses to 
protein and hapten antigens argues that memory B cells bearing isotype-switched receptors 
(Okomura, 1976; Hayakawa, 1987; McHeyzer-Williams, 1991), or memory B cells that 
switch rapidly after stimulation (Toellner, 1996) are a major responding B cell population. 
Certainly the expression of isotype-switched antigen receptors has been used as a marker 
for memory B cells, and the active role of these cells in memory is in keeping with 
numerous early cell transfer experiments where adoptively transferable memory could be 
depleted from primed lymphocyte mixtures by removal of IgG+ cells. In fact, isotype 
switching from IgM and IgD to downstream isotypes produces profound changes in the 
structure of the BCR within the membrane, and several studies have documented 
differences in signal transduction through switched receptors, both in vitro and in vivo. At 
this stage, however, it is unknown whether signalling through isotype-switched BCRs 
influences the TD memory response in vivo.
The aim of this thesis is to test whether switched BCR isotypes play a role in B cell 
responses to antigen in vivo, in isolation of the other factors induced by antigen priming. 
The next section will detail in vitro and in vivo evidence that switched BCR isotypes have 
distinct signalling properties and will outline the experimental design of the current study.
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Section 1.5. Evidence for isotype-specific BCR 
signalling in vitro and in vivo
The close association of isotype switching with memory B cells and the dominance of 
switched isotypes, especially IgG, in memory antibody responses is indirect evidence that 
BCR isotype may play a role in the responses of mature B cells to antigen. This is a 
correlation only, and isotype switching may simply provide a method of diversifying the 
effector function of secreted antibodies, with little impact on signal transduction via the 
BCR. The following sections will review various lines of evidence that show that isotype- 
specific BCR signalling may influence cellular responses in both naive and memory B 
cells.
1.5 (a) BCR isotypes differ in their structure within the
membrane
Membrane-bound immunoglobulin of all isotypes is produced via alternative splicing 
of Ig heavy chain exons to exclude short secretory segments and include two isotype- 
specific 3’ exons encoding the extracellular spacer, transmembrane and cytoplasmic 
sections that make up the membrane tail. The constant regions of mouse heavy chain 
isotypes vary, with either 4 (IgM, IgE), 3 (IgG, IgA) or 2 (IgD) Ch domains. This gives 
different degrees of flexibility to these molecules, with IgM and IgE relatively restricted by 
small hinge regions and IgD and some IgG isotypes relatively mobile with extensive hinge 
regions. The isotype-specific membrane tails provide further variation, especially in the 
extracellular spacer and cytoplasmic sections (Reth, 1992).
All isotypes share a similar predicted transmembrane domain, with 13 out of 25 
amino acids conserved across isotypes (see Figure 1-3). The most significant differences at 
this point include a conserved cysteine in mouse and human IgG isotypes and a proline in 
mouse IgD and mouse and human IgA. A number of hydrophilic residues are present in 
this domain, suggesting protein/protein interactions are required to mask these from the 
lipid bilayer. Amphipathic analyses of the predicted membrane-spanning alpha helix reveal 
that most of the conserved residues are located on one face of the molecule, possibly at a 
common contact point for the Igaß heterodimer (Reth, 1992). The other face may be 
involved in isotype-specific contacts.
By contrast, the extracellular spacer and cytoplasmic tail sequences differ extensively 
between isotypes, but are highly conserved between isotype subclasses in the same
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organism and between isotypes in different organisms. The extracellular spacers are rich in 
charged amino acids and vary in length between isotypes, for example, extracellular spacer 
regions in human isotypes vary from 13 aa (IgM) to 66 aa (IgE]0ng isoform). In addition, 
interchain disulfide bonds have been shown to form between conserved cysteine residues in 
the extracellular spacers of human IgG, IgA and IgE membrane isotypes (Bestagno, 2001), 
possibly playing a stabilising role. The conserved cytoplasmic sequences of membrane Ig 
isotypes also show large variation between isotypes. The predicted cytoplasmic sequence 
for IgM and IgD is just 3 aa long, while IgG and IgE have 28 aa tails and IgA a 14 aa tail 
(Reth, 1992), although this is subject to uncertainty and may depend on the techniques used 
to predict the membrane-spanning regions (Klein, 1985).
The high degree of conservation of these membrane tail regions within isotypes and 
between species suggests some evolutionarily conserved function of these sequences. It 
has been speculated that variation in the extracellular spacer regions leads to the association 
of various isotypes with differentially glycosylated forms of Igocß (Campbell, 1991; Pogue, 
1994), partly controls the strength of association with Igocß (Schamel, 2000), and may play 
a role in isotype-specific association with BCR-associated proteins (BAPs) (Batista, 1996). 
In addition, the extended cytoplasmic sequences found in IgG and IgE have been 
implicated in providing a partial endocytosis signal (Weiser, 1994; Achatz, 1997; Kaisho, 
1997; Knight, 1997; Nussenzweig, 1997). Experiments to determine isotype-specific BCR 
signalling functions will be outlined below.
1.5 (b) Attempts to delineate isotype-specific signalling
functions
Two approaches have been taken to study isotype-specific BCR signalling. One 
explores the details of BCR biochemistry, where signalling via the various isotypes is 
probed in vitro. The second approach relies on the ability of immunoglobulin transgenic 
and knockout mice to reveal similarities and differences between the behaviour of B cells 
expressing various BCR isotypes in vivo.
In vitro studies
All of the immunoglobulin subtypes associate with Igoc/ß (Venkitaraman, 1991; 
Batista, 1996; Leduc, 1997), however under some circumstances both IgG and IgD can be 
expressed on the cell surface in the absence of the Iga/ß heterodimer.
While IgG seems to associate with Igoc/ß if the complex is present, studies have 
shown that IgGi (Knight, 1997), IgG2a (Weiser, 1994) and IgG2b (Venkitaraman, 1991) can
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all be expressed at the surface of transfected cells in the absence of Iga/ß. Also, IgD can 
be expressed on the surface of the Iga/ß negative cell line J558L as a GPI-linked protein 
(Weinands, 1992). The implications of IgG and IgD expression without the lg a/ß 
complex for signal transduction in primary B cells is obscure as it is not known to what 
extent these Iga/ß-independent mechanisms lead to IgG and IgD expression in vivo.
Isotype-specific signalling has been studied most extensively in comparisons of IgM 
and IgD isotype BCRs. Developmentally-regulated changes in the expression of these 
isotypes suggests they may have distinct signalling functions. The best evidence that IgM 
and IgD transduce different signals comes from studies in immature B cell lines, showing 
that IgM crosslinking led to growth inhibition while IgD crosslinking had no effect (Ales- 
Martinez, 1988; Tisch, 1988). At present it is not clear what signals might explain these 
differences, although IgM and IgD have been shown to associate with differently 
glycosylated forms of the Iga/ß heterodimer (Campbell, 1991; Venkitaraman, 1991; Pogue, 
1994). Also, IgM and IgD associate with different intracellular proteins, termed BCR- 
associated proteins (BAPs) (Kim, 1994; Terashima, 1994). IgM interacts with BAP 
32/prohibitin, BAP 37 and BAP 41, while IgD interacts with BAP 29 and BAP 31. These 
proteins are much more ubiquitously expressed than the Iga/ß heterodimer and may play 
general roles, as regulators of proliferation and mitochondrial function (BAP 32/prohibitin 
and BAP 37) (Wang, 1999; Coates, 2001) or of protein trafficking (BAP 31) (Annaert, 
1997).
Given the high degree of sequence conservation in the membrane tail domains of 
isotype-switched BCRs, it is surprising that very few signalling pathways or interacting 
proteins unique for isotype-switched antigen receptors have been described. In terms of 
early signalling events, one report suggested that IgG transfectants of a murine lymphoma 
line were more sensitive to stimulation at the level of calcium mobilisation compared to 
IgM transfectants (Leung, 1994). The induction of tyrosine phosphorylation after receptor 
cross-linking has also been shown to be stronger in some human follicular lymphoma cell 
lines expressing IgG compared to IgM (Eray, 1998). However, another study using 
chimeric CD8a/y2a molecules concluded that the IgG2a cytoplasmic tail sequences alone 
could not induce tyrosine phosphorylation after crosslinking (Kim, 1993). In agreement 
with this, Pogue found that primary B cells from anti-HEL transgenic mice expressing an 
IgGi isotype BCR (Pogue, 2000) showed a profound defect in tyrosine phosphorylation 
induction in vitro compared to IgM transgenic cells (Pogue, 1996). Despite this, the 
calcium flux response in the anti-HEL IgG transgenic cells was more robust than the IgM 
transgenic cells suggesting the IgG and IgM receptors transduce qualitatively different 
signals.
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Figure 1-3. Sequence comparison of membrane Ig isotypes from various 
species at the extracellular, membrane-spanning and 
cytoplasmic regions
Sequence information was taken from a review by Reth (Reth, 1992). Asterisks denote the 
conserved residues in the putative transmembrane domain. Dashes show sequence identity 
with the uppermost sequence, membrane-bound mouse IgM. Note the extended predicted 
cytoplasmic sequences of isotype-switched IgG, IgE and IgA isotypes in comparison to 
IgM and IgD. Also, note that the predicted extracellular membrane-proximal domains of 
each isotype share minimal sequence identity.
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Potential differences in downstream signalling targets have also been seen between 
isotype-switched and naive BCRs. For example, IgG but not IgM isotype antigen receptors 
on tonsillar B cells or EBV-transformed B cell lines were able to activate an NADPH- 
dependent oxidase (Leca, 1991) complex in a Rac-dependent manner (Dorseuil, 1992). 
More recently, a B cell specific DNA recombination complex called SWAP has been 
described in the mouse, consisting of nucleophosmin, nucleolin, poly(ADP- 
ribose)polymerase and SWAP-70 (Borggrefe, 1998). Interestingly, the human homologue 
of SWAP is expressed in mature B cells and contains nuclear import, export and 
membrane-localising motifs. SWAP-70 seems to be located in the cytoplasm in resting B 
cells, however upon activation in vitro with either LPS or CD40/IL-4 it first associates with 
the plasma membrane then translocates to the nucleus and finally co-localises and can be 
co-precipitated with IgG, but not IgM (Masat, 2000). When SWAP-70 is disrupted in 
knockout mice, B cells show higher radiation sensitivity and impaired switching to some 
downstream isotypes, although the role of SWAP-70 in those processes is not clear 
(Borggrefe, 2001). Finally, a connection between isotype-switched BCR signalling and 
CD30/CD30L (CD 153) signalling has been suggested. It was found that CD30L signalling 
by receptor-crosslinking or interaction with CD30+ T cells in human IgM+IgD+ B cells lead 
to the suppression of isotype switching and terminal B cell differentiation (Cerutti, 2000). 
IgG+ tonsillar B cells were not inhibited by this interaction, suggesting the IgG isotype 
BCR transduces signals that are qualitatively different to IgM and IgD and can compensate 
for CD 153 inhibitory signalling.
Some proteins have been shown to associate specifically with isotype-switched 
receptors. Pogue found three phosphoproteins in M l2 lymphoma transfectants that 
associated preferentially with the cytoplasmic tail region of IgG i (Pogue, 1996). These 
were described as proteins of 20, 21 and 45 kDa that associated exclusively with 
intracellular immunoglobulin after immunoprecipitation from transfected cell lysates.
Also, in a comparison of two human IgE BCR isoforms expressed in WEHI-231 cells, 
Batista et al. found that both the long and short IgE isoforms but not the endogenous IgM 
BCR associated with proteins of 37 kDa and 41 kDa (Batista, 1996).
The final isotype-specific function that has been ascribed to isotype-switched 
receptors is in antigen presentation, involving the targeting of antigen/BCR complexes into 
the endocytic pathway for antigen degradation and loading onto MHC Class II molecules 
(Siemasko, 2001). Although IgM and IgD can both act as antigen presentation modules 
through signals in their heavy chains and associated Igoc/ß heterodimers, the YXXM motif 
found in the cytoplasmic tail domain of the IgG and IgE subtypes has been proposed to act 
as an additional antigen presentation motif (Achatz, 1997; Kaisho, 1997; Knight, 1997;
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Nussenzweig, 1997). YXXO motifs (where <h is a bulky, hydrophobic amino acid) has 
been shown to be a signal for the recruitment of the p.2 component of the AP-2 complex 
involved in the clathrin-mediated endocytosis (Kirchausen, 1997) of receptors such as 
CTLA-4 (Shiratori, 1997). It has been observed that a NIP-specific IgG2a BCR, expressed 
on the cell surface of J558L cells in the absence of Igot/ß could be efficiently internalised 
after the addition of antigen (Weiser, 1994). Interestingly an earlier study found that the 
cytoplasmic tail domain of IgG2b alone could not rescue the presentation of antigen when 
expressed as a chimera with IgM in the absence of Iga/ß (Patel, 1993), suggesting multiple 
signals in addition to the tail domain may be required for antigen presentation. As an 
extension to these findings, a tetanus toxin-specific IgGi BCR could be expressed in an 
Iga/ß-negative cell line yet still mediate antigen presentation to T cells, an event partially 
dependent on the cytoplasmic tail domain (Knight, 1997). The authors take this as 
evidence of an antigen-targeting motif in the IgGi cytoplasmic tail domain, although 
antigen presentation via IgGi in the absence of Igoc/ß is only partially reduced by deletion 
of the tail. The identification of this putative antigen-presentation signal in the cytoplasmic 
tail domain of IgG has been proposed to account for the decreased secondary antibody 
responses in mice with truncations of the cytoplasmic tail domains of IgGi (Kaisho, 1997) 
and IgE (Achatz, 1997), although there are alternative explanations for these in vivo studies 
that will be discussed later.
In vivo studies
Despite in vitro data that suggests there are signalling differences between IgM, IgD 
and isotype-switched receptors, the evidence for different biological functions between 
BCR isotypes in vivo from knockout and immunoglobulin transgenic models is scarce.
Knockout studies have attempted to delineate the roles of IgM and IgD in the 
development and functional maturation of B cells by disruption of one or other isotype by 
gene targeting. IgM seems capable of providing signals for the production of fully mature 
peripheral B cells capable of responding to T-dependent and T-independent antigens in the 
absence of IgD (Roes, 1991, 1993). The only noticeable effects of IgD deficiency was a 
selective disadvantage of IgD' cells in mice heterozygous for the mutation, as well as a 
slightly delayed rate of affinity maturation during the primary immune response to a T- 
dependent antigen. As well as IgM, IgD is also capable of promoting the production of 
fully mature peripheral B cells (Lutz, 1998). In a selective IgM';' mouse that continued to 
express IgD, B cell development through to mature B cells was normal, and IgD provided 
normal functions for antibody secretion, isotype switching, responses to T-independent 
type 2 and T-dependent antigens, and germinal centre formation. The only defects
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observed were in lower numbers of B220+CD5+ B-la peritoneal B cells and a delayed onset 
of neutralising antibody production to the cytopathic vesicular stomatitis virus.
These knockout studies mirror results from immunoglobulin transgenic mice in which 
rearranged IgM or IgD (or both) transgenes are inserted into the mouse genome (Goodnow, 
1992). Both IgM and IgD transgenes are capable of mediating endogenous heavy chain 
allelic exclusion (Weaver, 1985; Iglesias, 1987; Nussenzweig, 1987) and the formation of 
mature peripheral B cells. One early hypothesis claimed that the developmentally regulated 
expression of IgD inteferes with peripheral tolerance and that once IgD is expressed, B 
cells make proliferative rather than apoptotic responses (Carsetti, 1993) upon antigen 
exposure. This interpretation is unlikely for two reasons. Firstly it has been shown that 
signalling through either IgM or IgD leads to apoptosis in immature splenic B cells but not 
in mature splenic B cells (Norvell, 1996). Secondly IgM-only transgenic lines show no 
defects in response to T-dependent antigens, indicating that IgM can transmit activation 
signals (Brink, 1992). In fact it seems that apoptotic responses by peripheral B cells 
correlate with B cell maturation state rather than BCR isotype.
A limited number of knockout and transgenic studies have also investigated whether 
isotype-switched receptors can allow normal B cell development. The role of IgG in 
promoting allelic exclusion and B cell development has been studied extensively with IgG 
transgenic mice (Yamamura, 1986; Tsang, 1988; Offen, 1992; Tsao, 1992; Roth, 1993; 
Iliev, 1994; Kenny, 1995; Roth, 1995; Battegay, 1996; Kurtz, 1996; Pogue, 2000). The 
results have been confusing. While some studies have demonstrated IgG-mediated allelic 
exclusion of endogenous IgM expression in the bone marrow (Roth, 1993; Iliev, 1994; 
Kenny, 1995; Battegay, 1996), others have seen no evidence of allelic exclusion 
(Yamamura, 1986; Tsao, 1992). In addition, the ability of transgenic IgG expression alone 
to allow normal B cell development has been observed in some cases (Offen, 1992; Iliev, 
1994; Kenny, 1995) and not in others (Roth, 1993; Roth, 1995; Battegay, 1996). Recently 
Pogue and Goodnow produced a panel of anti-lysozyme IgGi transgenic lines and provided 
a hypothesis that may explain many of the disparate finding surrounding IgG transgenics 
(Pogue, 2000).
The transgenic lines were made using the same Vh/Vl anti-HEL combination 
described previously (Goodnow, 1988). In this case the heavy chain constant regions were 
either from IgGi or from a chimeric heavy chain (IgM/G) consisting of the IgM Ch exons 
and the IgGi Ml and M2 exons which encode the extracellular spacer, transmembrane and 
cytoplasmic sequences of the membrane tail of IgGi. It was noticed that a variable number 
of HEL-binding B cells were present in the peripheral compartments of the different lines, 
and this correlated with the transgene copy number integrated in the mouse genome, so that
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lines with more copies produced fewer peripheral B cells expressing the transgenic 
receptor. This observation was supported in spontaneous copy-loss variants derived from a 
high copy number IgM/G transgenic line where a clear increase in the proportion of mature 
HEL-binding lymphocytes was observed in both copy-loss variants (18 % and 52 %) 
compared to the parental line (6 %). The number of transgene copies correlated also with 
the level of HEL-binding receptor expressed on pro-B cells in the bone marrow of these 
mice. The hypothesis to explain this was that higher IgG heavy chain expression early in 
development leads to receptor editing away from the expression of the transgenic heavy 
chain and a subsequent decrease in the number of mature HEL-binding B cells in the 
periphery.
Importantly, these observations may help explain variable results gained from a panel 
of IgG2b transgenics carrying heavy chain genes from a Pseudomonas aeruginosa -specific 
antibody. Two of the transgenic lines from this panel (343-1, 348A) showed no evidence 
of normal mature IgG2b+ peripheral B cells (Roth, 1993), whereas one “variant” line from 
this panel showed both allelic exclusion and normal production of IgG2b+ peripheral B cells 
(343C). Both the 343-1 and 348A lines had relatively high transgene copy numbers (343-1, 
8 copies; 348A, 22 copies) whereas the variant 348C line had a lower transgene copy 
number (3 copies) (Roth, 1995). This line was derived in a similar way to the anti-HEL 
copy-loss variants as the by-product of a very high copy number parental line (348-4-8, 90 
copies) (Tsang, 1988).
In vivo studies of isotype-switched B cell antigen receptors
Only two studies, using identical approaches, have studied the role of isotype- 
switched receptors in B cell responses to antigen in vivo.
Targeted gene-knockout studies of IgGi (Kaisho, 1997) and IgE (Achatz, 1997) 
demonstrated the importance of the membrane expression of these isotypes for proper IgGi 
and IgE antibody responses. It is not surprising that the complete ablation of membrane 
IgGi or membrane IgE expression led to drastically decreased serum titres in pre-immune 
and immunised animals, given the requirement of BCR expression for peripheral B cell 
maintenance (Lam, 1997). More interestingly, knockouts in which only the extended 
cytoplasmic tail sequences of IgGi and IgE were removed (Atail mice) showed an 
intermediate defect in serum titres and immune reactivity during primary and secondary 
antibody responses.
In their study of IgGi, Kaisho et al. speculated that the IgGi cytoplasmic tail 
sequence acted to increase antigen presentation to helper T cells, on the basis of in vitro
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work suggesting an antigen presentation role for the IgGi cytoplasmic tail sequences 
(Knight, 1997). Despite this hypothesis, the cellular mechanism behind the action of the 
IgGi cytoplasmic sequence was not actually established in this study. For example, while 
Kaisho et al showed that fewer antigen-specific IgGi+ cells accumulated in Atail mice after 
a primary T-dependent antibody response, the reason for this could not be determined. 
Potentially, the IgG tail domain could have allowed more efficient cell activation, a greater 
rate of cell division, protection from cell death, or more efficient germinal centre formation.
More seriously, the experimental strategy employed by Kaisho et al. relied on the 
expression of a truncated form of the IgGi BCR. This mutant BCR lacked evolutionarily 
conserved membrane-proximal motifs, and was made with no prior knowledge of the effect 
of this modification on membrane insertion or the stability of cell surface expression. In 
fact there is compelling evidence that the expression of the Atail IgG BCR was decreased 
compared to IgG on normal wild-type B cells after stimulation with LPS and IL-4 in vitro 
(Kaisho, 1997). In addition, there was a greatly decreased IgGi serum antibody titre and 
many fewer IgGi+ B cells, even in pre-immune Atail mice. This raises an alternative 
interpretation for this study: namely that poor immune responses in Atail mice are not due 
to the disruption of a motif required for antigen presentation or cell activation, but that the 
inefficient surface expression of a truncated, mutant IgG BCR is not permissive for B cell 
survival.
In summary, the role of isotype-switched BCR expression in B cell responses to 
antigen in vivo remains an open question. The studies of Kaisho (Kaisho, 1997) and 
Achatz (Achatz, 1997), while showing the importance of the IgG and IgE cytoplasmic tail 
regions for B cell biology have not determined whether those sequences are involved in 
stable membrane expression or some signalling function associated with cell activation or 
antigen presentation. If their studies do reflect some isotype-specific signalling function for 
those regions, they have not established a cellular mechanism for their action, which may 
range from modulating cell activation, cell division, death or differentiation rates, to some 
aspect of affinity maturation.
Section 1.6. The current study
There have been very few experiments to directly test the role of isotype-switched 
BCRs in memory responses. As discussed above, this is due to the host of changes that 
accompany antigen-induced priming, and the lack of a strategy to separate these has meant
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that the specific role of isotype-switched signalling in memory responses has not been 
determined.
In order to fully address the role of isotype-switched receptors and their unique 
membrane tail domains in B cell responses to antigen in vivo, there are several 
requirements that must be met by an experimental system.
(1) Comparisons should be made between B cells bearing IgM versus IgG (or other 
isotype-switched BCRs) that share identical antigen specificity and affinity.
(2) B cells from the comparison groups must be matched in their maturation stage, 
antigen experience and precursor frequency.
(3) To test the role of the unique IgG membrane tail (for example), the “add-back” 
experiment should be performed, where the IgG membrane tail is added to IgM. This 
directly tests the ability of that segment to confer novel functions to IgM, and avoids 
the difficulty in interpreting loss of function phenotypes produced by deleting or 
mutating the membrane tail sequence.
To address these requirements and isolate the role of BCR isotype in B cell responses 
to antigen in vivo, this study has compared populations of naive B cells from anti-Hen Egg 
Lysozyme (HEL) immunoglobulin (Ig) transgenic mice that express uniformly high-affinity 
BCRs of a defined isotype (Goodnow, 1988; Brink, 1992; Pogue, 1994; Pogue, 1996; 
Pogue, 2000) (see Figure 1-4). In the different mouse lines, the constant region segments 
are IgM or IgD (naive BCR isotypes), or are IgG (isotype-switched BCR). The IgG 
expressing lines contain either the full IgG constant region, or a chimeric IgM/G constant 
region where the constant region exons of the secreted product are from IgM but the two 
membrane exons encoding the membrane tail are from IgG (see Figure 2-1). B cells from 
these transgenic lines were seeded into T-dependent immune responses in vivo, and the 
outcome in terms of clonal expansion and differentiation tracked at the single cell level.
This experimental design is able to control for many of the variables not accounted 
for by earlier work. Firstly, the panel of Ig transgenic mice share identical variable regions 
with a uniform high affinity for HEL. This ensures homogeneous populations of B cells 
are compared that share the same specificity and affinity for a specific antigen. Secondly, 
the transgenic constructs retain important conserved domains, such as the entire 
extracellular spacer, transmembrane and cytoplasmic sequences of IgGi and IgM. This 
ensures that membrane expression in these lines is equivalent, which is clear from an 
analysis of immature bone marrow B cells (Pogue, 2000). This removes the possibility that 
differences in responsiveness between lines is due to inefficient surface BCR expression.
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Most importantly, the issue of antigenic experience is controlled by the fact that all 
transgenic B cells are naive, having never encountered HEL prior to adoptive transfer. This 
removes the host of other phenotypic changes that accompany memory cell formation as a 
potential complicating factor in these experiments. Finally, adoptive transfer allows the 
number of antigen-specific B cells to be systematically varied. This means the precursor 
frequency of high affinity antigen-specific cells of a defined isotype can be controlled, and 
valid comparisons made between B cells carrying IgM or IgG isotype receptors that are 
present in equal numbers.
This thesis describes experiments using this system to investigate the question of the 
role of BCR isotype in B cell responses to a T-dependent antigen in vivo. This study will 
present evidence to show that the IgG transgenic B cells make more robust responses to 
antigen compared to B cells expressing IgM or IgD, and that the IgG membrane tail is the 
key molecular regulator of this response. The IgG membrane tail acts to protect B cells 
from cell death over successive cell divisions, resulting in a much greater clonal burst size 
and more antibody-forming cells compared to B cells expressing IgM and IgD. This 
establishes the expression of isotype-switched BCRs as a key part of “priming” the immune 
system to make more robust effector responses on re-exposure to T-dependent antigen.
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Figure 1-4. Structure of the BCR isotypes from the various transgenic 
strains used in this study
The various forms of BCR isotype used by each anti-HEL immunoglobulin transgenic line 
used in this study are shown. IgM isotype heavy chain is shown in outline. IgD heavy 
chain is shown in blue. Note the extracellular membrane-proximal section of IgD in the 
M8E lines. IgGi heavy chain is shown in red. Note the extracellular membrane-proximal, 
transmembrane and cytoplasmic sequences of the IgGi membrane tail in the MG lines. 
Light chains are shown in yellow. Each line shares an identical high-affinity HEL-specific 
heavy and light chain variable region derived from the anti-HEL hybridoma HyHELlO 
(Smith-Gill, 1982; Smith-Gill, 1984a; Smith-Gill, 1984b; Goodnow, 1988). The secreted 
antibody product produced by plasma cells from each line is also indicated.
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Section 2.1. Materials
All chemicals used in the production of buffers and stock solutions were AR grade or 
better. The source of specialised reagents and their grade has been indicated throughout the 
materials and methods section where appropriate.
Section 2.2. Mouse lines (description and housing)
All mice were housed under SPF conditions within the ACRF Medical Genome 
Centre at the John Curtin School of Medical Research, Australian National University, 
Canberra.
Immunoglobulin (Ig) transgenic mice were strains MD4 (Goodnow, 1988); MM4 
(Brink, 1992); GG4, MG2, MG6 and MG8 (Pogue, 2000); M5E1 and M5E2 (Pogue, 1994); 
DD6 (Brink, 1992) and (MM4xDD6)Fi. Ig transgene construct information and the 
sequence of the membrane tail regions encoded by exons Ml and M2 for each Ig transgenic 
strain is given in Figure 2-1. The TCR transgenic strain was 3A9 (Ho, 1994).
Ig transgenic lines were maintained on the C57BL/6, C57BL/6:RAGl‘/‘, 
(B10.BRxC57BL/6)Fi, (B10.BRxC57BL/6)F1:RAG'/' and B10.BR:RAGl'/_ backgrounds. 
TCR transgenic lines were maintained on the (B10.BRxC57BL/6)Fi, B10.BR and 
B 10.BR:FasLgld backgrounds.
Recipient mice for adoptive transfer experiments were either C57BL/6, B10.BR or 
(B10.BRxC57BL/6)Fi hybrids. No differences were noticed when male or female mice 
were used as recipients. Mice were used as recipients between 8 and 15 weeks of age.
Section 2.3. Transgenic mouse screening
TCR and immunoglobulin transgenic mice were screened by PCR analysis of ear 
punch DNA and by flow cytometric analysis of blood. PCR analysis of ear punch DNA 
was also used to screen the H-2 haplotypes of (MM4:H-2kb x DD6:H-2bb)Fi mice.
2.3 (a) PCR screening
Screening of mice by ear punch DNA and PCR was performed according to the 
method of Chen and Evans (Chen, 1990). Briefly, ear punches were collected in eppendorf 
tubes during the routine marking of mice. These punches were digested in 20 jil buffer
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containing 50 mM Tris.HCl (pH 8.0, Boehringer Mannheim, Indianapolis, IN), 2 mM 
NaCl, 10 mM EDTA, 1 %(w/v) SDS (Bio-Rad, Hercules, CA) and 1 mg/ml Proteinase K 
(Roche Molecular Biochemicals, Indianapolis, IN). Digestion was for 40 minutes at 55 °C 
with vigourous vortexing after 20 minutes. ddH20 was added to a final volume of 200 (ill 
and the samples boiled at 100 °C for 5 minutes to destroy Proteinase K activity. Digested 
samples were stored at -20 °C until PCR analysis.
PCR reactions were performed in a 50 pi volume containing 1 pi of digested ear 
punch, 5 pi lOx PCR buffer (where lx  = 67 mM Tris.HCl pH 8.8, 16 mM ammonium 
sulfate, 10 mM 2-mercaptoethanol and 2.5 mM magnesium chloride), 1 pi dNTPs (10 mM 
with respect to dATP, dCTP, dGTP and dTTP, Amersham Pharmacia Biotech, Uppsala, 
Sweden), 0.5 pi TX-100 (molecular biology grade, Sigma Chemical Co., St Louis, MO), 
oligonucleotide primers (BRF facility, JCSMR), 0.25 pi Taq polymerase (prepared in 
house) and sufficient ddH20 for 50 pi total volume. 2-mercaptoethanol was molecular 
biology grade from Sigma.
Oligonucleotide primer 5' —» 3' sequences and the amounts per reaction for each PCR 
screening protocol are given below:
(1) Immunoglobulin transgenic:
IgH-F i GCGACTCCATCACCAGCGAT 
IgH-F2 CTGGAGCCCTAGCCAAGGAT 
IgH-Rj ACCACAGACCAGCAGGCAGA
100 ng 
25 ng 
25 ng
(2) TCR transgenic:
TCR-F i GCAGTCACCCAAAGCCCAAG
TCR-Ri CCCC AGCT C ACCT AAC ACT G
IgH-Fi GCGACTCCATCACCAGCGAT
IgH-R! ACCACAGACCAGCAGGCAGA
150 ng 
150 ng 
100 ng 
25 ng
(3) H-2 haplotype:
Ecx5'
Ea3 '
K5'
AGT CTTCCC AGCCTT C AC ACT C AGAGGT AC 
CATAGCCCCAAATGTCTGACCTCTGGAGAG 
CAT GGGC ATAG AAAGGGC ACT CTTT G AACT
150 ng 
150 ng 
150 ng
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All PCR reactions were carried out in a Corbett Research FTS-960 Thermal Cycler 
using 35 cycles of 15 s denaturing at 94 °C, 30 s annealing at 60 °C and 45 s elongation at 
72 °C. 20 |il of PCR reaction products were run on a 2 % (w/v) agarose electrophoresis gel 
with incorporated ethidium bromide, and the products photographed under UV light.
Immunoglobulin transgenic PCR yielded a 430 bp immunoglobulin transgene band 
and a 264 bp endogenous immunoglobulin band. TCR transgenic PCR yielded a 371 bp 
TCR transgene band and a 264 bp endogenous immunoglobulin band. H-2 PCR yielded a 
150 bp H-2b haplotype band and a 250 bp H-2k haplotype band.
2.3 (b) Blood screening
For screening by blood, a small volume of tail vein blood was taken using a 26 gauge 
needle and a heparinised capillary tube (Hirschmann Laborgerate, Germany). Blood was 
blown into 100 pi Alsever's solution (prepared in house). After 2 rounds of erythrocyte 
lysis for 10 minutes at room temperature using Tris-Ammonium Chloride (TAC), cells 
were resuspended in flow cytometry wash buffer and stained as normal. For TCR 
transgenic mice, cells were stained with biotinylated anti-CD4 (Clone GK1.5, homemade) 
followed by streptavidin-phycoerythrin (SA-PE, Caltag, Burlingame, CA), as well as anti- 
Vp8.2-fluorescein isothiocyanate (FITC, clone F23.2, homemade). TCR transgenic mice 
were scored by an increased proportion of CD4+ Vp8.2+ lymphocytes in blood compared to 
non-transgenic littermates. For anti-HEL immunoglobulin transgenic mice, white blood 
cells were stained with HEL (200 ng/ml in PBS, Sigma) followed by HyHEL9-TriColor 
(homemade), as well as B220-PE (Clone RA3-6B2, Caltag). Immunoglobulin transgenic 
mice were scored by an increased proportion of HEL-binding B220+ lymphocytes in blood 
compared to non-transgenic littermates.
Section 2.4. In vivo cell transfers and immunisations
2.4 (a) Antigen/adjuvant preparation
Intraperitoneal immunisations with HEL (Hen Egg Lysozyme, Sigma) and TEL 
(Turkey Egg Lysozyme, Sigma) in Complete Freund's Adjuvant (CFA, Sigma) were 
performed using standard methods (Harlow, 1988). CFA was emulsified in a 1:1 volume 
ratio with PBS or with PBS containing HEL (or TEL) to give a final protein concentration 
of 1 mg/ml. The emulsion was formed by vigorous mixing using 3 ml glass syringes 
connected by a 2-way stopcock. The emulsion was then transferred to 1 ml syringes and 
injections performed using a 26 gauge needle.
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2.4 (b) Immunisation regimes
For immune responses in C57BL/6 recipients, Turkey Egg Lysozyme (TEL) was 
used, as the C57BL/6 strain is a poor responder to HEL (Hill, 1975) and the transgenic Ig 
binds TEL with comparable affinity (C. Goodnow, personal communication). Unirradiated 
C57BL/6 recipient mice were immunised intraperitoneally (i.p.) with 100 jig TEL in CFA. 
Immunisation was at the time of adoptive cell transfer, or 7 days before in order to prime 
endogenous recipient T helper cells. Primed mice were boosted with 50 jig TEL in PBS 
given i.p. or intravenously (i.v.) via the lateral tail vein.
In experiments with TCR transgenic helpers, unirradiated (B10.BRxC57BL/6)Fi 
recipient mice were immunised i.p. with 100 pig HEL in CFA at the same time as the 
transfer of TCR transgenic and Ig transgenic cells.
In some experiments unirradiated (B10.BRxC57BL/6)Fi recipient mice were primed 
for 6 days before transfer of Ig transgenic cells. In these cases recipients were immunised 
with 100 jig HEL in CFA at the same time as the transfer of 1'CR transgenic cells. After 6 
days, recipients received Ig transgenic cells and a dose of 100 jig soluble HEL i.v. To stop 
systemic anaphylactic responses, isoproterenol hydrochloride (Sigma) was given at the 
same time i.v., at a dose of 4.5 p.g/mouse (Han, 1995b).
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Figure 2-1. Construct information and membrane tail sequence
comparisons across the Ig transgenic lines used in this study
The general structure of the anti-HEL immunoglobulin transgenic constructs used to make 
the panel of mice used in this study is shown. Not drawn to scale. For a representation of 
the membrane-bound Ig protein, see Figure 1-4.
The sequences of the Ml and M2 exons that encode the extracellular spacer, 
transmembrane and cytoplasmic sections of the membrane tail are indicated for each 
transgenic line. Sequence information was taken from previous descriptions of MD4 
(Goodnow, 1988; Goodnow, 1989), MM4 (Brink, 1992), MG2, MG6 and MG8 transgenic 
lines (Pogue, 1996; Pogue, 2000), as well as the constructs used to make the M8E1 and 
M5E2 lines (Pogue, 1994).
Abbreviations used: LVDJ, rearranged heavy chain variable region gene segments from 
HyHELlO; Ep,, p intronic enhancer; SR p., p. switch region; SR p*, p switch region 
carrying a 2.8 kb internal deletion; SR p/yl, p/yl hybrid switch region.
Dashes indicate sequence identity with the p Ml and M2 exon sequences.
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2.4 (c) Transfer of Ig transgenic and TCR transgenic donor cell
suspensions into recipient mice
Donor animal spleen suspensions were screened individually by flow cytometry on 
the day of transfer to confirm PCR screening results and, in conjunction with cell counting, 
to accurately estimate the number of transgenic cells per spleen. Lysozyme-binding B cells 
in Ig transgenic donors were enumerated by staining with HEL (200 ng/ml, Sigma), 
HyHEL9-TriColor and B220-PE (clone RA3-6B2, Caltag). Transgenic T cells in TCR 
transgenic donors were enumerated by staining with CD4-bio (clone GK1.5) and Vß8.2- 
FITC (clone F23.2), followed by SA-PE (Caltag).
Prior to transfer, debris was removed from the donor cell inoculum by layering the 
cell suspension over a cushion of fetal bovine serum.
Ig transgenic cells alone, or an equal mixture of Ig transgenic and TCR transgenic 
cells were injected in 200 - 400 (ill of RPMI-1640 supplemented with 2 % fetal bovine 
serum (FBS) (Trace Biosciences, NSW, Australia) and 20 mM HEPES (Sigma) (from this 
point “complete” RPMI) via the lateral tail vein of recipient mice using a 26 gauge needle. 
Recipient mice were warmed briefly under a heat lamp prior to injection.
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Section 2.5. Antibody staining reagents for flow
cytometry, ELISA, histochemistry and 
Western blotting
Name Clone Isotype Conjugation Source Step
Avidin AP Sigma 2°
B220 (CD45) RA3-6B2 rt IgG2a FITC, PE 1, Caltag 1°
CD4 GK1.5 rt IgG2b bio, APC 1,1 1°
CD21 7G6 rt IgG2b bio 1 1°
CD23 B3B4 rt IgG2a PE PharMingen 1°
CD138 281-1 rt IgG2a un PharMingen 1°
HEL HyHEL9 m  IgG l FITC, TC, bio 1 ,1 ,1 1°
r t lg rb (pc) bio DAKO 2°
Iga (MB-1) rb (pc) un 1 1°
Igb (B-29) rb (pc) un 1 1°
IgD 11-26 rt IgG2a un S.B. 1°
IgD IgG fraction shp (pc) un T.B.S. 1°
IgDa AMS9.1 rt IgG2b FITC 1 1°
IgG F(ab’)2 g t(pc) HRP I.C.N. 2°
IgG l g t(pc) bio S.B. 1°
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rblgG gt(pc) HRP Zymed 2°
rtlgG gt(pc) HRP Jackson 2°
shp IgG rb (pc) HRP Jackson 2°
IgM gt (pc) AP S.B. 1°
IgMa RS3.1 m IgGl FITC, bio u 1°
kappa Lc gt(pc) bio, un S.B. 1°
Lyn rb (pc) un 1 1°
MOMA-1 MOMA-1 rt IgG2a un BMA 1°
Streptavidin AP Sigma 2°
CyC PharMingen 2°
FITC Caltag 2°
HRP Amersham 2°
PE Caltag 2°
p-Tyr 4G10 m IgG2b un U.B. 1°
Vb8.2 F23.2 m IgGl FITC 1 1°
Table 2-1. Antibody staining reagents used in this study.
All target antigens were mouse, unless otherwise indicated.
Abbreviations used: mouse (m); sheep (shp); rat (rt); rabbit (rb); goat (gt); polyclonal (pc); 
supplied by Prof. C. Goodnow (1); The Binding Site (T. B. S.); Southern Biotechnology 
Associates Inc. (S. B.); Upstate Biotechnology (U. B.); unconjugated (un); biotinylated 
(bio); alkaline phosphatase (AP); phycoerythrin (PE); horse-radish peroxidase (HRP);
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CyChrome (CyC); Tricolor (TC); allophycocyanin (APC); fluorescein isothiocyanate 
(FITC). “Step” refers to the staining reagent being used as a primary or secondary stain.
Supplier details: Serotec (Oxford, UK), DAKO (Denmark), Jackson ImmunoResearch 
Laboratories (West Grove, PA), Vector Laboratories (Burlingame, CA), The Binding Site 
(Birmingham, U.K.), BD PharMingen (San Diego, CA), Southern Biotechnology 
Associates Inc. (Birmingham, AL), Upstate Biotechnology (Lake Placid, NY), ICN 
Biomedicals Inc. (Aurora, OH), BMA Biomedicals Inc. (Augst, Switzerland), Zymed 
Laboratories Inc., San Francisco, CA).
Section 2.6. Cell isolation from mouse tissue
2.6 (a) Cell preparation
Mice were killed by cervical dislocation and spleens or lymph nodes of donor 
transgenic mice or mice used in phenotyping experiments were removed into 10 ml of 
complete RPMI. Spleens of recipient mice from adoptive transfer experiments were 
removed into 2.5 ml of PBS supplemented with 10 % FBS, 1 mM EDTA and 40 pg/ml 
hyaluronidase (Sigma) in order to fully release activated lymphocytes from the tissue.
In both cases single cell suspensions were prepared by disrupting the spleen capsule 
between the frosted ends of glass slides. Spleen suspensions from recipient mice were also 
passed four times through a 26 gauge needle using a 3 ml syringe. The suspensions were 
made up to 10 ml with complete RPMI, however in some cases, red blood cells were 
removed by washing once with 10 ml Tris-Ammonium Chloride. Cell suspensions were 
immediately pelleted by centrifugation at 200 g for 6 minutes then resuspended in complete 
RPMI. In all cases spleen suspensions were washed twice in complete RPMI before cell 
counting.
2.6 (b) Cell counting
Cell counts were performed in two ways, using a hemocytometer for a small number 
of samples and using a bead-based flow cytometric strategy for large numbers of samples.
For hemocytometer counting, 10 pi of a 1:10 dilution of spleen single cell suspension 
in white blood cell counting medium (1.5% acetic acid, 0.01 % gentian violet in ddH20) 
was introduced into a hemocytometer (Improved Neubauer type, Hausser Scientific, 
Horsham, PA). Counting was performed according to standard methods (Harrison, 1997).
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For flow cytometry based counting, a 10 pi volume of single cell suspension was 
mixed with 90 pi flow cytometry buffer containing -1000 fluorescent beads (Flow-Count, 
Coulter Corporation, Miami, FL). The sample was passed on a FACScan (BD, Becton 
Dickinson, San Jose, CA) using a log side scatter setting to visualise the counting beads. 
Acquisition continued until 200 bead events were counted, then the number of events in a 
lymphocyte gate set on forward and side scatter was recorded. A single sample was also 
counted using a hemocytometer. This allowed all samples to be normalised by taking the 
ratio of lymphocyte events and bead events in each individual sample and multiplying by 
the absolute counts from the sample counted using a hemocytometer.
Section 2.7. Flow Cytometry
Flow cytometry was performed at the JCSMR FACS facility. For routine analyses, 
including transgenic mouse blood screening, transgenic donor confirmation, surface 
phenotyping and flow cytometry-based cell counting, a FacScan (BD) cytometer running 
CellQuest (BD) software was used to acquire data. For sorting, a FacStar Plus (BD) 
cytometer was used. For acquisition of 4 colour data, a dual laser FacStar Plus (BD) or 
LSR (BD) cytometer was used. Spectral overlap compensation was performed in hardware 
as well as post-acquisition, using WinList v4.0 or v5.0 for Macintosh (Verity Software 
House, Topsham, ME) (Bagwell, 1993). Subsequent analysis was performed using 
CellQuest (BD) or FlowJo (Treestar, San Carlos, CA) software.
2.7 (a) Flow cytometry staining
Lymphocytes were stained for flow cytometry in 96-well round bottom plates. After 
counting, between 5x105 and 5x106 cells were washed once in FACS wash buffer, then 
resuspended in 50 pi FACS wash containing diluted first step antibodies and incubated at 4 
°C for 20 minutes. Samples were made up to 200pl with FACS wash and spun at 670 g  for 
6 seconds to pellet the cells. Supernatant was removed by a rapid flick, leaving the cell 
pellet in a small volume of buffer. After a second wash, cells were resuspended in 50 pi 
FACS wash containing diluted second step antibodies and incubated at 4 °C for 20 minutes. 
After washing twice in FACS wash as described above, cell pellets were resuspended in 
either FACS wash buffer (for immediate analysis) or FACS fixative (for analysis up to 24 
hours later) and transferred to polypropylene cluster tubes (Costar Corporations,
Cambridge, MA) for acquisition.
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2.7 (b) Flow cytometry sorting
Spleen cell suspensions were prepared for cell sorting by isolating donor spleens into 
complete RPMI with 10 % FBS. Single cell suspensions were prepared as described 
previously in 2.6 (a). Cells were then washed once into 14 ml of “staining buffer” 
consisting of 2 % FBS in PBS. Cell suspensions were pelleted and resuspended in 700 |il 
of first step antibodies diluted in staining buffer, then left at 4 °C for 20 minutes. After 
staining, the suspension was made up to 14 ml with staining buffer, cells were pelleted and 
then resuspended in 700 jdl (per spleen) second step antibodies diluted in staining buffer. 
After 20 minutes at 4 °C the cells were washed once in staining buffer then counted, and 
the cell concentration adjusted with staining buffer to give 5xl06 lymphocytes / ml. Cells 
were filtered through a 60 pm nylon mesh into polypropylene tubes (Costar) prior to 
sorting.
2.7 (c) Examples of flow cytometry gating strategies
Two gating strategies were used to visualise HEL-binding transgenic B cells amongst 
the splenic lymphocytes of adoptive transfer recipients, and are shown in Figure 2-2. These 
varied depending on the frequency of HEL-binding cells present, whether the B cells were 
CFSE labelled prior to transfer, or whether a co-transfer of two different transgenic B cells 
was performed. Details of the gating strategies are given in the figure legend.
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Figure 2-2. Gating strategies used to visualise HEL-binding B cells in 
adoptive transfer recipients
Splenocytes were prepared from adoptive transfer recipients as described in Section 2.6. 
Following the acquisition of flow cytometry files and post-acquisition software 
compensation, HEL-binding B cells were enumerated in several ways, depending on the 
experimental design:
A. For recipients that received Ig transgenic B cells, on days 3, 4 and 5 after immunisation, 
the following set of gates was used. Firstly, a generous lymphocyte gate set on forward and 
side scatter was used to include lymphoblasts. CD4-APC was then used as a “dump” 
channel to reduce autofluorescence, so that HEL-binding cells were analysed in the CD4‘ 
lymphocyte gate. HEL-binding cells were then detected by simultaneous staining with 
HEL-biotin followed by SA-PE and HyHEL9-TC. The HEL-binding cells are present as a 
tight diagonal population, distinct from autofluorescence (Townsend, 2001). In co-transfer 
experiments, the HEL-binding CD4' lymphocytes were queried for IgMa expression as 
shown. This was used to distinguish IgMa' IgG (GG4) B cells from co-transferred IgM 
(MM4) or IgM/G (MG2) B cells, both of which express IgMa. If the transgenic B cells 
were CFSE-labelled prior to transfer, they could also be queried for their CFSE dilution 
profile using the HELT CD4‘ lymphocyte gate.
B. For recipients that received CFSE-labelled transgenic B cells, a different gating strategy 
was employed to detect the cells on days 1 and 2 after immunisation and transfer, while 
HEL-binding cells were still rare. It was found that detecting CFSE-labelled HEL-binding 
B cells on the basis of CFSE and HEL/HyHEL9-TC staining was most sensitive, resolving 
the transferred CFSEbnght cells as a distinct population. In this example, CFSE-labelled 
IgM/G (MG2) transgenic B cells on day 1 after transfer into immunised recipients were 
detected by first gating on lymphoblasts amongst total splenocytes. Then, CFSEbnght HEL- 
binding lymphocytes were gated. The level of CFSE expression in the transferred 
transgenic B cells was then expressed as a histogram. In some cases the CFSEbnght HEL- 
binding gate was set on the CD4" lymphocyte population as described in (A).
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Section 2.8. CFSE Labelling
Labelling of donor splenocytes with 5-(and 6-)carboxyfluorescein diacetate 
succinimidyl ester (Molecular Probes, Eugene, OR) was performed as described elsewhere 
(Lyons, 1994; Warren, 1999), with minor modifications. Single cell suspensions were 
stained at room temperature for 7 minutes in a final CFSE concentration of 2.5 pM or 10 
pM in complete RPMI-1640 (10 % FBS). The labelling reaction was halted by addition of 
> 2 volumes of ice-cold complete RPMI-1640 (10 % FBS). Cells were washed extensively 
in complete RPMI-1640 (10 % FBS) at 4 °C then resuspended in complete RPMI-1640 (2 
% FBS) prior to adoptive transfer. In recipients that received CFSE-labelled transgenic B 
cells, donor B cells were tracked using CFSE and HEL / HyHEL9-TriColor on day 1 and 
day 2 of the immune response as described in Figure 2-2, part B. On days 3, 4 and 5, 
transgenic B cell net clonal expansion was determined by staining with two fluorochromes 
for HEL simultaneously (Townsend, 2001) as described in Figure 2-2, part A.
Section 2.9. ELISPOT
ELISPOT assays were performed as described (Sedgwick, 1986) using biotinylated 
goat anti-mouse IgGi, biotinylated anti-IgMa (Clone RS3.1) and avidin-alkaline 
phosphatase (Sigma).
Briefly, 1 mg/ml HEL in 0.05 M bicarbonate buffer (pH 9.6) was bound to 24-well 
tissue culture plates (Linbro, ICN Biochemicals, Aurora, OH). After blocking with 1 % 
BSA (Fraction V, Sigma) in PBS, spleen or bone marrow single cell suspensions were 
added and cultured for four hours at 37 °C in a 5 % CO2 incubator. After washing with 
PBS and PBS supplemented with 0.05 % Tween-20, the plates were blocked with a mixture 
of BSA and skim milk powder at 37 °C for 30 minutes. First step biotinylated antibody 
was added at 4 °C overnight, followed by second step avidin-alkaline phosphatase at 37 °C 
for 1 hour. Plates were developed using 5-bromo-4-chloro-3-indoyl phosphate (BCIP, 
Sigma). One volume of 3 % (w/v) agarose was mixed with 4 volumes of 1.25 mg/ml BCIP 
in 2-amino-2-methyl-l -propanol buffer (AMP, Sigma), then the mixture added to the 
plates. After colour development, dilutions showing ~200 spots were counted manually 
using a dissecting microscope.
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Section 2.10. Serum ELISA
Anti-lysozyme antibodies in sera were measured as previously described (Rathmell, 
1994), in this case using alkaline phosphatase conjugated goat anti-mouse IgM, biotinylated 
goat anti-mouse IgGi or biotinylated goat anti-mouse kappa (all from Southern 
Biotechnology), followed by avidin-alkaline phosphatase (Sigma).
Briefly, 96-well flat bottom plates (Maxisorb, Nunc A/S, Roskilde, Denmark) were 
coated with HEL (10 pg/ml) in 0.05 M bicarbonate buffer (pH 9.6) overnight. Plates were 
blocked with 0.1 % BSA in PBS for 2 hours at 37 °C. Serum dilutions prepared in 50 p,l of 
0.1 % BSA/PBS were applied to the plate, covered with adhesive plastic and incubated at 
37 °C for 2 hours. First step antibodies were diluted in 0.1 % BSA in PBS, and 50 jllI  added 
per well. Plates were incubated at 37 °C for 1-2 hours. Secondary antibodies were diluted 
in 0.1 % BSA in PBS and 50 [i\ added per well. Plates were incubated at 37 °C for 1 hour. 
To develop, nitrophenyl phosphate (5 mg tablets, Sigma) was prepared at 1 mg/ml in NPP 
buffer and 100 jil added to each well. After visible colour change, absorbance was 
measured at 405 nm and 650 nm using a 96-well plate reader (THERMOmax, Molecular 
Devices Corp., CA). Plates were washed extensively with 0.5 % Tween-20 in PBS in 
between each step.
Reference sera from IgM and IgG transgenic mice containing IgM or IgGi anti­
lysozyme antibodies with the same V regions and kappa chains were used to standardise the 
ELISA. The same pool of reference sera was used throughout all these studies and was 
frozen in small aliquots at -80 °C then each aliquot thawed once. The IgG transgenic 
reference serum was assigned a value of 10,000 anti-lysozyme kappa units and the 
corresponding level of anti-lysozyme kappa units in the IgM transgenic reference sera was 
determined in parallel using the same anti-mouse kappa detecting reagent. IgG and IgM 
standard curves were constructed using these reference sera detected with anti-mouse IgM 
and anti-mouse IgG reagents on each plate used to measure the test sera at multiple 
dilutions. Lysozyme-binding IgM and IgG levels in any test serum could then be related 
back to the IgG and IgM standard curves, for which the level of anti-lysozyme kappa units 
was known.
Section 2.11. Histology
Spleens were removed and half of the tissue taken for histology. This was 
immediately snap frozen in liquid nitrogen for sectioning, then stored in tin foil at -80 °C. 
For sectioning, spleens were mounted on a cold metal chuck using OCT compound (Sakura
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Finetek, Torrance, CA) and placed in a cryostat (Bright Instrument Co. Ltd., Huntingdon, 
U.K.) chilled to - 20 °C. After carefully exposing the spleen using a scalpel, 5-7 pm 
sections were cut and mounted on glass slides. Sections were allowed to air dry and were 
then fixed in ice cold acetone at 4 °C for 20-30 minutes. After acetone fixing, sections 
were sealed in small plastic bags and stored at -20 °C until staining.
Sections were rehydrated in Tris-buffered saline (TBS) for 10 minutes before 
staining. Staining was performed at room temperature in a humidified chamber and 
incubation times were 1 hour for all staining steps except for the 1 ° and 2 ° stains for HEL- 
binding cells that were 30 minutes each. All staining reagents were diluted in TBS with 0.1 
% BSA. All sections were washed twice in TBS between staining steps. All secondary 
reagents were incubated with 10 % normal mouse serum in TBS for 30 minutes to decrease 
non-specific staining of mouse tissue. The sequence of stains for each target antigen is 
given in
Table 2-2.
Target 1 ° 2 ° 3 ° 4 ° 5 ° D A B Fast Blue
HEL-
binding
cells
HEL H yH EL9-bio HEL HyHEL9-
bio
SA-
AP
Y es
C D 138
(Syndecan)
rt-a-
m CD 138
rb-a-rt bio SA-AP - - - Y es
I g D ( l ) rt-a-m lgD gt-a-rt HRP - - - Y es -
IgD (2) shp-a-m lgD rb-a-shp HRP - - - Y es -
M OM A-1 rt-a-
mM OM A-1
gt-a-rt HRP - - - Y es -
Table 2-2. Schematic showing the staining and developing steps for
immunohistochemical detection of various target antigens.
Abbreviations: r t rat, m mouse, shp sheep, rb rabbit, gt goat, HRP horse radish 
peroxidase, PNA peanut agglutinin, SA-AP streptavidin-alkaline phosphatase.
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Sections were developed sequentially. Firstly, peroxidase-labelled antigens were 
developed using diaminobenzidine (DAB, Pierce, Rockford, IL) solution at 1 mg/ml in 
TBS with a 1:1000 dilution of hydrogen peroxide (from a 30 % solution, Pierce). DAB 
solution was filtered through a 0.45 pm syringe mounted filter (Millipore, Bedford, MA) 
directly onto the section. Secondly, alkaline-phosphatase labelled antigens were developed 
using a Fast Blue kit (Vector), following the manufacturers instructions. Levamisole 
(Sigma) was added at 1 pM to the Fast Blue reagent to inhibit endogenous alkaline 
phosphatase activity.
After washing with ddFLO sections were air-dried and mounted using Immumount 
(Shandon Inc., Pittsburgh, PA).
Section 2.12. Biochemistry techniques
2.12 (a) Cell stimulation and lysis
After counting and TAC lysis, cells were resuspended in complete RPMI-1640 at a 
concentration of 107 per 200 pi. Cells were allowed to warm at 37 °C for 3 minutes prior to 
stimulation. Cells were then stimulated ± HEL at 10 pg/ml for 3 minutes. Different lysis 
conditions were used from this point, depending on the desired cell fractionation. In all 
cases the lx lysis buffer contained the following inhibitor cocktail: protease inhibitors - 2.5 
mM PMSF (Sigma), 200 pM leupeptin hemisulfate (Calbiochem-Norabiochem Corp., La 
Jolla, CA), 200 pM aprotinin (Sigma) and phosphatase inhibitors - 10 pM sodium 
orthovanadate (Sigma, pre-activated using H2O2), 100 pM phenylarsene oxide (Sigma), 25 
mM NaF (Sigma)
Cytoskeletal stabilising buffer (CSB) lysis
After stimulation, cells were pelleted by spinning at 850 g for 3 minutes in a benchtop 
microfuge. Media was aspirated and the pellet washed once in 200 pi complete RPMI- 
1640. After washing, 200 pi “low salt” CSB buffer (+ inhibitors) was added, the pellet 
resuspended and the lysate left at 4 °C for 10 minutes. The “low salt” soluble cell fraction 
was recovered as supernatant after spinning for 10 minutes (380 g, 4 °C) and immediately 
added to 50 pi of boiling 3x sample buffer (lx sample buffer contained: 2 % (w/v) SDS, 10 
% (v/v) glycerol, 62.5 mM Tris.HCl (6.8), 0.01 % (w/v) bromophenol blue, ±3.3 % (v/v)
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2-mercaptoethanol). The sample was boiled for 5 minutes then snap frozen in dry 
ice/MeOH and stored at -70 °C. CSB buffer components are described in Section 2.13.
After washing once in 100 pi “low salt” CSB buffer, the detergent-insoluble pellet 
was resuspended in 100 pi “high salt” CSB buffer and the lysate left at 4 °C for 10 minutes. 
The “high salt”-extractable material was recovered from the detergent-insoluble pellet after 
centrifugation for 10 minutes (380 g , 4 °C) and immediately added to 25 pi of boiling 3x 
sample buffer. The sample was boiled and stored as above.
The lysate pellet, corresponding to detergent insoluble cytoplasmic and nuclear 
fractions was added to 100 pi of boiling lx sample buffer. The sample was boiled and 
stored as above.
TX-100 lysis
After HEL stimulation, cells were pelleted by centrifugation at 850 g  for 3 minutes in 
a benchtop microfuge. After aspirating the supernatant, the pellet was resuspended in 200 
pi TX-100 lysis buffer and left on ice for 10 minutes. TX-100 lysis buffer comprised 1% 
(v/v) TX-100, 10 mM EDTA, 50 mM Tris.HCl (pH 7.5), 250 mM NaCl, as well as the 
inhibitor mixture described above.
After lysis, samples were spun at 16000 g, 4 °C, in a benchtop centrifuge (Labofuge 
400R, Heraeus Instruments, New Jersey). The 200 pi supernatant fraction corresponding to 
detergent-soluble cell structures was immediately added to 100 pi boiling 3x sample buffer 
for 5 minutes. Also, the detergent insoluble pellet was solubilised by boiling for 5 minutes 
in 100 pi lx sample buffer. Both fractions were snap frozen in dry ice/MeOH and stored at 
-70 °C until analysis.
2.12 (b) Western Blotting
Discontinuous polyacrylamide gel electrophoresis under reducing or non-reducing 
conditions was used to separate proteins within detergent lysates. Gels were prepared using 
standard recipes (Sambrook, 1989) in the Mini-Protean II mini-gel format (BioRad). 
Samples were thawed, boiled for 5 minutes and spun at 16000 g in a benchtop microfuge to 
clarify insoluble material prior to loading. Coloured broad range molecular mass standards 
(BioRad) were run in parallel to estimate sample protein molecular mass. These ranged 
from 20-200 kDa apparent molecular mass when run on a 10 % polyacrylamide gel. These 
were also boiled and centrifuged prior to loading.
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Western blotting to a PVDF membrane (Immobilin P, 0.45 pm, Millipore, Bedford, 
MA) was performed according to standard methods, using the Mini-Protean II (BioRad) 
mini-gel format. Blotting was performed overnight at 40 Volts or over 1 hour at 100 Volts, 
in both cases at 4 °C.
After blotting, the membrane was blocked overnight or for 2 hours at room 
temperature with 3 % (w/v) BSA dissolved in TBS/Tween (TBS for Western blot -  20 mM 
Tris.HCl (pH 7.5), 100 mM NaCl, 2 mM EDTA, with 0.1 % (v/v) Tween-20). The 
blocking solution was syringe-filtered (0.45 pm, Millipore) prior to use. After 3x5 minute 
washes in TBS/Tween, primary antibody diluted in TBS/Tween with 1 % (w/v) BSA and 
0.1 % sodium azide was added to the blot and incubated for 1 hour at room temperature. 
The primary antibody was saved for reuse, and after washing the HRP-conjugated 
secondary antibody was diluted in TBS/Tween and added for 30 minutes at room 
temperature. After the final wash, blots were developed using chemiluminescence. The 
chemiluminescent substrate (Rennaisance, NEN, Boston, MA) was prepared and incubated 
for 30 seconds with the blot. After removing the excess substrate, the blot was wrapped in 
cling-film, exposed to X-ray film in a cassette (X-OMAT AR, Eastman Kodak Co., 
Rochester, NY), and developed.
Section 2.13. Buffers, media and stock solutions
Buffers
m  AMP Buffer
1 M 2-amino-2-methyl-l-propanol (Sigma)
0.7 mM MgCE
0.01% (v/v) TX-100 
0.1 % (w/v) Sodium azide 
pH 10.25
(2) Carbonate buffer
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NaHC03 1.59 g/L, Na2C03 2.93 g/L dissolved in ddH20, pH 9.6
(3) Tris Buffered Saline (TBS) for histology
60.6 g Trizma.HCl (Sigma)
13.9 g Trizma Base (?)
87.7 g NaCl 
Dissolved in 10 L ddH20, pH 7.6
(4) Phosphate Buffered Saline (PBS) -  prepared in house, JCSMR media
8.0 g/L NaCl
1.25 g/L Disodium hydrogen orthophosphate
0.35 g/L Sodium dihydrogen orthophosphate (monohydrate)
(5) FACS wash solution
3 % (v/v) FBS and 0.1 % (w/v) sodium azide in PBS. Stored at 4 °C.
(6) FACS fixative
1 % (w/v) paraformaldehyde in PBS. Stored at 4 °C.
Media
(1) RPMI 1640- prepared in house, JCSMR media
10.44 g/L RPMI powder (GibcoBRL, Life Technologies, NY, USA)
2.0 g/L Sodium bicarbonate
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Solution microfiltered (0.2 pm) and aseptically dispensed into sterile Schott bottles. 
pH 73-7.5.
Stock solutions
(1) Alsever's solution (modified) -  prepared in house, JCSMR media 
For a 1 L stock:
8 g sodium citrate
4.2 g sodium chloride
20.5 g glucose
0.8 g citric acid
Dissolve ingredients in 1 L ddH20. Adjust pH to 6.1 with 10 % citric acid. Autoclave and 
store at 4 °C.
(2) Nitrophenvl phosphate fNPP) buffer
15 mM 
35 mM 
0.1 mM 
0.1 % (w/v) 
pH 9.8
Na2CC>3
NaHCOs
MgCl2
sodium azide
(3) Tris Ammonium Chloride (TAC) -  Red blood cell lysis buffer 
Lysis buffer contains 0.02 mM Tris and 0.1 M ammonium chloride in PBS. 
1.03 g Tris and 3.375 g ammonium chloride dissolved in 500 mL PBS.
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pH adjusted to 7.2 with cone. HC1.
Autoclaved and stored at room temperature.
(4) Cvtoskeletal Stabilising Buffer (CSB)
0.1 % (v/v) TX-100 (Sigma)
20 mM HEPES (Sigma)
300 mM Sucrose 
0.1 mg/ml BSA
20 mM sodium chloride ("low salt" buffer) OR 150 mM sodium chloride ("high salt" 
buffer)
5 mM magnesium chloride
prepared in ddH20
Chapter 3. The IgG membrane tail is a
regulator of B cell clonal 
expansion in vivo
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Section 3.1. Introduction
Memory antibody responses to T-dependent antigens are characterised by the rapid 
production of high titres of antigen-specific antibody (Burnet, 1959). The prevailing view 
is that antigen-specific memory B cells are maintained after clonal expansion during the 
primary immune response and are responsible for the features of the secondary response 
(Celada, 1971; Gray, 1993; Sprent, 1994; Ahmed, 1996).
Defining the basis for these heightened memory responses has been complicated, 
however, because the first priming with antigen brings about numerous interconnected 
changes in the antigen-specific B cell pool. For example, clonal expansion increases the 
frequency of antigen-specific B cells (Hayakawa, 1987; Schittek, 1990) and antigen-driven 
selection in germinal centres leads to the appearance of B cells bearing somatically mutated 
high affinity antigen receptors (Eisen, 1964; Weiss, 1990). Also, phenotypic changes such 
as the altered expression of cell surface molecules (Klein, 1998; Tangye, 1998), modified 
homing patterns (Liu, 1991; Liu, 1995; Tierens, 1999) and lower activation requirements 
(Liu, 1995) are characteristic of memory B cells. In addition, isotype switching during the 
formation of many memory B cells leads to the replacement of surface IgM and IgD with 
downstream isotypes, notably IgG in the case of protein antigens.
Isotype switching to IgG is an irreversible molecular change that has been used in 
many studies as a marker for memory B cells (Hayakawa, 1987; Maruyama, 2000). The 
expression of switched isotypes confers a significant alteration in the membrane lg B cell 
antigen receptor (BCR), as each carry a distinct extracellular spacer, transmembrane and 
extended cytoplasmic tail sequence that are highly conserved within isotypes and between 
species (Reth, 1992; Nussenzweig, 1997) (Figure 1-3). Relatively few studies have 
investigated the signalling consequences of isotype switching, however, especially with 
respect to the function of the conserved membrane tail during memory B cell responses in 
vivo.
In vitro studies of the function of switched isotype receptors have focussed on a 
conserved YXXM motif in the cytoplasmic tail sequence of IgG and IgE and its role as a 
putative internalisation signal for antigen processing and presentation. It has been reported 
that both IgG2a (Weiser, 1994) and IgGi(Knight, 1997) isotype antigen receptors can be 
internalised when expressed in cell lines that lack the accessory molecules Iga and Igß and 
that antigen presentation in vitro by IgGi isotype receptors expressed without Igaß is 
partially disrupted by mutation of the YXXM motif (Knight, 1997). The physiological 
significance of these findings is not clear however, as mutation of the YXXM motif has no
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effect on the rate of antigen presentation in vitro when IgGi is associated with Igccß 
(Knight, 1997). Also there is no indication in vivo that IgG isotypes are expressed at any 
stage of B cell development in the absence of Igaß.
Recent studies using gene-targeted mice which lack either IgGi or IgE cytoplasmic 
tail sequences have established that these segments are needed by B cells expressing these 
isotypes in vivo, although the role they serve has not been identified. Mice carrying a 
targeted disruption of the cytoplasmic tail sequences of IgG, (Kaisho, 1997) or IgE 
(Achatz, 1997) generated poor antigen-specific IgG, or IgE primary and secondary 
antibody responses. For IgG tail-truncation mutant mice, profound differences in antigen 
receptor affinity and responding IgG cell frequency existed between mutants and wild type 
mice. This raises the possibility that cells with truncated receptors had either poor 
activation, increased cell death, a defect in germinal centre formation or a lower rate of cell 
division. Kaisho et al. (Kaisho, 1997) found lower surface expression of the truncated Atail 
IgG BCR on unselected lipopolysaccharide (LPS) blasts in vitro, suggesting the alternative 
explanation that the IgG tail is needed for adequate surface expression of this isotype rather 
than for a distinct function of IgG BCRs.
To investigate how BCR isotype switching affects the way B cells respond to antigen 
in vivo, independent of changes in specificity, frequency and priming, we have examined 
the response of B cells from immunoglobulin gene (Ig) transgenic mice. We have used a 
panel of transgenic mice which all share the same high affinity variable region specific for 
the protein antigen Hen Egg Lysozyme (Goodnow, 1988; Brink, 1992; Pogue, 2000)
(HEL). The BCR isotypes expressed are IgM or IgD, which are characteristic of naive B 
cells, or are IgG, an isotype strongly associated with B cell memory. In addition to B cells 
expressing native IgM or IgG BCRs, we also engineered transgenic strains with HEL- 
binding B cells expressing a chimeric IgM/G BCR, where the exons of the secreted product 
are from IgM but the membrane tail exons are from IgG (Pogue, 2000) (see Figure 3-1 part 
A and Figure 2-1).
This strategy avoids the problems interpreting loss of function results from truncated 
receptors, because we test whether any unique functions of the IgG membrane tail can be 
gained by IgM through the transfer of these segments. By seeding transgenic B cells from 
these lines into normal immune responses, it becomes possible to control for many 
variables. Firstly, precursor frequency can be precisely controlled. Also, the responding B 
cells are all naive and can be prepared at matched stages of development, bearing antigen 
receptors of a defined isotype with an identical affinity for antigen. Finally, the use of high 
affinity transgenic B cells allows clonal expansion and differentiation to be followed at the 
single cell level by flow cytometry.
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Using this strategy, it was found that changing the BCR isotype from IgM to IgG 
confers a greatly increased production of plasma cells during extrafollicular T cell- 
dependent antibody reactions. The IgG membrane tail is sufficient to confer this burst­
enhancing property on IgM, and the enhanced response results from decreased attrition of 
progeny cells rather than enhanced activation or proliferation.
Section 3.2. IgG-bearing B cells produce more antibody 
than IgM-bearing B cells during an immune 
response
To test the effect of high-affinity precursor frequency and antigen receptor isotype on 
antibody production during a primary immune response, varying numbers of naive 
lysozyme-binding B cells from IgM isotype and IgG isotype donors were seeded in a 1:1 
ratio into unirradiated C57BL/6 recipient mice immunised with lysozyme. This co-transfer 
design had the advantage of controlling for any other differences affecting helper T cells or 
other cells, although the same results were obtained seeding IgM and IgG cells into 
separate recipients.
Serum was collected from the primary response on day 10 after immunisation and 
from the secondary response 5 days after boosting. The magnitude of the anti-lysozyme 
IgM and IgG immune response was then determined by ELISA (Figure 3-1, part B). The 
kappa light chains shared in common by the transgenic IgM and IgG were used to 
standardise the assay to allow the amounts of each to be directly compared (see Section 
2.10, materials and methods). The endogenous primary and secondary IgM responses were 
of low titre and were not increased by transfer of up to 106 transgenic B cells bearing the 
high-affinity antigen-specific IgM isotype BCR. By contrast, as few as 104 transgenic B 
cells bearing high-affinity antigen-specific receptors of the IgG isotype increased the 
primary IgG response —400 fold. Groups of mice that received 105 or 106 IgG B cells made 
a primary anti-lysozyme IgG immune response that equalled the magnitude of the 
endogenous secondary response to lysozyme.
Section 3.3. The IgG membrane tail is the molecular 
determinant responsible for heightened 
antibody responses
The role of the unique membrane tail of IgG in this heightened antibody response was 
tested by comparing the response of IgG B cells to B cells bearing IgM or the chimeric 
IgM/G receptor. After seeding into a primary antibody response, the IgM/G cells mounted
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a comparable serum antibody response to the IgG cells that was 40-fold higher than the 
IgM cells (Figure 3-1, part C).
In additional experiments, C57BL/6 recipient mice were primed with lysozyme to 
expand and differentiate the pool of helper T cells, then mixtures of IgG and IgM, or IgG 
and IgM/G transgenic B cells were co-transferred and the recipients were boosted. 
Antibody production was assessed by ELI SPOT assay to enumerate splenic antibody­
forming cells (AFCs). It was found that IgM transgenic B cells made 10-fold fewer AFCs 
than IgG transgenic B cells, whereas IgM/G cells made comparable numbers of AFCs to 
IgG cells (Figure 3-2, part A). Data pooled from a number of experiments confirms that 
IgM transgenic B cells made 10-fold fewer AFCs compared to IgG or IgM/G transgenic B 
cells in this system (Figure 3-2, part B). These data identify the IgG membrane tail region 
as the crucial domain that leads to the large differences in serum antibody production and 
splenic AFC numbers between IgG and IgM transgenic cells during an immune response.
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Figure 3-1. Seeding a primary antibody response with naive B confers
memory-response characteristics when the receptors contain 
the unique IgG membrane tail
A. Schematic illustrating membrane Ig sequence differences in the carboxy-terminal 
membrane tails of mouse IgM, IgD and IgGi. Diagrams below show the transgenic lines 
used in this chapter, transgenic BCR structures and secreted immunoglobulin isotypes.
B. Mixtures of splenocytes containing equal numbers of IgG and IgM HEL-binding 
transgenic B cells were prepared. Inocula containing 10 , 105, 104, or 103 of each type of 
HEL-binding B cell was injected into recipient C57BL/6 mice that were immunised with 
lysozyme in CFA (i.p.) and boosted with soluble lysozyme (i.v.) 21 days later. Filled 
circles show serum anti-lysozyme IgGi levels and open circles give serum anti-lysozyme 
IgM levels in individual animals on day 10 and day 26 as determined by ELISA (see 
Section 2.10 for a description of anti-lysozyme kappa units). The limit of detection for 
anti-lysozyme IgM was 100 kappa units and the limit of detection for anti-lysozyme IgG 
was 2 kappa units.
C. As in (B), except 106 lysozyme-binding B cell mixtures of the indicated types were 
transferred and the serum response measured on day 10 by ELISA.
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Figure 3-2. The IgG membrane tail increases the production of antibody­
forming cells
A. C57BL/6 recipient mice were immunised with TEL in CFA to prime helper T cells. 
Seven days later each recipient received mixtures of 106 IgG transgenic B cells with either 
106 IgM or 106 IgM/G transgenic B cells and was boosted with soluble TEL in PBS (i.v.). 
Recipient splenocytes were isolated 5 days after transfer and lysozyme-binding AFCs 
enumerated by ELISPOT. Filled circles give the anti-lysozyme IgGi AFC levels and open 
circles give the anti-lysozyme IgMa AFC levels per 107 recipient lymphocytes.
B. Ratio of lysozyme-specific IgMa .AFCs to lysozyme-specific IgGi AFCs from individual 
mice. Filled circles show the ratio of IgMTgG AFCs in recipients that received a mixture 
of IgG and IgM transgenic B cells. Open circles show the ratio of IgMTgG AFCs in 
recipients that received a mixture of IgG and IgM/G transgenic B cells. Data was pooled 
from several transfer experiments performed as described in (A).
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Section 3.4. The IgG tail augments B cell clonal
expansion during an immune response
Heightened antibody production from IgG or IgM/G cells could have been due to 
either the greater clonal expansion of those cells or the differentiation of a greater fraction 
into AFCs. These ideas were tested by seeding the primary antibody response with large 
numbers of lysozyme-specific helper T cells from 3A9 TCR transgenic mice (Ho, 1994), as 
well as lysozyme-specific B cells. Provision of greater T cell help allowed a large fraction 
of the transferred B cells to be activated synchronously after immunisation, making it 
possible to compare directly the initial proliferation of the different B cells. As before, IgG 
or IgM/G B cells produced 100-fold more AFCs than IgM B cells (Figure 3-3, part A). 
MD-4 transgenic B cells that co-express IgM and IgD naive isotypes (Goodnow, 1988; 
Goodnow, 1989) also yielded relatively few AFCs, at least 10-fold fewer than the IgG or 
IgM/G B cells. Flow cytometric enumeration of the HEL-binding B cells (Figure 3-3, parts 
B and C) showed that the difference in AFC production is mostly explained by an increased 
net clonal expansion of IgG or IgM/G B cells compared to the IgM or IgM/IgD isotype B 
cells.
Importantly, comparisons have been made using four lines expressing the IgG 
membrane tail (GG4, MG2, MG6 and MG8, Pogue, 2000), as well as four IgM or IgD 
transgenic lines which express either IgM or IgD alone (MM4, Brink, 1992), co-express 
IgM and IgD (MD4, Goodnow, 1988) or express IgM with the 27-amino acid extracellular 
spacer domain of IgD (M8E1 and M5E2, Pogue, 1994). These lines were made with 
constructs that differed in the type and the extent of the transgene switch regions. In every 
case, the transgenic lines expressing the IgG membrane tail make at least a 10-fold greater 
immune response in vivo on the basis of clonal expansion and AFC production (Figure 
3-4). This strongly supports the conclusion that expression of the IgG membrane tail 
confers enhanced reactivity to antigen in vivo.
The possibility that line to line variation in transgenic constructs as well as the effect 
of IgD expression in this system will be considered in more detail in Chapter 6.
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Section 3.5. increased clonal expansion conferred by 
the IgG membrane tail is due to decreased 
death over successive cell divisions
The much larger clonal expansion conferred by the IgG membrane tail region could 
have reflected a greater fraction of cells activated initially by helper cells, a greater rate of 
cell division leading to many more progeny, or a lower attrition of progeny cells. To 
distinguish between these possibilities transgenic B cells were loaded with the cell-division 
tracking dye carboxyfluorescein diacetate succinimidyl ester (CFSE, Lyons, 1994) prior to 
transfer. Cell division was then followed by flow cytometry on day 1, day 2 and day 5 after 
immunisation (Figure 3-5). There was no evidence for division of the transferred 
transgenic B cells on day 1. On day 2, a comparable fraction of the IgM, IgG and IgM/G B 
cells had divided, shown by dilution of CFSE on a fraction of cells relative to controls.
This suggests there is no difference in the initial activation of the IgM, IgG and IgM/G B 
cells by the available T cell help. By day 5 however, the net clonal expansion of the IgG 
and IgM/G cells was much greater than the IgM cells. On day 5 the remaining IgM B cells 
had nevertheless diluted CFSE staining to a comparable degree to the IgG and IgM/G B 
cells. In three separate experiments there was no difference in the intensity of CFSE 
staining of the remaining IgM or IgM/G transgenic B cells, simply a difference in the 
absolute number of cells. This implies that IgM B cells are capable of dividing at least 6 to 
8 times and suggests little difference in the overall rate of cell division. Instead, IgM 
transgenic B cells must undergo a greater rate of loss during clonal expansion. This is not 
due to migration to the bone marrow or preferential differentiation into AFCs at other sites, 
as few bone marrow IgM AFCs form during this response (see Figure 4-2, part E). Also, 
production of serum anti-lysozyme IgM, which is a measure of global antibody production, 
is not increased by seeding even 106 IgM transgenic B cells into a primary anti-lysozyme 
response (Figure 3-1, parts B and C). The most reasonable explanation for these data is that 
the IgM transgenic B cells die in situ. Thus, expression of the IgG membrane tail does not 
alter the rate of activation or proliferation in T cell-driven responses, but greatly diminishes 
the attrition of progeny B cells between day 3 and day 5, during the later phases of clonal 
expansion. This leads to an increased net clonal burst size, increased production of effector 
cells and a rapid rise in serum IgG antibody titre.
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Figure 3-3. The IgG tail augments clonal expansion
Recipient (B10.BRxC57BL/6)Fi mice received 106 3A9 TCR transgenic CD4+ T cells to 
increase the number of lysozyme-specific helper T cells, together with mixtures of 106 
transgenic B cells of the indicated types (i.v.). Recipients were immunised at the same 
time with lysozyme in adjuvant or adjuvant alone (i.p.).
A. Levels of splenic anti-lysozyme AFCs enumerated by ELI SPOT on day 5 after donor 
cell transfer and immunisation. Anti-lysozyme IgGj AFCs in individual recipients are 
represented by filled circles, anti-lysozyme IgMa AFCs by open circles.
B. Number of splenic lysozyme-binding B cells in the same animals as (A), enumerated by 
FACS. Comparable results were obtained in 2 separate co-transfer experiments and in 
three additional experiments where IgG (GG4), IgM (MM4), IgM/G (MG2) and IgM/IgD 
(MD4) B cells were transferred singly into separate recipients. Filled circles: IgG 
transgenic B cells; open circles: IgM, IgM/G and IgM/IgD transgenic B cells.
C. Representative FACS analysis from samples in (B). Staining for cell surface HEL- 
binding receptors and IgMa is shown gated on HEL+ CD4' lymphocytes from transfer 
recipients. The percentage of total splenic lymphocytes in each quadrant is given. Details 
of the FACS gating strategy can be found in 2.7 (c).
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Figure 3-4. All transgenic lines expressing the IgG membrane tail make an 
equivalent response to antigen in vivo
Recipient (B10.BRxC57BL/6)Fi mice were immunised with HEL in CFA (i.p.), and at the 
same time received 106 TCR transgenic T cells and 106 of the indicated type of transgenic 
B cell (i.v.).
A. ELI SPOT data from day 5 after transfer and immunisation demonstrating the equivalent 
behaviour of transgenic lines expressing the IgG membrane tail (MG2, MG6 and MG8) 
compared to lines expressing IgM alone (MM-4) or IgM8E (M8E1 and M8E2). This graph 
shows the levels of lysozyme-specific IgGi (filled circles) and IgMa (open circles) AFCs in 
the spleens of transfer recipients, expressed as the number of AFCs per 107 total 
lymphocytes.
B. Clonal expansion data showing lysozyme-binding cell numbers per 10 total 
lymphocytes from the same mice described in (A). Again all the transgenic lines bearing 
the IgG membrane tail made an ~10-fold greater clonal expansion response compared to 
transgenic lines bearing IgM or IgD. Note single “non-responding” mice in MG2 and MG6 
groups. These may represent mice that received a sub-optimal i.p. injection of HEL/CFA 
due to puncture of the gut or bladder.
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Figure 3-5. IgG, IgM/G and IgM transgenic B cells enter cell division at the
same time yet undergo different net clonal expansion during a T- 
dependent response to antigen in vivo
Ig transgenic donor spleen cells were labelled with CFSE and 106 IgG, IgM or IgM/G 
lysozyme-binding B cells transferred per (B10.BRxC57BL/6)Fi recipient mouse. Each 
recipient also received 106 TCR transgenic CD4+ T cells and was immunised with 
lysozyme in CFA or CFA alone. Recipient spleen cells were analysed by FACS on day 1, 
day 2 and day 5 after immunisation to enumerate lysozyme-binding B cells and to measure 
cell division by the dilution of CFSE. For gating strategies to detect HEL-binding B cells, 
see 2.7 (c). Histograms show CFSE staining (x-axis) versus cell number, gated on 
lysozyme-binding B cells of the indicated types. Numbers above gates indicate the 
percentage of divided or undivided cells amongst the lysozyme-binding B cells. Numbers 
in the lower right comer show the percentage of lysozyme-binding B cells in the original 
lymphocyte gate.
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Section 3.6. Chapter summary
The basis for heightened secondary antibody responses has been a longstanding 
unanswered issue confounded by the normally connected differences in specificity, affinity, 
frequency, priming, and developmental status of antigen-binding B cells in naive or primed 
individuals. This study has tracked the in vivo immune response of B cells from Ig- 
transgenic mice using homogeneous populations of B cells bearing a uniform, well- 
characterised, high-affinity antigen receptor. The BCR only differs within the constant 
region segments (IgM versus IgG) or only in the carboxy-terminal membrane tail (IgM/G). 
These results show that IgG BCRs confer a greatly increased clonal burst during the 
extrafollicular antibody response driven by T cells, and show that the unique membrane tail 
of IgG is the sole determinant of this heightened burst. The cellular basis for heightened 
response does not lie in any difference in the activation or rate of proliferation, but is 
brought about by decreasing the attrition of progeny cells from the later phases of the 
response.
It is often assumed that immunological memory in antibody responses requires the 
long-term maintenance of an enlarged pool of antigen-specific B cells (Burnet, 1959). The 
findings here indicate that an enlarged population of antigen-specific B cells is not 
sufficient to confer a heightened memory antibody response to a T cell-dependent antigen. 
Instead, the presence of small numbers of antigen-specific B cells that bear IgG receptors is 
sufficient for the heightened antibody response, because the unique tail of membrane IgG 
triggers a greatly increased proliferative burst when the B cell encounters antigen and 
helper T cells. These findings explain a number of earlier observations. First, the greater 
proliferative burst of IgG cells provides a mechanism for the dominance of IgG isotypes in 
memory responses to T-dependent antigens, and for the observation that depletion of IgG 
bearing B cells from primed lymphocyte mixtures removes most of the memory potential 
(Coffman, 1977; Yuan, 1977), despite the paradoxically low numbers of isotype-switched 
B cells present normally in mice and humans (Gray, 1993). The results presented here also 
explain the augmented ability of IgG bearing cells to produce AFCs upon in vitro 
stimulation (Yefenof, 1986).
These findings are also consistent with previous studies showing the ten-fold 
lowering of antigen-specific IgG or IgE responses in knockout mice with truncated IgG or 
IgE tails lacking the cytoplasmic segment (Achatz, 1997; Kaisho, 1997). The findings from 
the tail-truncation mice established that an intact cytoplasmic segment is important for IgG- 
bearing B cells, but failed to establish whether the intact cytoplasmic sequence is needed 
for correct surface expression of IgG or for some specific process during the formation,
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survival or response of IgG+ cells. IgG+ B cells lacking the cytoplasmic segment exhibited 
lower surface Ig expression on LPS blasts in vitro but expression appeared normal on the 
few cells that could be detected in vivo (Kaisho, 1997). This raises the possibility that the 
reduced numbers of IgG+ cells and IgG serum antibody in tail-truncation mice resulted 
from reduced stability of surface IgG expression. The transgenic approach taken here 
avoids these problems by directly comparing the function of IgM and IgG in its normal 
structure, and by adding the complete IgG membrane tail segments to IgM at the natural 
junction point between the secreted and membrane Ig proteins.
The downstream biochemical mechanism for augmenting B cell clonal expansion 
through the IgG membrane tail will be of future interest. Some reports have suggested that 
the YXXM sequence within the IgG cytoplasmic tail domain acts as an endocytosis signal 
of the YXX<j) type (where <j) is any bulky, hydrophobic amino acid) to increase antigen 
presentation through the MHC Class II pathway (Achatz, 1997; Kaisho, 1997;
Nussenzweig, 1997), perhaps with a reduced dependence for accessory signaling molecules 
(Knight, 1997). We cannot rule out the IgG membrane tail playing a role in this process, 
although we find no evidence that the priming of IgG transgenic cells is more efficient than 
IgM transgenic cells during their initial activation in vivo. It is probable that the IgG 
membrane tail has other signaling functions, specifically in promoting cell survival during 
successive cell divisions. It is interesting that the burst-enhancing effect of the IgG 
membrane tail parallels the burst-enhancing effect of CD28 costimulation or CTLA4- 
deficiency in helper T cell proliferation (Gudmundsdottir, 1999; Doyle, 2001). In each 
case, a major mode of action is to decrease the attrition of progeny cells to yield many more 
effector cells. Collectively, these results underscore the control of cell loss rather than cell 
proliferation as a key regulatory point for controlling the magnitude of immune responses 
in vivo.
Chapter 4. An examination of factors which
affect transgenic B cell responses 
to antigen in vivo
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Section 4.1. Introduction
In the previous chapter the IgG membrane tail was shown to have a unique, isotype- 
specific function in vivo. Transgenic B cells expressing the membrane tail of IgG were 
shown to produce a more robust response compared to IgM transgenic B cells and the 
effect was due to greater net clonal expansion during a T-dependent immune response.
This was not due to more efficient activation of B cells bearing the IgG membrane tail, as 
the initial entry into cell cycle on day 2 after immunisation was similar in all transgenic B 
cells tested. By day 5 after immunisation, however, there was a large net clonal expansion 
of IgG and IgM/G transgenic cells, while very few IgM transgenic cells could be detected 
by FACS.
This chapter will address the location of the transgenic cells during the immune 
response in a more detailed study of the events between day 2 and day 5 after 
immunisation, during a primary anti-lysozyme response in the presence of transgenic T cell 
help. Also, possible explanations will be explored for the large difference in behaviour 
between the transgenic B cells expressing or lacking the IgG membrane tail.
Section 4.2. The location and phenotype of IgG and IgM 
transgenic B cells during an immune 
response
For experiments described in Section 4.2, 106 IgM/G or 106 IgM transgenic B cells 
were seeded along with 106 TCR transgenic T cells into lysozyme-immunised recipient 
mice (for details see legends to Figure 4-1, Figure 4-2).
4.2 (a) Histology
In order to follow the fate of the transgenic B cells in the time period between days 2 
and 5, spleen sections were cut on days 3, 4 and 5 after immunisation and transfer from 
recipients that received IgM/G or IgM transgenic B cells (Figure 4-1). By staining for 
HEL-binding cells, syndecan-binding cells and B cell follicles it was possible to follow the 
expansion, location and differentiation of the transferred transgenic B cells. The results are 
consistent with a predominantly extrafollicular response for both IgM/G and IgM 
transgenic B cells during a primary response to lysozyme in the presence of transgenic T 
cell help.
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In both cases IgM/G and IgM transgenic B cells are syndecan negative on day 3, and 
were found in small perifollicular foci, often near the bridging channels which connect the 
T zone and red pulp (Figure 4-1, parts A—>D). On day 4, in the case of IgM/G recipients, a 
few transgenic cells had started to migrate via bridging channels to the red pulp, although 
the majority were still syndecan negative. For both IgM/G and IgM recipients, transgenic 
cells on day 4 were in perifollicular areas, often forming a distinctive ring around the edge 
of B cell follicles. There seemed to be fewer IgM transgenic B cells compared to IgM/G 
transgenic B cells in the three mice of each type analysed at this timepoint (Figure 4-1, 
parts E—>H).
On day 5 there were large differences in the extent of transgenic B cell net clonal 
expansion between IgM and IgM/G transgenic recipients (Figure 4-1, parts I, J). In the case 
of IgM/G transgenic cells, small foci were no longer apparent and the bridging channels 
and the T zones were filled with HEL-binding cells that were syndecan positive. This may 
have represented the transition from small extrafollicular foci to dispersed red pulp plasma 
cells described previously in the NP system (Sze, 2000). In the case of IgM recipients, 
HEL-binding syndecan-positive cells were visible in very few areas of the spleen in similar 
locations (see Figure 4-3, panels K, L). In most regions however, there were very few 
HEL-binding IgM transgenic B cells. They were no longer in perifollicular foci had 
probably died in situ.
Reports using the NP hapten system have suggested that extrafollicular plasmablast 
foci are not sustained by the presence of antigen-specific T cells (Han, 1995a; Gulbranson- 
Judge, 1996), but rather associate with CD1 lchl dendritic-morphology cells (Garcia de 
Vinuesa, 1999). In addition, the relative number of these plasmablast-associated dendritic 
cells (PDCs) may be an extrinsic limiting factor determining plasma cell numbers in the 
spleen (Sze, 2000). Translating those observations to this system, it may be that the IgG 
membrane tail makes IgM/G transgenic B cells less dependent on limiting survival signals 
provided by PDCs within extrafollicular foci. Alternatively, the IgG membrane tail may 
protect IgM/G transgenic B cells from death-inducing signals during exposure to a highly 
cross-linking form of HEL, possibly immune complex held on the surface of PDCs (see 
section 4.2 (b)).
The spleens of transfer recipients that received IgM/G or IgM transgenic cells showed 
no evidence of germinal centre or follicular expansion by day 5. Under this immunisation 
protocol, both IgM and IgM/G transgenic cells were induced to expand and differentiate in 
extrafollicular sites. Experiments to investigate the follicular/GC pathway of expansion 
and differentiation will be decribed in more detail in Section 4.3.
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Figure 4-1. Histological analysis of IgM, IgM/G or non-transgenic recipient 
spleens on day 3, day 4 and day 5 after immunisation and 
transfer.
106 IgM/G (A, B, E, F, I, J) or 106 IgM (C, D, G, H, K, L) donor transgenic B cells were 
transferred with 106 TCR transgenic T cells into (B10.BRxC57BL/6)Fi recipients and the 
animals immunised with HEL in CFA. Recipient spleens were harvested on day 3 (A, B, 
C, D), day 4 (E, F, G, H) and day 5 (I, J, K, L) after immunisation and B cell transfer and 
half of the sample frozen in liquid nitrogen.
Serial 5pm frozen sections were prepared and stained as described in materials and 
methods (Section 2.11) for either HEL-binding cells (A, C, E, G, I, K) or syndecan positive 
cells (B, D, F, H, J, L) in blue and for IgD to show B cell follicles in brown. Bars represent 
150 pm. Markings on the sections indicate the location of follicles (F), red pulp (R), 
junctional zones (J) and the PALS (P).
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4.2 (b) FACS
In addition to locating the transferred transgenic B cells on days 3,4 and 5 after 
immunisation, it was important to track their expansion by FACS. Cell division 
progression was investigated on days 3,4 and 5 after transfer by loading IgM/G and IgM 
transgenic B cells with a higher concentration of CFSE (10 pM compared to 2.5 pM) prior 
to transfer, to try to increase the range of cell division cycles that could be measured.
On day 3 after immunisation and transfer, HEL-binding B cells in both IgM/G and 
IgM recipients could be located as a small on-diagonal population when stained for HEL 
using two fluorochromes simultaneously (Figure 4-2, part A). The CFSE profiles of the 
detectable HEL-binding cells revealed that both IgM/G and IgM transgenic cells had 
undergone a similar number of cell division cycles (~4-6) by day 3 (Figure 4-2, part B). 
This implies that IgM and IgM/G transgenic cells have similar rates of cell division up to 
day 3 after immunisation and transfer.
On day 4 after immunisation and transfer, HEL-binding B cells of the IgM/G and 
IgM transgenic types could not be detected by FACS (Figure 4-2, part A). This was not 
due to a failure of the staining protocol, as HEL-binding cells were clearly visible in a 
positive control containing “spiked” IgM/G transgenic B cells that were added just prior to 
staining. Also, ELISPOT measurements on samples from day 4 suggested that HEL- 
specific AFCs were present at this timepoint (Figure 4-2, part C), and both IgM and IgM/G 
transgenic B cells were visible by histology in sections at this timepoint (Figure 4-1, panels 
I—>L). The FACS staining method relies on detecting the anti-HEL BCR, suggesting that 
transgenic B cells strongly modulate surface Ig expression at this timepoint. The 
phenomenon of receptor modulation in vivo during a T-dependent response has been 
noticed by others using the anti-HEL MD4 line (Garside, 1998). In the present study, 
modulation may have reflected exposure to a multivalent form of HEL, perhaps as immune 
complex between low-affinity endogenous anti-HEL IgM produced early in the response 
and HEL presented by FcR-mediated binding on the surface of dendritic cells. If this is 
correct, it may offer a mechanism for the dramatic loss of IgM transgenic cells after this 
timepoint, as exposure of IgM transgenic cells to this modulating form of antigen may have 
induced cell death, while transgenic B cells expressing the IgG membrane tail were 
protected.
By day 5 after immunisation and transfer, both IgM/G and IgM transgenic B cells 
could be detected by FACS using stains directed against the BCR (Figure 4-2, part A), 
however there was a large, > 10-fold difference in net clonal expansion. The ability to
104 Chapter 4
visualise HEL-binding cells by FACS correlated with the timepoint at which IgM/G and 
IgM transgenic cells were no longer in perifollicular foci, but were located near the 
bridging channels and red pulp.
The expansion rate of IgM/G transgenic B cells at extrafollicular sites between days 3 
and 5 is very rapid, as estimated by FACS. -20,000 IgM/G transgenic B cells could be 
enumerated per spleen on day 3 and these gave rise to -2,000,000 cells per spleen on day 5 
(Figure 4-2, part D). Even in the absence of cell death, the cell division cycle time on the 
basis of these numbers must have been -  8 hours. Certainly there is precedence for cells of 
the B lineage to undergo very rapid cell division of the order of -6-7 hours per cycle in the 
specialised microenvironment of the germinal centre dark zone (Zhang, 1988; Liu, 1991). 
Estimates for cell division cycle time during plasmablast expansion in non-GC 
extrafollicular sites during a primary response vary, but may be of the same order. Jacob 
and Kelsoe (Jacob, 1991) estimated a 16-20 hour division time in foci during the primary 
NP response, but Sze et al. (Sze, 2000) and Toellner et al. (Toellner, 1996) showed that 
plasmablast expansion could proceed with a cell cycle time closer to 10-14 hours. This at 
least shows that the estimates for cell division rate presented here for extrafollicular 
plasmablasts on the basis of FACS enumeration are plausible.
An alternative possibility is that the day 3 FACS enumeration is an underestimate, 
perhaps due to BCR modulation masking the transgenic B cells, as described above. In the 
future it may be possible to use non-BCR markers such as CD45 allotypes to track the 
transgenic B cells, to see if there are discrepancies between the actual number of cells 
present and the number of cells that can be detected during the clonal expansion process by 
staining for BCR expression.
4.2 (c) AFC production
As well as the location and expansion of Ig transgenic B cells over the course of the 
immune response, their differentiation into AFCs was measured by ELISPOT. AFC 
production in the spleen was assessed on days 3,4 and 5 after immunisation and transfer in 
both IgM and IgM/G recipients (Figure 4-2, part C). By this assay, the number of anti-HEL 
IgMa-secreting cells increased steadily from day 3 through day 5 for both the IgM and 
IgM/G transgenic recipients. This assay had the advantage that it did not rely on detecting 
transgenic cells by the expression of high levels of BCR. Clearly there was a quantitative 
difference in the production of AFCs between transgenic lines, with approximately 100- 
fold more IgM/G derived AFCs on day 4 and day 5 compared to IgM AFCs.
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Interestingly, transgenic cell enumeration by FACS and AFC numbers by ELISPOT 
agreed very well for both IgM and IgM/G recipients on day 5, suggesting the majority of 
transgenic cells were at some stage of plasmacytoid differentiation.
This result provides further evidence that IgM transgenic B cells are capable of 
differentiating to antibody-secreting cells, as there are nearly 1000-fold more IgM-derived 
AFCs on day 5 compared to day 3. Despite this, the IgM transgenic B cells consistently 
produce fewer AFCs compared to the IgM/G transgenic B cells. One possible explanation 
could be preferential migration and plasma cell differentiation of IgM transgenic B cells in 
the bone marrow, an important site of long-term antibody production (Benner, 1981; Slifka, 
1998a). This was ruled out by measuring the anti-HEL IgMa AFC response in recipient 
bone marrow on day 5 after immunisation and transfer of IgM/G or IgM transgenic cells 
(Figure 4-2, part E). There were very few AFCs in the bone marrow of either IgM/G or 
IgM transgenic recipients at day 5, suggesting plasma cell migration to the bone marrow 
cannot explain the differences in spleen clonal expansion or AFC production.
4.2 (d) Summary
These experiments showed that there are few qualitative differences in the response 
of IgM/G and IgM transgenic B cells during a primary immune response to HEL. Neither 
IgM/G nor IgM transgenic B cells were located in follicular or germinal centre sites during 
this response, nor was there significant formation of anti-HEL AFCs in the bone marrow. 
Rather, both types of transgenic B cell followed an exclusively extrafollicular pathway of 
expansion and differentiation. They were present in small extrafollicular foci on day 3 and 
those cells detectable by FACS had undergone an equivalent number of cell division cycles. 
The most striking differences manifested on days 4 and 5, as the transgenic B cells 
underwent a transition from extrafollicular foci of syndecan-negative cells to become more 
dispersed syndecan-positive plasmablasts that fill the bridging channels and red pulp. On 
day 4 after transfer there was a striking down-modulation of IgM and IgM/G BCRs, 
possibly due to exposure to multivalent HEL in immune complex. The large quantitative 
difference between IgM and IgM/G transgenic B cell expansion on day 5 by both FACS 
and histology suggests that the protective effect of the IgG membrane tail manifests late in 
the clonal expansion process.
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Figure 4-2. Timecourse of expansion by transferred IgM and IgM/G
transgenic B cells and AFC production in the spleen and bone 
marrow
106 CFSE-labelled IgM or IgM/G transgenic or non-transgenic B cells were transferred 
along with 106 TCR transgenic T cells into (B10.BRxC57BL/6)Fi recipients immunised at 
the same time with FIEL in CFA.
A. Representative FACS plots of IgM/G and IgM transgenic B cells showing the FACS 
enumeration of HEL-binding cells on days 3, 4 and 5 after transfer. Transgenic B cells 
were stained for transgenic BCR on two channels simultaneously, and form a tight on- 
diagonal population. These contour plots are gated on CD4' lymphocytes and show the 
gate used to detect HEL-binding cells. The number refers to the cells falling in the HEL- 
binding gate and is given as a fraction of total splenic lymphocytes.
B. CFSE histograms of IgM/G and IgM transgenic B cells in recipient spleen suspensions 
on days 3 and 5 after immunisation with HEL/CFA or CFA alone. These histograms were 
gated on HEL-binding CD4' lymphocytes, as shown in (A). The numbers within the plots 
refer to the fraction of total splenic lymphocytes that the cells represent. Also on day 3 
histograms the small numbers show approximate cell division cycle numbers, based on the 
position of the undivided peaks in the CFA immunised samples.
C. Graph showing anti-lysozyme IgMa AFC production on days 3 (open circles), 4 (shaded 
circles) and 5 (filled circles) by IgM/G and IgM transgenic B cells. Data is given as total 
AFCs per recipient spleen.
D. Graph showing the net clonal expansion of IgM and IgM/G transgenic B cells on days 3 
(open circles) and 5 (filled circles) enumerated by FACS as described in (A). Data is given 
as total HEL-binding cells per spleen.
E. Graph showing anti-lysozyme IgMa AFC production in the spleen and bone marrow of 
recipients that received IgM/G and IgM transgenic B cells, on day 5 after immunisation and 
transfer. These data are taken from a separate experiment to (A), (B), (C) and (D), and are 
included to show the low numbers of anti-lysozyme bone marrow AFCs detected on day 5 
of the response.
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Section 4.3. Germinal centre and follicular expansion 
of IgM/G and IgM transgenic B cells
The lack of a follicular or germinal centre responses by both IgM/G or IgM 
transgenic B cells on day 5 after immunisation and transfer into unprimed recipients was an 
interesting observation. In a similar system in which antigen-specific transgenic T and B 
cells were seeded into immunised recipients, antigen-specific germinal centres were noticed 
in recipient lymph nodes on day 4 after immunisation and transfer (Garside, 1998).
It was important to determine whether the lack of germinal centres in this system was 
due to the inability of IgM/G and IgM transgenic B cells to participate in germinal centres, 
or to other factors such as the type and location of T cell help. To test this, recipient mice 
were primed with antigen and TCR transgenic cells for 6 days prior to the injection of 
transgenic B cells with a boost of soluble antigen. This was a system that had been used 
previously to study the consequences of antigen engagement on HEL-specific germinal 
centre B cells (Shokat, 1995). It was reasoned that priming with antigen in adjuvant would 
induce normal anti-lysozyme germinal centres, and that transferred transgenic B cells 
would then participate in the germinal centre reaction.
Three days after the introduction of the transgenic B cells into primed mice, both IgM 
and IgM/G B cells were dispersed inside the B cell follicles, with no evidence of 
extrafollicular foci by histology (Figure 4-3, panels A —>D). Numerous PNA+ germinal 
centres that contained HEL protein staining on follicular dendritic cell networks were 
visible at this timepoint (Figure 4-3, panels M and N).
By day 5 after the introduction of transgenic B cells into primed mice, very few HEL- 
binding B cells were located within the B cell follicles by histology (Figure 4-3, panels 
E-»H). HEL-binding B cells seemed to be present in some germinal centres in both IgM 
and IgM/G recipients. It is not known whether these germinal centres nucleated around the 
transgenic cells, or whether transgenic B ceils were able to move into existing germinal 
centres. Also, it seems unlikely that all of the transgenic B cells visible at day 3 moved into 
germinal centres. Many may have died in situ between day 3 and day 5, possibly because 
they were unable to incorporate into already-established germinal centres.
The histological picture of Ig transgenic B cells seeded into primed mice is in direct 
contrast to the system where Ig transgenic B cells were seeded into unprimed recipients 
(Figure 4-3, panels I—>L). In the absence of priming, no prominent germinal centres were
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present, and both IgM/G and IgM transgenic B cells formed exclusively extrafollicular foci 
of HEL-binding cells.
One explanation for these observations is that the type and location of T cell help is 
different in the two adoptive transfer systems. It seems likely that in the case where both 
transgenic B cells and transgenic T cells are naive upon transfer and immunisation, the high 
affinity of the Ig BCR leads to synchronous, early activation of most transgenic B cells.
The majority of the transgenic B cells may be directed by the early T cell help and 
abundant soluble antigen to seed extrafollicular foci. This is the fate of many B cells which 
are activated early during both T-dependent and T-independent immune responses (Liu, 
1991; Smith, 1996).
By contrast, in the experimental system where transgenic T cells are primed by 
antigen in adjuvant for 6 days, observations from the pigeon cytochrome c TCR transgenic 
system suggest that T cell help shifts to be located mostly in B cell follicles (Kearney,
1994; Ansel, 1999). This is probably due to the requirement for T cells to upregulate the 
chemokine receptor CXCR5 and become responsive to the chemokine CXC13 before they 
can enter B cell follicles and provide help to B cells to support germinal centres (Ansel, 
1999; Breitfeld, 2000; Schaerli, 2000; Kim, 2001). Although direct evidence for primed 
3A9 TCR transgenic T cells being located in B cell follicles after 6 days of priming is not 
available, the fact that transgenic B cells expand exclusively in the B cell follicles or 
primed mice is suggestive of the fact. In the future it may be possible to use the clonotypic 
antibody 1G12 to investigate the location of the TCR transgenic T cells histologically 
during a primary response and after 6 days of antigen priming.
Section 4.4. IgM transgenic B cells do not undergo
preferential apoptosis via FasL expressed 
on transgenic helper T cells
When IgM and IgM/G transgenic B cells were seeded into unprimed recipients in the 
presence of antigen and naive T cell help they were activated to a similar degree (Figure 
3-5). In addition, the rate of proliferation of IgM and IgM/G transgenic B cells was similar, 
yet there was a profound difference in net clonal expansion (Figure 4-2, parts A, B and E). 
Net clonal expansion is a balance between the rate of cell proliferation and the rate of cell 
death, raising the likelihood that IgM transgenic cells undergo a greater rate of death during 
successive cell divisions.
One candidate pathway for cell death that is important for both lymphocyte tolerance 
(Rathmell, 1994; Rathmell, 1995; Goodnow, 1996; Rathmell, 1996) and as a brake on T
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cell immune responses (van Parijs, 1998) is mediated by the TNF/TNFR family member 
Fas (CD95). Fas is expressed by activated B cells and FasL is expressed by activated T 
cells. Only acute antigen stimulation through the BCR saves naive B cells from elimination 
via this pathway (Rathmell, 1996), chronic antigen exposure in anergic cells leads to Fas- 
mediated apoptosis. There is some evidence that memory and naive B cells may be 
regulated differentially via this pathway, as while memory B cells express low levels of 
Fas, they have been reported to be resistant to cell death via Fas ligation (Liu, 1995).
To test whether IgG or IgM transgenic B cells were more or less sensitive to Fas- 
mediated apoptosis induced by transgenic helper T cells during an immune response in 
vivo, IgM and IgG transgenic B cells were transferred into HEL-immunised recipient 
animals along with normal TCR transgenic cells or TCR transgenic cells carrying the 
FasLgld mutation. The FasLgld phenotype is due to a mutant FasL on transgenic T cells that 
is unable to bind Fas expressed by naive IgM or IgG transgenic B cells (Goodnow, 1995).
It was reasoned that under these conditions, Fas-mediated transgenic T cell killing of IgM 
transgenic cells would be absent, so IgM and IgM/G transgenic B cells should show similar 
clonal expansion and antibody production if this pathway was solely responsible for the 
observed differences (Figure 4-4).
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Figure 4-3. Follicular and germinal centre expansion of IgM and IgM/G 
transgenic B cells in primed recipients
Histology of recipient mouse spleen sections on days 3 and 5 after transfer of IgM 
transgenic (panels A, B, E, F, I, J, M, N), IgM/G transgenic (C, D, G, H, K, L) or non- 
transgenic (O, P) B cells.
“Primed” recipient (B10.BRxC57BL/6)Fi mice were given 106 TCR transgenic cells and 
HEL in CFA 6 days prior to the transfer of 106 transgenic B cells with 50 jig boosting 
soluble antigen and isoproterenol (panels A—»H, M, N, O, P).
“Unprimed” recipients (panels I—>L) were treated as described previously in Figure 4-1.
5 p.m frozen sections were prepared, and B cell follicles stained for IgD (brown) and HEL- 
binding (blue), or PNA and HEL-binding together (panels M and N). Bars represent 200 
pm. Note the lack of HEL-binding cells in non-transgenic recipient spleens that were 
immunised with HEL/CFA (panels O and P), demonstrating that only B cells bearing 
transgenic anti-lysozyme receptors are stained by this protocol.
Labels on the sections indicate germinal centres (GC), B cell follicles (F), PALS (P) and 
junctional zones (J).
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Clearly, even when TCR:FasLgld transgenic T cells are co-transferred with IgM and 
IgM/G transgenic B cells there is still a 10-100-fold greater net clonal expansion of IgM/G 
transgenic cells compared to IgM transgenic cells (Figure 4-4, part A). Interestingly, the 
level of clonal expansion and especially AFC production in both IgM and IgM/G transgenic 
recipients was decreased when TCR\FasLgId H-2kk helper cells were used compared to 
normal FasL expressing TCR H-2kk transgenic cells (Figure 4-4, part B). This is in 
accordance with previous observations that Fas/FasL contact can provide a mitogenic 
signal during acute B cell activation with antigen (Rathmell, 1996).
This experiment contains a number of controls. Firstly, a similar level of clonal 
expansion was seen when TCR H-2kk transgenic cells were used as helpers compared to 
TCR H-2kb helpers (see Figure 3-3), showing thatTCR H-2kk helpers were able to provide 
adequate T help to the H-2kb Ig transgenic cells. Secondly the dependence of this response 
on contact between antigen-specific TCR and Ig transgenic cells was highlighted by the 
fact that in the absence of transferred transgenic T cells, both IgG and IgM transgenic B 
cell responses were significantly depressed.
This experiment demonstrated that the Fas/FasL-mediated apoptosis induced by 
transgenic T cell help is not responsible for the differences in net clonal expansion between 
IgM and IgG transgenic B cells, as crippling signalling via FasL on transgenic T cells does 
not rescue clonal expansion or antibody production by IgM transgenic B cells. This is not 
surprising, given the finding that antigen-specific CD4+ T cells do not localise to 
extrafollicular foci (Jacob, 1991; Gulbranson-Judge, 1996), the major site of IgM 
transgenic B cell loss in this system. It remains possible that other recipient components (T 
cells, DCs) are responsible for the apoptotic loss of IgM transgenic B cells via Fas/FasL or 
some other pathway. To formally exclude other sources of Fas/FasL-mediated killing, the 
adoptive transfer could be performed in FasL8,d recipients. In addition, it should be 
possible to test the role of apoptosis in general in the loss of IgM transgenic B cells by 
over-expressing an anti-apoptotic factor such as Bcl-2 in that line.
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Figure 4-4. Crippling the Fas/FasL pathway in transgenic T cell help does 
not rescue clonal expansion of IgM transgenic B cells in vivo
106 IgM:H-2kb or IgG:H-2kb transgenic B cells were transferred along with 106 TCR H-2kk 
or 106 TCR:FasLgld H-2kk transgenic T cells into B10.BR (H-2kk) recipients immunised at 
the same time with HEL in CFA or CFA alone.
A. Clonal expansion o f IgG and IgM transgenic B cells in the presence o f TCR or 
TCR:FasLgld transgenic T cells, measured by FACS on day 5 after immunisation and 
transfer. Data is shown as the number o f HEL-binding B cells per 107 recipient splenic 
lymphocytes.
B. ELISPOT measurements o f splenic anti-lysozyme IgGi and IgMa AFCs from recipient 
mouse spleens in (A), measured on day 5 after immunisation and transfer. Data is 
presented as the number of anti-lysozyme AFCs per 107 splenic lymphocytes.
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Section 4.5. Do other changes associated with memory 
play a role in the magnitude of antibody 
responses?
This study has presented evidence that BCR isotype plays a critical role in primary B 
cell responses to antigen in vivo. To isolate BCR isotype, this has been done using naive 
transgenic B cells seeded into a primary response. The role of this phenomenon in memory 
is more difficult to assess, given the host of other phenotypic changes that accompany the 
memory state. For example, memory B cells are present in distinct anatomical locations 
near antigen-draining sites (Liu, 1991; Liu, 1995) and display reduced thresholds of 
activation, possibly due to their ability to act as APCs (Liu, 1995; Bar-Or, 2001). In 
addition, memory B cells have been shown to have distinct cell surface phenotypes (Klein, 
1998; Tangye, 1998; McHeyzer-Williams, 2000) and in some studies a greatly enhanced 
lifespan (Schittek, 1990; Maruyama, 2000). This study has shown that the expression of 
the IgG membrane tail on naive B cells is sufficient to greatly enhance antigen-specific B 
cell responses. To assess the role of BCR isotype in memory responses a comparison was 
attempted between naive or memory transgenic B cells bearing defined receptor isotypes.
To try to generate Ig transgenic memory cells, IgM and IgM/G transgenic B cells 
were seeded along with soluble antigen into recipient mice primed with TCR transgenic 
cells and 100 pg HEL in CFA 6 days previously (Shokat, 1995). It was reasoned that the 
normal site of memory B cell production is germinal centres rather than extrafollicular 
sites, so the experimental system that allowed IgM and IgM/G follicular expansion and 
germinal centre entry was used. The number of antigen-specific B cells was measured on 
days 4 and 34 after B cell transfer. Recipient mice were maintained for 60 days prior to 
secondary challenge, in accordance with other studies examining memory B cells 
(Okomura, 1976; Yefenof, 1985; Hayakawa, 1987; Linton, 1989; Liu, 1991; McHeyzer- 
Williams, 2000). Recipients were then boosted with 100 pg soluble HEL given i.v. This 
was done because one of the distinguishing features of the memory antibody response is 
that antigen need not be given in adjuvant (Liu, 1991; McHeyzer-Williams, 1991). At the 
same time, separate recipients were immunised with 100 pg HEL in CFA (i.p.) and either 
106,105 or 104 IgM or IgM/G transgenic B cells were transferred along with TCR 
transgenic cells to simulate a primary immune response and provide a comparison group 
for the putative “memory” response.
As shown in Figure 4-5, the magnitude of AFC production in response to a secondary 
boost with soluble antigen on day 65 after priming was much lower than the magnitude of 
AFC production from 106 IgM or IgM/G transgenic B cells seeded into a primary response.
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Furthermore, it is impossible to compare the recipients making a primary response with the 
recipients making a putative memory response, as even on day 34 after B cell transfer into 
primed mice neither IgM nor IgM/G transgenic B cells could be detected by FACS. The 
increased numbers of AFCs above background in primed recipients that received IgM/G 
transgenic cells on day 65 after re-exposure to soluble antigen is suggestive that some 
antigen-specific cells persisted for this period and were induced to differentiate and secrete 
antibody on re-exposure to soluble antigen. Without knowing how many cells were present 
before boosting with soluble antigen it is impossible to know what fold clonal expansion 
this represents and therefore whether the IgM/G or IgM isotype “memory” cells were more 
or less responsive to antigen compared to the corresponding “naive” cells in the primary 
response.
One problem with this experimental design is the form of antigen used to elicit a 
“memory” response. Without administration with adjuvant, soluble HEL is cleared very 
rapidly from the circulation (So, 1999). Nevertheless, soluble antigen elicits a clear 
secondary response in normal mice in the absence of HEL-specific transgenic B or T cells 
(Figure 3-1, part B). It is possible that the presence of transgenic T helper cells interfered 
with the production of memory B cells. The ability of the 3A9 TCR transgenic helper T 
cells to provide selective signals in the germinal centre is unknown. It would be useful to 
repeat these experiments in mice that do not receive transgenic T cells. In addition, a more 
reliable method of detecting antigen-specific memory cells at low frequency must be 
developed. Marking the transgenic B cells using CD45 allotypic markers in addition to 
antigen-specificity may allow unequivocal enumeration of frequency prior to the secondary 
immunisations. This may allow the “clonal burst” of those cells to be accurately measured 
during the secondary response, to answer the question of whether memory transgenic B 
cells bearing the IgG membrane tail respond more robustly to antigen.
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Figure 4-5. Long-term memory B cells are poorly generated from naive 
transgenic B cells in short-term primed recipients
Recipient (B10.BRxC57BL/6)Fi mice were primed with 106 TCR transgenic T cells and 
antigen in adjuvant 6 days before the transfer of 106 of the indicated type of transgenic B 
cell boosting soluble antigen.
On days 4 and 34, recipient spleen and bone marrow in primed mice was analysed for 
lysozyme-specific IgMa AFCs. No HEL-specific B cells could be detected in the spleen at 
either timepoint by FACS.
On day 60, recipients were boosted with soluble antigen (100 jig HEL in PBS, i.v.) and 
analysed by ELISPOT on day 65. In parallel on day 60, unprimed recipient mice were 
immunised with HEL in CFA and received 106 naive IgM or IgM/G transgenic B cells with 
106 naive TCR transgenic T cells, as a comparison group. Bone marrow and spleen 
samples from these mice were also analysed on day 65 by ELISPOT.
The graph shows the levels of IgMa anti-lysozyme AFCs in the spleen and bone marrow for 
the various experimental groups. The labels M/G, M and non denote IgM/G transgenic, 
IgM transgenic or non-transgenic donor lymphocytes. Data is shown as the number of anti­
lysozyme IgMa AFCs per 107 recipient splenic lymphocytes.
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Section 4.6. Chapter summary
This chapter extends the evidence presented in Chapter 3 suggesting that differences 
in IgM, IgG and IgM/G transgenic B cell clonal expansion and effector cell production are 
quantitative rather than qualitative. The previous chapter showed an equivalent rate of cell 
activation and cell division between IgM, IgG and IgM/G transgenic B cells but a large 
difference in net clonal expansion on day 5 during a primary anti-lysozyme response.
This chapter has presented a more detailed analysis of events between days 3 and 5 
after transfer and immunisation. It has shown that the differences between the transgenic B 
cells expressing or lacking the IgG membrane tail manifest during an immune response at 
the time when extrafollicular foci disperse to generate syndecan-positive effector cells in 
the bridging channels and red pulp. IgM transgenic cells progress through a similar number 
of cell division cycles between day 3 and day 5 compared to IgM/G transgenic B cells, 
however produce far fewer effector cells. The hypothesis that the IgM cells are dying 
during clonal expansion in the spleen is supported by the lack of AFC production in the 
bone marrow. Finally, transgenic helper T cell-induced Fas/FasL apoptosis is not 
responsible for the poor expansion of IgM transgenic cells, as crippling this pathway does 
not rescue IgM clonal expansion and effector production. Apoptotic cell death is not ruled 
out by this finding, however, as endogenous recipient T cells and DCs could still express 
FasL.
The poor net clonal burst of IgM transgenic B cells is not the result of a differential 
preference for germinal centre versus extrafollicular clonal expansion. IgM and IgM/G 
transgenic cells can participate in both pathways, a decision possibly mediated by the type 
and location of transgenic T cell help during the primary or pseudo-primary immune 
responses described here.
Finally, an attempt was made to test the relative importance of BCR isotype versus 
other phenotypic and functional changes in the qualities of the memory response. This is 
an important extension of the work presented in Chapter 3, as while the use of nai've Ig 
transgenic B cells is critical in isolating BCR isotype from the other phenotypic changes 
that underlie antigen experience, that strategy gives no indication of the relative importance 
of BCR isotype versus these other changes during a recall response. To address this, it was 
reasoned that comparisons of transgenic memory B cells expressing IgG or IgM isotype 
BCRs to naive transgenic B cells bearing the same isotypes would show whether other 
factors associated with the memory state alter responses to antigen. To generate memory 
transgenic B cells, naive transgenic B cells were seeded into short-term primed recipient
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mice. This approach was not successful, as technical difficulties such as poor memory cell 
formation and persistence did not allow any conclusions to be made about the relative 
reactivity of memory or naive transgenic B cells.
Section 4.7. Future Work
In the future it will be important to directly test some of the predictions in this 
chapter, namely that IgM transgenic B cells fail to make a strong clonal expansion response 
because they undergo apoptosis, due to interaction with a highly cross-linking form of 
immune-complexed HEL held by dendritic cells.
Histologically it may be possible to demonstrate a co-localisation of CD1 lchl “PDCs” 
and Ig transgenic B cells in the extrafollicular foci seen on days 3 and 4 after immunisation 
during the primary response. This may help determine whether these dendritic cells are 
involved in the pattern of cell loss observed in IgM transgenic B cells.
In addition, crossing the IgM, IgG and IgM/G transgenic lines with mice 
overexpressing anti-apoptotic proteins such as Bcl-2 will show whether apoptosis is the 
mechanism of IgM cell loss. If Bcl-2 overexpression restores IgM clonal expansion to 
similar levels compared to IgG and IgM/G transgenic B cells, this would provide good 
evidence that apoptosis is responsible for the loss of IgM transgenic B cells normally in this 
system.
It may be possible to determine the role of immune complex in IgM transgenic cell 
loss by performing these transfer experiments in RAG-deficient mice that are unable to 
produce endogenous, lower affinity multivalent IgM. If IgM transgenic cell clonal 
expansion is rescued under those conditions it would then be possible to introduce immune 
complex and determine whether immune complex can induce cell loss.
Connected to this issue is the observation that transgenic B cells on day 4 of a 
primary response in the presence of transgenic T cell help are undetectable on the basis of 
BCR staining. We would hypothesise that this is due to BCR downmodulation after 
contact with mulit-valent HEL presented as immune complex. Transfer experiments using 
CD45 allotypic markers would allow transgenic B cells to be tracked at this timepoint 
without relying on surface BCR expression. This would allow the accurate enumeration of 
transgenic B cells during the later phase of clonal expansion.
In order to complement the current study, transfer experiments will be performed 
using B cells from anti-HEL knockin mice (a kind gift from Dr. J. G. Cyster, UCSF). This
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will help to show the normal magnitude and locations of primary IgM and IgG responses in 
B cells that can switch isotype. This will be important for determining whether the primary 
responses by the Ig transgenic IgM and IgG B cells used in this study deviate from a 
situation where isotype switching is normal.
Also, striking differences in the location of clonal expansion of Ig transgenic B cells 
was noticed between a primary response with nai’ve T cells and a pseudo-primary response 
with primed T cells. It would be interesting to use CD45 allotypic markers and anti- 
clonotype antibodies to track the expansion of 3A9 TCR transgenic T cells over the course 
of these experiments. To extend this, the cell surface phenotype of the transgenic T cells 
could be assessed. For example, the expression of the chemokine receptor CXCR5 seems 
to be a useful marker to distinguish CD4+ T cells that are capable of entering B cell follicles 
(Ansel, 1999; Breitfeld, 2000; Schaerli, 2000; Kim, 2001). Staining for this, in conjunction 
with immunohistochemistry to localise the transgenic T cells would provide a powerful 
way of addressing the issue of the type and location of T cell help during these responses.
Perhaps the most critical future work to extend the experiments presented in this 
chapter is to determine the relative importance of BCR isotype versus other antigen- 
induced changes in memory B cells that determine the magnitude of the memory response. 
It will be important to repeat similar experiments to that described in Section 4.5 in an 
attempt to generate memory B cells that have defined BCR isotypes. As well as 
enumerating the memory cells at various timepoints, it will be interesting to see where they 
localise, what surface phenotype they adopt and how they behave when sorted populations 
bearing different isotypes are transferred into immunised recipient mice.
Chapter 5. Marginal zone and follicular B cell
subsets vary in different anti-HEL 
transgenic lines
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Section 5.1. introduction
The marginal zone and follicular B cell subsets represent phenotypic and 
geographically distinct compartments of the spleen. In this chapter these subsets were 
examined in a range of anti-HEL transgenic mouse lines bearing a variety of different BCR 
isotypes.
Marginal zone or follicular enrichment of particular B cell clones has been 
demonstrated in several transgenic systems (Martin, 2000b), including marginal zone 
enrichment in the He transgenic 8lx and M1671ines and follicular enrichment in the anti- 
HEL MD2 line. It is hypothesised that the enrichment phenotypes in the marginal zone 
depend on some quality of BCR signalling, as they are absent in Btl?ld animals (Martin, 
2000b).
Previous observations of the B cell subsets in mice carrying the IgG membrane tail 
showed an accumulation of CD21hl HEL-binding B cells in those lines (Pogue, 1996; 
Pogue, 2000), which was suggestive of a marginal zone phenotype. This was an interesting 
observation that may impact on the adoptive transfer system discussed in the previous 
chapters. Marginal zone cells have been associated with rapid effector cell production 
during memory (Liu, 1991) and T-independenttype II responses (Martin, 2000a), so 
differences in HEL-binding marginal zone B cell fractions between IgG, IgM/G and IgM 
transgenic lines may provide a mechanism for their differential reactivity to antigen on 
adoptive transfer.
This chapter will present evidence that there are striking differences in the proportion 
of HEL-binding cells present in the marginal zone subsets of a range of anti-HEL 
transgenic lines expressing a variety of BCR isotypes. While individual anti-HEL BCR 
isotypes seem more or less able to support marginal zone entry and accumulation, the 
analysis is complicated by a correlation between the degree of marginal zone entry and the 
proportion of competing, endogenous B cells present in each transgenic line.
Section 5.2. Peripheral B cell subsets in IgG, IgM/G and 
IgM transgenic lines
A consistent finding in this study and previous work by Pogue and Goodnow (Pogue, 
1996; Pogue, 2000) was a decreased proportion of antigen-binding transgenic B cells in the 
periphery of mice expressing IgG or chimeric IgM/G BCR isotypes. This selection away
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from HEL-binding was shown to correlate with transgene copy number and may reflect 
stronger signalling via the IgG isotype when it is expressed early in B cell development, 
leading to some form of receptor editing (Pogue, 2000). However, as well as dictating the 
proportion of peripheral HEL-binding B cells, expression of the IgG membrane tail 
produced an unusual pattem of CD21 expression on mature, peripheral HEL-binding B 
cells when compared to IgM transgenic B cells.
Figure 5-1 shows representative FACS plots from IgG (GG4), IgM/G (MG2), IgM 
(MM4) and non-transgenic control spleen cells on the (B10.BRxC57BL/6)Fi background. 
Note that the proportion of HEL-binding lymphocytes is reduced in IgG (~10 %) and 
IgM/G (~18 %) transgenic mice compared to IgM transgenic mice (~28 %) (Figure 5-1, 
part A). In addition, the CD21 profiles of the HEL-binding cells show a predominant 
CD21hl and smaller CD21med population in both IgG and IgM/G transgenic lines compared 
to the main CD21med population in the IgM transgenic line or non-transgenic control 
(Figure 5-1, part B). Interestingly, the proportion of transgenic cells in the CD21hl subset is 
even more pronounced in the IgM'G transgenic line compared to the IgG transgenic line 
(52 % IgM/G versus 40 % IgG), and this is a consistent finding (see Table 5-1).
Section 5.3. Marginal zone and follicular B cell analysis 
in IgG, IgM/G and IgM transgenic lines
High expression of CD21 has been associated with marginal zone and transitional 
type 2 B cells, and in conjunction with CD23 allows the marginal zone (CD21hl, CD23') 
and follicular (CD21med, CD23+) subsets to be distinguished (Loder, 1999). To investigate 
whether the enlarged CD21hl population in the IgG and IgM/G transgenic lines was due to 
changes in the marginal zone B cell compartment, spleen cells were stained for CD21, 
CD23 and HEL to distinguish transgenic and non-transgenic marginal zone and follicular 
subsets (Figure 5-2).
Figure 5-2, part A is gated on lymphocytes to show the marginal zone (CD21hl, 
CD23'), follicular (CD21med, 0023"") and other lymphocyte (CD21,o/\  CD23') subsets from 
representative IgG, IgM/G, IgM and non-transgenic mouse spleens. In this case, the 
marginal zone compartment in IgG (~16 %) and IgM/G (~20 %) transgenic mice was 
expanded relative to the marginal zone in IgM (~8 %) transgenic mice or non-transgenic (~ 
8 %) controls. Figure 5-2, part B shows the relative proportion of HEL-binding and non- 
transgenic B cells in both the marginal zone (M) gate and follicular (F) gate. The most 
striking finding was the partitioning of HEL-binding cells between the MZ and FO 
compartments in the IgM transgenic line. Over 90 % of the follicular subset in those mice
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Figure 5-1. Peripheral B cells in IgG, IgM/G and IgM transgenic lines vary in 
CD21 expression profile and in the fraction of B cells that bind 
HEL
FACS plots show representative IgM, IgM/G, IgG transgenic and non-transgenic spleen 
cells. The IgG Tg, IgM Tg and non-Tg samples were stained and analysed at the same 
time. The IgM/G Tg sample was stained and analysed in a separate experiment. The first 
set of plots show the lymphocyte gates set on forward and side scatter. The numbers refer 
to the fraction of cells within the gate.
A. HEL-binding versus CD21 expression on gated lymphocytes, showing the variable 
proportion of HEL-binding B cells in each line (also see Table 5-1). Numbers refer to the 
fraction of lymphocytes within the HEL-binding gate.
B. Histograms showing CD21 expression, gated on the HEL-binding lymphocytes from 
(A) for IgG, IgM and IgM/G transgenic samples, or gated on CD21+ lymphocytes in the 
non-transgenic control. The histograms highlight the variation in CD2110, CD21med and 
CD21hl subsets between the transgenic lines. Numbers refer to the fraction of cells in the 
CD2110, CD21med and CD21hi regions.
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Figure 5-2. IgG, IgM/G and IgM transgenic spleens show different
recruitment of peripheral B cells into the splenic marginal zone 
and follicular subsets by FACS
A. FACS plots gated on splenic lymphocytes (see Figure 5-1), showing IgG, IgM/G, IgM 
transgenic and non-transgenic marginal zone (CD21hl CD23‘), follicular (CD21med CD23+) 
and other lymphocyte (CD2110 CD23*) subsets. Numbers indicate the fraction o f 
lymphocytes falling within each gate.
B. Histograms showing HEL-binding BCR expression levels gated on marginal zone (M) 
or follicular (F) subsets from (A). Two regions are shown on each histogram, HEL-binding 
and non-binding lymphocytes. The numbers refer to the fraction o f gated cells falling in 
each region.
C. Histograms showing forward scatter versus cell number for each sample, gated on the 
marginal zone (M) or follicular (F) subsets from (A).
D. Gated lymphocytes were first sub-divided into HEL+ and HEL* subsets as depicted by 
regions on HEL-binding histograms, and CD21 versus CD23 contour plots produced to 
determine the marginal zone and follicular fractions in each subset. Numbers on the 
contour plots refer to the fraction of HEL-binding or non-binding lymphocytes falling 
within the marginal zone (CD21hl CD23'), follicular (CD21med CD23+) or other lymphocyte 
(CD2l'° CD23") gates.
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Figure 5-3. Spleen histology showing the location of HEL-binding cells in 
IgG, IgM/G and IgM transgenic mice
Serial 5 jim frozen spleen sections from IgG, IgM/G, IgM transgenic and non-transgenic 
mice were stained for the presence of HEL-binding cells (blue), and for either IgD or 
MOMA-1 in brown, as indicated above each column.
The IgD stain shows the B cell follicles, while the MOMA-1 stain shows the marginal zone 
metalophilic macrophages that line the follicular side of the marginal sinus.
The first two columns show a lower power view of the spleen, and the second two columns 
are high-powered fields from representative areas of the same samples. Bars represent 200 
jam.
High powered fields are annotated, showing the location of the splenic marginal zone 
(MZ), B cell follicles (F), PALS (P) and metalophilic macrophages (M4>).
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were HEL-binding cells, while only 37 % of the marginal zone subset bound HEL. 
Figure 5-2, part C shows that the marginal zone compartment (M) in all lines contains 
larger cells on the basis of forward scatter compared to the follicular compartment (F), a 
characteristic phenotype of MZ B cells noted by others (Oliver, 1997a). Figure 5-2, part D 
shows the relative marginal zone and follicular partitioning of HEL-binding (HEL+) and 
other (HEL') lymphocytes in the various lines. HEL-binding lymphocytes were 
equivalently partitioned between MZ and FO subsets in IgM/G transgenic mice, are present 
in a 2:1 FO: MZ ratio in IgG transgenic mice and are predominantly follicular (5:1 FO:
MZ) in IgM transgenic mice.
The results from multiple animals from a range of strains is also consistent with wide 
variation in the fraction of HEL-binding cells that have a marginal zone or follicular 
phenotype, ranging from ~68 % marginal zone in the MM4xDD6 line to ~10 % marginal 
zone in the MM4 line (Table 5-1).
Histological examination of IgG, IgM/G and IgM transgenic lines also supported the 
FACS data showing differences in HEL-binding marginal zone and follicular compartments 
(Figure 5-3). In IgG transgenic spleen sections, HEL-binding B cells were visible 
throughout the marginal zone and follicular areas. In IgM/G transgenic spleen sections, 
HEL-binding B cells were clearly positioned towards the outer edge of the B cell follicle, 
with IgD-expressing endogenous B cells compressed towards the PALS. Using MOMA-1 
staining to illuminate the marginal zone metallophilic macrophages, many IgM/G HEL- 
binding B cells surrounded the marginal sinus on the red pulp side, consistent with the 
marginal zone cell surface phenotype of a larger fraction of HEL-binding B cells in this 
line. By contrast, IgM transgenic B cells showed a preference for the follicular area of the 
spleen, as sections co-stained with MOMA-1 and HEL-binding showed the majority of 
HEL-binding B cells are on the follicular side of the metalophilic macrophages. Again, this 
is consistent with the FACS data showing that most HEL-binding B cells in this line have a 
follicular phenotype.
Section 5.4. Marginal zone and follicular subset
differences are retained and augmented in 
RAGI''' mice
The histological and FACS data clearly illustrate striking differences in the 
partitioning of HEL-binding and non-binding B cells in the marginal zone and follicular 
compartments of different Ig transgenic mice. It was important to find out whether the
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increased entry of HEL-binding B cells into the marginal zone compartment in IgG and 
IgM/G transgenic cells was due to the presence of the competing "non-transgenic” B cells 
in the follicles or marginal zone, or due to some T-dependent antigen-driven process. To 
answer this, IgG (GG4), IgM/G (MG2) and IgM (MM4) transgenic lines were crossed to 
the RAGE7' background. RAGE7' IgG, IgM/G and IgM transgenic mice produce similar 
proportions of mature peripheral HEL-binding B cells, as shown in Figure 5-4, panel A and 
in Table 5-1. Only ~10 % of IgM:RAGE7' HEL-binding B cells have a marginal zone 
phenotype, while a much larger proportion of HEL-binding B cells in IgG:RAGT7' (~64 %) 
and IgM/GiRAGl'7* (~43 %) transgenic mice show a marginal zone phenotype (Figure 5-4 
and Table 5-1).
The relative accumulation of HEL-binding B cells into the marginal zone in the IgM 
transgenic line is not affected by the removal of competing B cells or T cells, as the 
majority of HEL-binding B cells in the IgM:RAGE7' mice retain a follicular phenotype. 
This is not the case for the IgG and IgM/G transgenic lines. On the RAG1+/T background, a 
greater proportion of IgM/G HEL-binding cells were in the marginal zone subset compared 
to the IgG transgenic line (IgG:RAGl+/+, 30.9 % ± 5.8, n = 6; IgM/G:RAGl+/+, 48.6 % ± 
4.9, n = 13, see Table 5-1). On the RAGT7' background these differences are no longer 
apparent, and a similar proportion of HEL-binding B cells accumulate in the marginal zone 
subset in each line (IgGiRAGl'7', 57.7 % ± 8.5, n = 11; IgM/G:RAGE7*, 58.0 % ± 4.1, n =
5, see Table 5-1).
Why do the differences in the marginal zone subset between IgG and IgM/G lines 
disappear on the RAGl'7' background? The key may be the removal of clonal competition 
between HEL-binding and other B cell specificities for marginal zone entry. HEL-binding 
IgG B cells form a smaller fraction of total peripheral B cells compared to IgM/G HEL- 
binding B cells (see Figure 5-1 and Table 5-1). This implies a greater degree of 
competition for marginal zone entry between HEL-binding and non-binding B cells in the 
IgG:RAGl+7̂  line compared to the IgM/G:RAGl+/+ line. When competing B cells are 
removed by crossing to RAGE7', the marginal zone bias of the IgG membrane tail is 
separated from competition effects, and both IgG and IgM/G transgenic cells fill the 
marginal zone to the same extent.
There is already data suggesting that inter-clonal competition affects B cell entry into 
the marginal zone. In the HEL system, most B cells in the Hc+Lc MD4 line are HEL- 
binding and form a well-developed marginal zone (Mason, 1992). In the MD2 Hc-only 
transgenic line, a much smaller proportion of B cells are HEL-binders. Under these 
conditions, very few HEL-binding cells are found in the marginal zone, presumably due to
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increased competition from non-HEL-binding B cells bearing other specificities (Martin, 
2000b). The same phenomenon has also been observed in the 8lx transgenic system. In 
50:50 competition bone marrow chimeras, only a small fraction (< 3 %) of the CD21hl 
marginal zone subset was composed of Tg-|i positive B cells, whereas in the normal 8lx Tg 
mice the CD21hl compartment was filled with B cells expressing the Tg-|i heavy chain 
(Martin, 1997).
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Figure 5-4. Increased entry into the marginal zone compartment by IgG and 
IgM/G transgenic B cells still occurs on the RAG1'/_ background
A. Contour plots of IgG: RAGE7', IgM/G: RAGE7' and IgM: RAGE7' transgenic spleen 
cells gated on lymphocytes by forward and side scatter, showing HEL-binding versus 
B220. Numbers indicate the fraction of lymphocytes within each quadrant. Note the 
similar proportion of HEL-binding B220+ lymphocytes in each line.
B. Contour plot showing marginal zone (CD21hl CD23') versus follicular (CD21med 
CD23+) subsets in the RAGE' transgenic spleen samples, gated first on small lymphocytes. 
Numbers indicate the fraction of lymphocytes within each gate.
C. Contour plot showing marginal zone and follicular HEL-binding spleen subsets, gated 
first on HEL-binding lymphocytes using the indicated histogram gates. Numbers indicate 
the fraction of HEL-binding lymphocytes within each gate.
B
220-PE
 
C
D
23-PE 
H
E
L/H
y9-FITC
 
C
D
23-PE
CQ
TD
>
CD
CQ
S
CD
TD
>
CD
CQ
CD
TD>
CD
H
E
L-binding cells
140 Chapter 5
Section 5.5. Marginal zone and follicular subset 
differences are present in other HEL 
transgenic lines
The accumulation of HEL-binding cells in the marginal zone compartment was not 
restricted to lines expressing the IgG membrane tail. In fact, the other transgenic lines 
tested showed a wide variety of HEL-binding marginal zone and follicular subsets (Table 
5-1). It is important to note that the assignment of “marginal zone” and “follicular” 
phenotypes to these subsets has been performed by FACS, in the future histological 
examination will be necessary to confirm these data.
Two factors may combine to produce the observed patterns of marginal zone and 
follicular B cells in this system. Firstly, marginal zone recruitment could reflect some 
quality of “basal” BCR signalling through the various combinations of anti-HEL Ig 
isotypes. If this is correct, some isotype-specific differences must play a role in driving 
accumulation in one subset or another, as the BCRs expressed in these lines share identical 
variable regions, so would interact equivalently with any selecting ligands. The possibility 
of isotype-specific signalling leading to marginal zone enrichment is most clearly 
illustrated in the increased proportion of HEL-binding B cells in the marginal zone of 
IgGiRAGl'7' and IgM/G:RAGl'7' transgenic mice compared to IgMiRAGl'7' mice. 
Secondly, the degree of marginal zone recruitment of HEL-binding B cells may also be 
dependent on the level of competition provided by other B cells in the spleen that do not 
express the transgenic receptor. This possibility is illustrated by the unequal fraction of 
marginal zone HEL-binding B cells in IgG and IgM/G animals in the presence of variable 
numbers of endogenous B cells on the RAG1+/+ background.
These factors are difficult to separate, unless competition can be completely removed, 
as in the IgM, IgG and IgM/G lines crossed to the RAGE7' background. However, there are 
several difficulties in analysing all of the transgenic lines in this way. Firstly, RAG1'7" mice 
lack an adaptive immune system, with no natural antibody and disturbed gut immunity.
This complicates the simple interpretation of the removal of B cell competition by 
introducing several new variables. Secondly, it would be very time consuming to cross all 
of the transgenic lines to RAGE7'.
Alternatively, the effect of competition from non-transgenic B cells on marginal zone 
entry by HEL-binding cells can be examined by comparing the proportion of transgenic 
marginal zone cells with the proportion of splenic lymphocytes that bind HEL across the
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various lines. This compares the degree of marginal zone enrichment by HEL-binding B 
cells with the degree of clonal competition provided by non-HEL-binding B cells bearing 
endogenous specificities. Figure 5-5 shows the result of this analysis. In general, as the 
proportion of “competing” non-transgenic B cells increases, the proportion of HEL-binding 
cells that have a marginal zone phenotype decreases (trend indicated by the filled circles). 
There are, nevertheless, some clear exceptions to this trend (open circles). Most strikingly, 
the IgM-only MM4 transgenic line has comparatively few HEL-binding marginal zone 
cells even on the RAGT7' background in the complete absence of competing B cells. By 
contrast, the IgM/G chimeric line MG8 has few HEL-binding B cells and many competing 
non-transgenic B cells, yet a large proportion of the HEL-binding B cells have a marginal 
zone phenotype.
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Table 5-1. Cell numbers and the fractions of HEL-binding B cells in
marginal zone and follicular subsets for each transgenic line
Each of the transgenic lines used in this study is listed. The numbers in parentheses refer to 
the number of individual animals tested for each criterion. The range indicated is ± 1 
standard error and is shown only for measurements with >2 repetitions.
The number of splenic lymphocytes denotes cells counted by hemocytometer as described 
in section 2.6 (b) of the materials and methods. It is expressed as the number of 
lymphocytes per spleen.
The other criteria have been determined by FACS stains, as described in the legends of 
Figure 5-1, Figure 5-2 and Figure 5-4.
The % of B220+ HEL+ lymphocytes denotes the fraction of lymphocytes gated by scatter 
that stain for HEL-binding and B220.
The % of marginal zone and follicular lymphocytes denotes the fraction of total 
lymphocytes gated by scatter that have either a marginal zone (CD21hl CD23') or follicular 
(CD21med CD23+) phenotype.
The % of HEL+ marginal zone or follicular lymphocytes denotes the fraction of HEL- 
binding lymphocytes that have either a marginal zone (CD21hl CD23') or follicular 
(CD21med CD23+) phenotypes.
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Figure 5-5. Correlating the effects of inter-clonal competition on entry into 
the marginal zone
To correlate the fraction of HEL-binding cells with a marginal zone phenotype with the 
level of clonal competition, the percentage of HEL-binding cells adopting a marginal zone 
phenotype (x-axis) was plotted against the percentage of B220+ lymphocytes that bind HEL 
(y-axis) for each transgenic line used in this study.
The general trend, shown by points as filled circles, indicates that as the proportion of 
HEL-binding B cells increases, the proportion of HEL-binding marginal zone phenotype B 
cells also increases. In other words, as the level of clonal competition from non-HEL- 
binding B cells decreases, a greater fraction of HEL-binding B cells adopt a marginal zone 
phenotype.
Transgenic lines that do not follow the trend are shown by open circles. They include the 
IgM-only line MM4 on both the RAG1+/+ and RAGl"7' background, the IgM/IgD line MD4 
and the IgM/G line MG8.
Error bars are ± 1 standard error and are given for all lines with data points from >2 mice.
MG2:RAG1*/'
GG4:RAG1 MM4XDD6
MM4:RAG1
O Outlier 
#  Trend
M5E2
% HEL-binding cells that have a MZ phenotype
Preference of HEL-binding cells 
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Section 5.6. Summary
In this chapter the findings of Pogue and Goodnow (Pogue, 1996; Pogue, 2000) have 
been extended to show that differences in the level of CD21 expression amongst mature 
splenic B cells from the IgG, IgM/G and IgM HEL-transgenic lines reflects a differential 
recruitment of HEL-binding B cells into the marginal zone subset. This may be the result 
of two factors. On the one hand, BCR isotype seems to regulate marginal zone entry, as 
transgenic B cells expressing the IgG membrane tail form a greater fraction of the marginal 
zone compared to B cells expressing IgM alone. This is further evidence for differential 
signalling through the IgG isotype BCR during the formation of mature, peripheral HEL- 
binding B cells in IgG transgenic mice, along with previously reported receptor editing and 
receptor down-modulation phenomena (Pogue, 2000).
The role of BCR isotype signalling in allowing marginal zone recruitment is 
complicated, however, by the fact that inter-clonal B cell competition for marginal zone or 
mantle zone entry appears to also play a role. This has been noticed previously in both the 
HEL and 8lx transgenic systems, where increasing proportions of “non-transgenic” 
endogenous B cells tend to lower the fraction of transgenic B cells that enter or accumulate 
in the marginal zone (Martin, 1997; Martin, 2000b). Thus far, competition has been 
removed in the IgM, IgM/G and IgG transgenic anti-HEL lines by crossing them to RAGl'7' 
. When there are no competing B cells, both the IgG and IgM/G transgenic lines have an 
equivalent, high proportion of HEL-binding cells in the marginal zone subset, while HEL- 
binding cells in the IgM transgenic line retain a predominantly follicular phenotype. A 
more useful way of modelling clonal competition in the future would be the construction of 
competition bone marrow chimeras, as these will retain intact adaptive immune systems, 
unlike RAGT ' mice.
Expression of the IgG membrane tail is not the only feature that allows increased 
marginal zone accumulation by HEL-binding B cells. For example, in MM4xDD6 mice 
that co-express IgM and IgD, over 60 % of HEL-binding B cells have a marginal zone 
phenotype. The analysis of these other transgenic lines is complicated, however, because 
of the variable effects of inter-clonal competition. In general, as the proportion of HEL- 
binding B cells in the spleen is increased, the fraction of HEL-binding cells that have a 
marginal zone phenotype is increased (see Figure 5-5). It may be that the transgenic lines 
that follow this trend (GG4, MG2, MG6, MG8, DD6, M8E1, M5E2 and MM4xDD6) carry
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BCR isotype combinations that are equally able to drive recruitment of HEL-binding B 
cells into the marginal zone subset. This possibility can only be tested, however, by 
normalising the levels of competing “non-transgenic” B cells across each line (see Section 
5.7).
In summary, this chapter has presented new evidence for differential signalling 
through IgG and IgM isotype BCRs in the formation of different peripheral B cell subsets. 
Mice expressing the IgG membrane tail are able to support a much greater fraction of HEL- 
binding marginal zone B cells compared to mice bearing IgM alone. It is unclear at present 
whether this is a unique feature of the IgG isotype BCR, as other combinations of IgM and 
IgD isotype receptors also allow accumulation of HEL-binding marginal zone B cells. In 
all of these analyses the action of BCR isotype in allowing marginal zone entry and 
accumulation is complicated by the variable effects of inter-clonal competition.
Section 5.7. Future work
In the future it will be important to address the issue of inter-clonal competition in 
determining marginal zone entry using competition bone marrow chimeras to normalise the 
number of competing endogenous B cell. Varying mixtures of Ig transgenic and non- 
transgenic bone marrow could be used to reconstitute irradiated recipient mice. By 
comparing mice with similar levels of “competing” non-transgenic B cells the ability of 
each BCR isotype to drive marginal zone recruitment could be more accurately assessed. A 
reciprocal study where each transgenic line was crossed to the RAG l ’7' background would 
also allow the degree of marginal zone formation to be assessed in the absence of 
competition. This may not be as useful as bone marrow chimeras, as the interpretation of 
RAG experiments is complicated because it introduces new variables by the removal of T 
cells, natural antibody and a loss of gut adaptive immunity.
It will also be important to determine whether the presence of transgenic cells in the 
marginal zone subsets of the various transgenic lines is due to differences in the rate of 
production of marginal zone cells or differences in their lifespan after marginal zone entry. 
This could be done by BrdU labelling or by the transfer of immature B cells into RAGT7" 
recipients to track their differentiation into the various mature B cell compartments.
Finally, it will be important to address the signals downstream from the HEL-binding 
BCRs of the various lines that allow recruitment into the marginal zone subset. Candidate 
signalling molecules include Btk, CD 19 (Martin, 2000b), Aiolos (Cariappa, 2001) and 
NFkB p50 (Cariappa, 2000).
Chapter 6. Line to line variation does not
explain differential B cell 
responses to antigen in vivo
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Section 6.1. Introduction
The previous chapters have demonstrated that transgenic B cells from a variety of 
lines bearing the IgG membrane tail make a more robust response to antigen than 
transgenic B cells bearing combinations of IgM or IgD isotype BCRs. The hypothesis 
presented in this thesis is that differential responses to antigen by transgenic lines bearing 
the IgG membrane tail is a reflection of isotype-specific signalling via IgG.
Despite these observations, the assumption that BCR isotype is the only difference 
between the Ig transgenic lines used in this study is not appropriate for several reasons.
At the most fundamental level, line to line variation due to transgene integration site 
and transgene copy number differences are a source of variation. As described previously 
(Pogue, 2000) there are also significant differences in peripheral B cell phenotypes between 
the IgM-only, IgG and IgM/G transgenic lines, such as receptor editing and BCR 
modulation that correlate with transgene copy number.
In addition, the transgenic constructs used to make the different lines vary in both the 
extent and the type of switch region included upstream from the constant region gene 
elements. Although isotype switching is not a normal event in most Ig transgenic systems 
due to the He transgene integrating in a location separate from the IgH locus, it is possible 
that switch recombination could initiate at the transgene locus and lead to chromosome 
exchanges or breakage, resulting in cell death.
Finally, as described in the Chapter 5, differences in B cell development between 
transgenic lines do not simply alter the fraction of peripheral B cells that bind HEL. Large 
variations in the proportion of mature HEL-binding B cells with marginal zone versus 
follicular phenotypes are also apparent. This is a particularly interesting finding, as 
marginal zone B cells show evidence of a pre-activated phenotype and may respond more 
robustly than follicular B cells to certain types of antigen (Liu, 1991; Martin, 2001). In 
particular, IgG and IgM/G transgenic lines have a much greater fraction of HEL-binding 
MZ cells compared to the IgM-only line, providing a potential explanation for the 
differences in reactivity to antigen on adoptive transfer that were described in Chapter 3 
and Chapter 4.
This chapter describes a range of experiments designed to test whether differences 
other than BCR isotype could explain the pattem of reactivity amongst transgenic lines to 
antigen in vivo.
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Section 6.2. Line to line variation in construct
integration site, transgene copy number or 
transgene switch regions does not explain 
different responses to antigen
Figure 6-1 shows the results of two experiments comparing GG4, MG2, MG6, MG8, 
MM4, M8E1, M8E2, DD6 and MM4xDD6 transgenic lines. Recipient animals received 
106 Ig transgenic B cells, 106 TCR transgenic T cells and immunising antigen in adjuvant. 
On day 5 after transfer B cell clonal expansion was assessed by FACS, and AFC 
production measured by ELISPOT. Numerous comparisons can be made from these 
experiments to test the role of line to line variation in transgenic B cell responses to 
antigen.
Firstly, comparisons were made between three independent IgM/G lines (MG2, MG6 
and MG8) produced with the same transgenic construct, as well as between two 
independent IgMSE lines (M8E1 and M8E2), again produced using the same construct. As 
shown in Figure 3-4 and Figure 6-1, all MG lines produced a similar number of AFCs and 
underwent a similar degree of clonal expansion. Similarly, both M8E lines were 
comparable by these criteria, although making a smaller response. This shows that 
independent transgenic lines made with the same construct gave a consistent pattern of 
reactivity to antigen in vivo, and that the effects of random transgene integration are 
unlikely to explain the variations between the various Ig transgenic lines in vivo.
Secondly, from this experiment it was possible to compare transgenic lines that 
contained different transgene switch regions (see Table 6-1 and Figure 2-1). Switch 
regions are GC-rich simple tandem repeat DNA sequences of 1-10 kb length found 
upstream of constant region gene segments (except 8) (Stavnezer, 2000), and were included 
in the transgenic constructs used to make the panel of mice. The MM4 (Brink, 1992) and 
MD4 (Goodnow, 1988; Goodnow, 1989) lines contained intact jx switch regions, while the 
MG (Pogue, 2000) and M8E lines (Pogue, 1994) all had an identical partial |i switch region 
containing a 2.8 kb internal deletion. The GG4 line (Pogue, 2000) contained a hybrid f i / y l  
switch region, and the DD6 line lacked a switch region (Brink, 1992). The impact of this 
variation on B cell responses to antigen in vivo was not clear. While interchromosomal 
switch recombination between the endogenous IgH locus and the transgene is considered a 
rare event (Durdik, 1989), one of the outcomes of the induction of switch recombination at 
the transgene locus might be the introduction of chromosomal breakages (Renter, 1999), 
leading to cell death. It was not known whether the complete transgenic |i switch regions 
might present a better target for the recombination machinery than partial ji switch regions.
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Also, it was possible that ji/yl hybrid switch regions were targeted differently to p switch 
regions. It was therefore important to investigate this as a cause of differential clonal 
expansion and cell loss amongst the transgenic lines during an immune response to antigen 
in vivo.
Switch region variation can be ruled out as a cause of differential responses by 
several observations. Firstly, the GG4 and MG lines contain different switch regions yet 
make comparable responses to antigen. In GG4, the switch region is a jn/yl hybrid, 
whereas in the MG lines it is a partial p switch region. Secondly, each MG and M8E line 
carries an identical partial p switch region, yet the MG lines consistently make at least 10- 
fold more AFCs and a 10-fold greater clonal expansion response to antigen compared to the 
M5E lines. Similarly, both the MM4 and MD4 transgenic constructs carry a complete jii 
switch region. Despite this, transgenic B cells from the MD4 line consistently make more 
robust responses to antigen compared to the MM4 line (see Figure 3-3). Finally, the 
reactivity of the MM4 line is “rescued” by crossing to the DD6 line, and MM4xDD6 
transgenic B cells now make a comparable response to antigen as lines carrying the 
membrane tail of IgG. This is contrary to the expected result if improper switch 
recombination at the p transgene was a major determinant of reactivity in vivo. In the 
MM4xDD6 line, the IgM transgene is still transcriptionally active (Bell, S. and Goodnow, 
C., unpublished observations), despite IgM protein being out-competed by IgD for 
expression as the predominant surface isotype. This suggests that switch recombination at 
the transgenic p switch region would still be induced at the same rate in the MM4xDD6 
line compared to the MM4 line. As the MM4xDD6 transgenic B cells make a robust 
response to antigen, switch recombination at the transgenic p locus is unlikely to be 
responsible for the cell loss observed with the MM4 line.
Collectively, these results demonstrate that variations in the transgene integration 
sites and transgene switch regions of the various transgenic lines does not explain the 
pattern of antigen reactivity seen in vivo.
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Table 6-1. The type and extent of switch regions used in each transgenic 
construct
Transgenic Line Heavy chain constant region Switch region
GG4 gamma ll/gamma hybrid
MG2, MG6, MG8 ji/gamma hybrid p*
MM4
MD4 |x and delta
MdEl, MdE2 ji/delta hybrid |i*
DD6 delta none
MM4xDD6 |i and delta (independent)
Abbreviations used: |i, mu heavy chain constant region or switch region; ji*, 
mu switch region carrying a 2.8 kb internal deletion
References: GG4, MG2, MG6, MG8 (Pogue, 1996; Pogue, 2000); MM4, 
DD6 (Brink, 1992); MD4 (Goodnow, 1988; Goodnow, 1989); MÖE1, M5E2 
(Pogue, 1994)
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Figure 6-1. A comparison of immune responsiveness between transgenic B 
cells from lines GG4, MG2, MG6, MG8, M5E1, M5E2, MM4, DD6 
and MM4xDD6
In both transfer experiments outlined in (A) and (B), 106 transgenic B cells of the indicated 
type were transferred along with 106 TCR transgenic T cells into (B10.BRxC57BL/6)Fi 
recipient mice immunised at the same time with HEL in CFA or CFA alone. On day 5 after 
transfer, spleen samples were analysed by FACS and ELISPOT to enumerate the number of 
HEL-binding cells and the number of anti-HEL AFCs.
A. Clonal expansion response as measured by FACS for both experiments. Data is shown 
as the number of HEL-binding lymphocytes per 107 recipient lymphocytes.
B. Anti-lysozyme IgGi, IgDa or IgMa AFC responses as measured by ELISPOT for both 
experiments.
C. Graph showing the geometric mean fluorescence intensity of IgMa (open circles) and 
IgDa staining (filled circles) on B220+ peripheral blood lymphocytes from MM4xDD6, 
MM4, DD6 and MD4 transgenic mice. Each point represents a separate mouse. Data in 
this panel was acquired during a single phenotyping experiment and all the blood samples 
were stained identically using the same batch of reagents.
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6.2 (a) Variations in the proportion of HEL-binding B cells do
not explain different responses to antigen
The high affinity of the anti-HEL BCR for antigen allows the unequivocal staining of 
cells bearing a high density of transgenic BCR by FACS (Townsend, 2001). In contrast to 
other anti-HEL lines, the GG4 and MG lines (MG2, MG6 and MG8) accumulate a 
significant population of non-HEL-binding B cells in the periphery, apparently the result of 
editing (Pogue, 2000). High-affinity HEL-binding cells in these lines are negative for IgD 
expression, suggesting effective allelic exclusion in the cells that retain HEL-binding. The 
transfer experiments in this study mostly used whole, unfractionated spleen suspensions 
and relied on high-affinity HEL-binding as a measure of the number of “transgenic” B cells 
in the transfer inoculum, but it is difficult to completely rule out some low-level of 
expression of anti-HEL BCR on non-HEL-binding “edited” B cells. If some non-HEL- 
binding B cells in the lines expressing the IgG membrane tail retained a low level 
expression of the transgenic receptor, it may be that a greater number of antigen-reactive 
cells were transferred into recipient mice, leading to their apparently greater response to 
antigen in vivo.
To exclude this possibility, GG4, MG2 and MM4 lines were crossed to the RAGl'7' 
background. As seen in Figure 5-4 and Figure 6-3, all the splenic and lymph node B cells 
in the GG4, MG2 and MM4 lines on the RAGE7' background are high affinity HEL- 
binding cells. In one experiment, RAGE7' transgenic B cells were co-transferred into an 
anti-lysozyme immune response in C57BL/6 mice that had been previously primed with 
lysozyme in CFA to expand endogenous helper T cells. Figure 6-2 shows that IgGiRAGl'7' 
and IgM/G:RAGE7' B cells make a similar number of AFCs, while IgG:RAGl'7' B cells 
make ~10-fold more AFCs than IgMiRAGl'7' B cells. This is an identical result to transfer 
experiments conducted with RAG1+/+ Ig transgenic lines, and shows that B cells bearing the 
membrane tail of IgG make an enhanced response to antigen on a per cell basis even in the 
absence of non-HEL-binding peripheral B cells. The same result was obtained by the 
adoptive transfer of IgGiRAGl'7', IgM/G:RAGl'7' and IgMiRAGE7' transgenic lymph node 
B cells, where IgG and IgM/G RAGE7" B cells made similar AFC responses that were 100- 
fold greater than an equivalent number of IgMiRAGl'7' B cells (Figure 6-3).
Collectively, these data rule out the possibility that non-HEL-binding B cells 
contribute to the pattem of antigen reactivity described in this work.
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Section 6.3. Marginal zone and follicular subsets differ 
between lines but do not correlate with 
reactivity to antigen
The previous chapter documented the wide variation in HEL-binding marginal zone 
and follicular subsets in the spleens of the various Ig transgenic lines used in this study. 
Numerous properties have been attributed to marginal zone B cells, including a pre­
activated phenotype (Liu, 1995; Martin, 2000a; Martin, 2001) and enhanced APC abilities 
(Liu, 1995), as well as rapid, predominantly extrafollicular antibody responses against 
various antigens (Liu, 1991; Martin, 2001). So, while an equivalent number of splenic 
HEL-binding cells were used from each line for adoptive transfer, there were considerable 
differences in the fraction of these HEL-binding cells with marginal zone versus follicular 
phenotypes. This was an attractive explanation for differences in reactivity between, for 
example GG4, MG2 and MM4 lines. Both GG4 and MG2 have a much greater fraction of 
marginal zone phenotype HEL-binding cells (30.9 ± 5.8 % and 48.6 ± 4.9 % respectively) 
compared to the MM4 line (10.7 ± 3.2 %), and this seems to correlate with the reactivity to 
antigen seen during adoptive transfer.
To test whether variations in the marginal zone and follicular phenotypes of 
transgenic B cells from the various lines was responsible for their varying reactivity to 
antigen in vivo, four experimental approaches were taken.
6.3 (a) The proportions of MZ versus FO subsets in different
lines do not correlate with responses to antigen
Data presented in Chapter 5, in conjunction with the experiments described in Figure 
6-1 suggest that marginal zone versus follicular subset differences between the transgenic 
lines do not correlate with B cell reactivity in vivo on adoptive transfer.
In terms of reactivity to antigen, from Figure 6-1 and Figure 3-3 it is possible to rank 
each transgenic line from highest to lowest:
GG4 ~ MG2 ~ MG6 ~ MG8 ~ DD6 > MM4xDD6 > MD4 ~ M5E1 ~ M8E2 > MM4
In terms of the fraction of HEL-binding cells that have a marginal zone phenotype, it 
is also possible to rank B cells from each transgenic line (Table 5-1):
MM4xDD6 > MG8 > MG2 ~ M8E1 ~ DD6 ~ M8E2 > GG4 ~ MD4 > MG6 > MM4
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Figure 6-2. Transgenic B cells on the RAG1'7' background show the same 
pattern of reactivity to antigen in vivo
106 IgG:RAGl'' transgenic B cells were mixed in a 1:1 ratio with either 106 IgMiRAGl'7' 
or 106 IgM/G:RAGrA transgenic B cells. These were injected i.v., along with a boost of 50 
jig soluble TEL into C57BL/6 recipients that had been primed with 100 jig TEL in CFA 7 
days previously.
On day 5 after immunisation and transfer spleen samples were taken and ELISPOT assays 
performed to enumerate anti-lysozyme AFCs. The results are given as the number of anti­
lysozyme IgGi AFCs (closed circles) and the number of anti-lysozyme IgMa AFCs (open 
circles) per 107 recipient splenocytes.
RAG1-A 
Tg B cells
-------
TEL in CFA
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In some cases, the fraction of marginal zone phenotype HEL-binding cells correlates well 
with the reactivity of a particular line. For example the MM4 line has a comparatively 
small fraction of HEL-binding marginal zone cells, and B cells from this line consistently 
make the poorest response to antigen in vivo. However there are some notable exceptions. 
For example both the MG6 and GG4 lines have comparatively low fractions of HEL- 
binding MZ phenotype B cells, yet these consistently produce the most robust immune 
responses in vivo. In addition, while the M8E1 and M5E2 lines have a comparable 
proportion of HEL-binding marginal B zone cells compared to the MG2 line, they 
consistently produce ~100-fold fewer anti-HEL AFCs and undergo at least a 10-fold lower 
clonal expansion response compared to the MG2 line.
Due to these inconsistencies between the observed reactivity of each line and the 
fraction of HEL-binding cells that have a marginal zone phenotype, it is clear that 
differences in the partitioning of HEL-binding cells into one peripheral subset or another is 
not the only factor affecting B cell responses to antigen.
6.3 (b) Immature sorted B cells retain differential responses to
antigen
To directly examine whether differences in the mature B cell subsets are required for 
differential responses to antigen, immature bone marrow B cells from IgG (GG4) and IgM- 
only (MM4) transgenic lines were sorted on the basis of HEL-binding and a lack of CD21 
expression. CD21 expression gradually increases during B cell ontogeny, and CD2L bone 
marrow cells are immature (Gelfand, 1974; Aheam, 1989). The sorted immature B cell 
bone marrow subsets from the IgG and IgM transgenic lines show no evidence of selection, 
and form a similar proportion of bone marrow lymphocytes in both cases (Pogue, 1996; 
Pogue, 2000).
Figure 6-3 part A shows the results of the transfer experiment using the sorted 
immature cells. Representative FACS plots of HEL-binding and CD21 expression on bone 
marrow lymphocytes from IgG and IgM donor transgenic mice show that the CD2L HEL- 
binding subsets are identical in frequency and surface Ig receptor levels. When seeded into 
immunised recipients along with TCR transgenic T cells, IgG isotype immature HEL- 
binding B cells still produced -100-fold more AFCs on a per cell basis compared to IgM 
isotype immature HEL-binding B cells. This demonstrates that identical B cell populations 
that differ only in BCR isotype expression but show no evidence for selection still produce 
differential responses to antigen on adoptive transfer. This argues that the selective 
differences in splenic peripheral B cell subsets are not necessary for differential responses 
to antigen in this system.
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6.3 (c) IgG, IgM/G and IgM transgenic lymph node B cells retain
differential responses to antigen
Lymph node B cells from IgG, IgM/G and IgM RAG 1-deficient mice show no 
evidence of selection (Figure 6-3). These provided an identically-matched pool of mature 
B cells with which to further test the role of selection in B cell responses to antigen. As 
shown in Figure 6-3 part B, lymph node cells from these lines are homogeneous B220+ 
HEL-binding cells, with a predominantly follicular phenotype on the basis of CD21 and 
CD23 expression.
Mature lymph node B cells from IgGiRAGl'7', IgM/GiRAGl"' and IgMiRAGl'7' 
mice were transferred along with FCR transgenic F cells into immunised recipients. As 
shown in Figure 6-3 part B, lymph node-derived transgenic B cells that bear the IgG 
membrane tail make a 100-fold greater AFC response compared to lymph node-derived 
transgenic B cells with IgM isotype receptors.
This is further evidence that differences in marginal zone versus follicular subset 
partitioning in the spleen is not necessary to explain differential reactivity to antigen in this 
system. In this case phenotypically equivalent mature B cells still retain differential 
responses to antigen, and the only factor determining their response is the presence or 
absence of the IgG membrane tail.
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Figure 6-3. Immature bone marrow B cells and mature lymph node B cells 
from different transgenic lines retain differential responses to 
antigen
A. Immature phenotype CD21' HEL-binding B cells were sorted from IgG and IgM 
transgenic bone marrow. FACS plots show CD21 expression (x-axis) and HEL-binding (y- 
axis) on bone marrow lymphocytes from IgG and IgM transgenic mice. Gates indicate the 
sorted populations and numbers give the fraction of bone marrow lymphocytes that are 
CD2L and HEL-binding in both samples. 105 sorted B cells were transferred along with 
105 TCR transgenic T cells into immunised (B10.BRxC57BL/6)Fi recipients, and the 
production of anti-lysozyme IgGi (filled circles) and IgMa (open circles) AFCs measured 
on day 5 by ELISPOT. Data is given as the number of anti-lysozyme AFCs per 107 
recipient splenocytes.
B. Lymph node cells from IgGiRAGl'7', IgM/GiRAGl'7* and IgM:RAGl'7' transgenic mice 
were used as a source of donor B cells. As shown by FACS dot plots, B cells from all of 
these lines represent a homogeneous population of B220+ HEL-binding cells that have a 
predominantly CD21med CD23+ follicular phenotype. No CD21hl CD23' cells were present 
in the samples (gates were set on spleen samples analysed in parallel). 106 HEL-binding 
lymph node cells of each type were transferred along with 106 TCR transgenic T cells into 
immunised B10.BR recipient mice. On day 5 after transfer the production of anti-lysozyme 
AFCs in the spleen of recipient mice was measured by ELISPOT. Anti-lysozyme IgGi 
AFCs are given by filled circles and anti-lysozyme IgMa AFCs are given by open circles.
IgG BM IgM BM
X
1 0 « 
io 3 
102 
10 
1
1 10 102 103 IO4 10 102 103 10"
CD21-bio/SA-PE-------------------------- ►
co
a
o
o
c
0 )
Q .
CO
CD 
Q. 
<O
Ü
UL<
1 0 5 
104 
1 0 3 
102 
10 
0
Transgenic donor for 
immature B cells
o
2
>>
X
104
103
102
lgG:RAGVA IgM/GiRAGV lgM:RAG1
0 . 6 6
■0 :  .
8 5 . 6
0 . 1 5
8 0 . 4
0 . 5 2
f
8 0 . 8
1 2 1 . 7 5 1 6 . 8 2 . 6 4
.
■ 5
1 5 . 2 3 . 4 6
B220-PE
L_J . - _ -  • , . - „  | i inj . , . . . .ju-j ' , ,,-JV
C J 1 10  1 0 2 1 0 3 1 0 4 1 0  1 0 2 1 0 3 1 0 4 1 0  1 0 2 1 0 3 1 0 4
CD23-PE
CO
S s  1 0 4
o
o
£ 103
CL
CO
b  102
CD
CL
CO
O
LL<
Tg B cell donor
O
-0- -
o
1
1
1
Ö ------1....................................
<5> 1
" ö - " 8
IgG IgM/G IgM non 
---------  HEL/CFA --------
- Q  — - 0 —
IgM/G IgM non 
-------- no A g -----
164 Chapter 6
Figure 6-4. Sorted marginal zone and follicular phenotype spleen cells from 
IgG or IgM RAG1'/_ mice retain differential responses to antigen
Marginal zone phenotype (CD21hl CD23') and follicular phenotype (CD21med CD23+) B 
cells were sorted from IgGiRAGl"7' and IgMiRAGT7' transgenic donor mice.
FACS contour plots are gated on lymphocytes by scatter, and show unsorted, sorted 
marginal zone and sorted follicular phenotype spleen cells from IgG and IgM RAGT' 
transgenic mice. The gates used to sort the marginal zone and follicular subsets are 
indicated on each plot, as well as post-sort samples showing the purity of the sorted cells.
105 of each type of sorted or unsorted transgenic B cell was transferred along with 2x1 (F 
TCR transgenic T cells into immunised (B10.BRxC57BL/6)Fi recipients. On day 5 after 
immunisation and transfer the number of AFCs was determined by ELISPOT. Bars show 
the geometric mean for each experimental group.
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6.3 (d) Sorted MZ versus FO subsets retain differential
responses to antigen
To directly test the reactivity of the different splenic peripheral B cell to antigen, 
marginal zone and follicular peripheral B cell subsets were sorted (Figure 6-4).
For this experiment, IgGiRAGl'7' and IgMiRAGl" transgenic mice were used as a 
source of transgenic B cells. These RAG l '7' IgG and IgM transgenics show large 
differences in marginal zone and follicular B cell partitioning. As all peripheral B cells are 
FIEL-binding (see Figure 5-4), it was not necessary to stain and sort on the basis of BCR 
specificity. Marginal zone and follicular B cells were sorted from IgG and IgM RAGT7’ 
transgenics on the basis of CD21 and CD23 expression. Also, IgG:RAGl'7' and 
IgM:RAGr7' spleen samples were stained and treated identically to the sorted fractions, 
except they did not pass through the flow cytometer. These were transferred into 
immunised recipients at the same time as the sorted subsets, to control for the effects of 
CD21 and CD23 ligation on cell viability and activation status. After sorting from IgG and 
IgM transgenic donors, 105 MZ or FO phenotype B cells were transferred into immunised 
recipients along with 2 x 105 TCR transgenic cells.
Figure 6-4 shows the results of this experiment as the number of anti-HEL AFCs per 
recipient on day 5 after immunisation and transfer. In all groups the IgG transgenic B cells 
produced more AFCs on average compared to the corresponding IgM transgenic B cells. 
This experiment is difficult to interpret, however, as there were large variations in the AFC 
response within each experimental group. This may be due to the relatively low numbers 
of B cells transferred, resulting in variable loss upon injection and variable incorporation 
into lymphoid tissues. Also, the effects of staining marginal zone and follicular subsets 
with antibodies that cross-link CD21 and CD23 may have influenced both the viability and 
the activation status of the cells prior to transfer. For example, the sorted marginal zone 
subsets made a poorer AFC response compared to the sorted follicular subsets, possibly as 
a result of crosslinking CD21 which is more highly expressed on marginal zone B cells 
(Loder, 1999) and might differentially affect cell viability. Alternatively, marginal zone B 
cells are non-recirculating cells (Kumararatne, 1981a; Kumararatne, 1981b) which may not 
home from the blood to the spleen efficiently, thereby reducing the observed response in 
those groups. In the future it should be possible to repeat this experiment, perhaps using 
alternative sorting markers such as CD Id (Roark, 1998), as well as transferring 5 or 10 
times more transgenic B cells per recipient to unequivocally confirm these results.
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Section 6.4. The effect of IgD expression on transgenic 
B cell responses to antigen in vivo.
Throughout this study, B cells from Ig transgenic mice expressing the IgG membrane 
tail have made robust responses to antigen in vivo. The responses of the various lines 
expressing combinations of IgM and IgD isotype receptors have been more variable. There 
are several possibilities for the source of this variation. There are differences in transgenic 
construct types, line-to-line variation due to transgene integration site and differences in the 
development and surface phenotype of peripheral B cells in these lines, although none of 
these parameters correlate perfectly with responses to antigen in vivo. Another possibility 
is that these variations are a real reflection of isotype-specific signalling through IgM and 
IgD antigen receptors in the context of the anti-HEL transgenic system.
The IgM-only MM4 line consistently makes fewer AFCs and a poorer clonal 
expansion response compared to the IgM/IgD co-expressing line MD4 (see Figure 3-3). To 
extend this observation, the IgM-only line MM4 was also compared to lines M5E1, M8E2, 
DD6 and MM4xDD6 using adoptive transfer with TCR transgenic T cells into immunised 
recipients. Figure 6-1 shows results from two such experiments.
Consistent with previous findings, the IgM-only line MM4 made a three-fold poorer 
clonal expansion response compared to either IgM8E line. Interestingly, the IgD-only line 
DD6 made a similar response to the IgG line GG4 and the IgM/G lines MG2, MG6 and 
MG8, both in terms of clonal expansion and AFC production. Co-expression of transgenic 
IgD from the DD6 transgene with IgM from the MM4 transgene in the (MM4 x DD6) F i 
hybrid also produced strong clonal expansion and AFC production of comparable level to 
lines expressing the IgG membrane tail.
How could this pattern of reactivity be reconciled with differences in IgM and IgD 
isotype signalling?
Firstly, it is possible that the increased response made by the IgM8E lines compared 
to the IgM-only line reflects altered signalling through the BCR complex, as the transgenic 
constructs used to make the IgM8E lines contain the 27-amino acid extracellular spacer of 
IgD. This small section was shown in vitro to confer an IgD-like glycosylation pattern to 
Iga associated with the BCR (Pogue, 1994). It may be that this change in glycosylation 
pattern confers a more “IgD-like” signal upon antigen engagement of the BCR.
Secondly, there is a previous precedent for differences in the responsiveness of IgM 
and IgD transgenic B cells to antigen in this system. A similar order of reactivity to antigen
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in vivo was seen amongst MM7, MD4 and DD6 anti-HEL transgenic B cells seeded into 
irradiated recipients immunised with HEL-SRBC (Brink, 1992). In that case, the IgM-only 
(MM7, sister line to MM4) cells produced ~10-fold lower serum IgMa compared to the 
MD4 cells. In addition, the MD4 cells produced ~10-fold lower serum IgMa compared to 
the level of serum IgDa made by DD6 cells.
In the current study there are several possible reasons for the strong clonal expansion 
and AFC response made by the DD6 and MM4xDD6 lines. Firstly, the DD6 and 
MM4xDD6 lines express similar, elevated levels of anti-HEL IgDa compared to the MM4 
or MD4 lines (Figure 6-1, part C). Ignoring isotype, it is conceivable that the simple ~2- 
fold higher expression levels of antigen-specific BCR in the DD6 and MM4xDD6 lines is 
responsible for their stronger response to antigen. This seems unlikely, however, as the 
GG4 line makes very robust responses to antigen, yet has ~5-fold lower anti-HEL receptor 
levels compared to the MM4 line (Pogue, 1996) (also see Figure 5-4). If isotype is taken 
into account, it could be argued that the DD6 and MM4xDD6 lines respond well to antigen 
because of unusually high anti-HEL IgD BCR expression when compared to the MM4, 
MD4 or M8E lines. The signalling through the IgD BCR complex on those cells would 
then be hypothesised to protect from apoptosis during the process of clonal expansion, in a 
similar way to the action of the IgG membrane tail.
Despite these speculations, it is difficult to provide a physiological interpretation for 
the increased reactivity of lines expressing high levels of anti-HEL IgD. Firstly, the 
dysregulated expression of IgD from a transgene during bone marrow development and the 
secretion of IgD by plasma cells does not mirror the tight regulation of IgD expression 
during B cell development in either normal or MD4 mice (Brink, 1992). Secondly, 
functional differences between IgD and IgM in vivo have been largely discredited, despite 
early suggestions that signalling through IgD was responsible for the switch from tolerance 
to immune responsiveness that accompanies the immature to mature B cell transition 
(Carsetti, 1993). Subsequent experiments showed that IgM-only transgenic B cells develop 
into mature B cells normally and make normal responses to antigen in the absence of IgD 
(Brink, 1992), and the only defects noticed in IgM knockout mice were slightly delayed 
responses to some viral antigens (Lutz, 1998). These experiments suggest that the 
maturation state of the B cell seems more important than isotype expression in determining 
the response the B cell makes to antigen (Norvell, 1996).
This raises the possibility that B cells in these various transgenic lines are somehow 
“stuck” in different developmental stages. In support of this, the MM7 line (generated from 
the same construct as MM4) has a greater fraction of HSAhl B22010 phenotype splenic B 
cells compared to the MD4 line, possibly indicating a greater fraction of immature
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phenotype B cells in the spleen (Brink, 1992). Despite this, all of the lines tested in this 
study make phenotypically normal mature follicular B cells, which means a simple 
explanation for differences in immune responsiveness in terms of B cell maturation state is 
unlikely.
To summarise, the interesting observation of variable immune responsiveness 
amongst MM4, MD4, M8E1-2, DD6 and MM4xDD6 lines hints that varying levels of IgD 
expression may play a role in naive anti-HEL transgenic B cell responses to antigen in vivo. 
Whether this is due to the simple variation in antigen receptor levels, some consequence of 
acute antigen stimulation via IgD isotype receptors, or a reflection of developmental 
differences in peripheral B cells between the lines remains to be determined.
Section 6.5. Chapter summary
This chapter has dealt with the important issue of line to line variation as a source of 
differential responses to antigen by the variety of transgenic lines reported in previous 
chapters. This is a critical point that is central to the interpretation of the results presented 
in this thesis, as this experimental system relies on comparisons between B cells that must 
be as closely matched as possible apart from the expression of different BCR isotypes. If 
this condition can not be met or be shown experimentally, then this system cannot be used 
to isolate the role of BCR isotype in B cell responses to antigen.
There is clear evidence for differences between the various lines used in this study 
which are not connected with BCR isotype. As with any panel of conventional Ig 
transgenic mice, line to line variation due to copy number and integration site effects must 
be taken into account (Goodnow, 1992). Variation in the switch region sequences of the 
transgenic constructs used to make this panel of mice (Table 6-1) must also be addressed.
In addition, differences in B cell development exist between the lines that may be 
connnected to the expression of different BCR isotypes. For example, edited B cells that 
have lost HEL-binding accumulate in the periphery of IgG and IgM/G transgenic lines 
(Pogue, 1996; Pogue, 2000). The degree of editing varies with transgene copy number 
which may reflect the strength of signalling by the IgG membrane tail, leading to 
developmental arrest and editing. This complicates the analysis, as edited peripheral B 
cells may retain some low-level expression of HEL-binding BCR, and peripheral HEL- 
binding B cells in these lines might be altered by editing events that do not take place to the 
same degree in the other transgenic lines.
170 Chapter 6
This thesis has also extended the analysis of the differences in peripheral B cells 
between these lines, by showing that there are large variations in the fraction of peripheral 
HEL-binding cells that have a marginal zone versus follicular surface phenotype. This may 
be connected to BCR expression, but whatever the cause, it means that adoptive transfers 
with unfractionated spleen cells transfer different proportions of marginal zone and 
follicular B cells.
The results presented in this chapter rule out several trivial explanations for the 
responses of the various Ig transgenic B cells to antigen in vivo. Line to line variation is 
excluded as a source of differential responses to antigen, as consistent responses are made 
by the three independent MG lines and the two independent M8E lines. In addition, 
construct switch region type has no bearing on the magnitude of the response. Lines 
bearing identical transgene switch regions but differing in surface Ig isotype (e.g. MG lines 
and M5E lines) make very different responses to antigen, while lines bearing different 
transgene switch regions but sharing the IgG membrane tail make similar responses to 
antigen (e.g. GG4 and MG lines). In addition, the presence of an intact p. switch region is 
not responsible for the reduced net clonal expansion of the MM4 line, as the MM4xDD6 
line, while retaining that switch region, still makes a very robust response to antigen. It is 
important to note that transcription and translation of the IgM transgene remains high in the 
MM4xDD6 B cells (Bell, S. and Goodnow, C.C., unpublished observations).
Most importantly, phenotypic heterogeneity within the peripheral B cell 
compartments can be excluded as an explanation for differential responses to antigen 
between the various transgenic lines. Transfer experiments using transgenic B cells from 
RAG 1-deficient spleen and lymph node rule out the possibility that the edited non-HEL- 
binding B cells that accumulate within the spleen of IgG and IgM/G transgenic lines carry 
low levels of HEL-binding receptors or are involved in immune responses upon adoptive 
transfer. Also, transfer experiments using homogeneous matched immature bone marrow B 
cells or mature lymph node B cells demonstrate that phenotypic variation or selection in the 
peripheral splenic marginal zone and follicular subsets of donor mice is not necessary for 
differential responses to antigen. The transfer experiment using sorted splenic MZ and FO 
phenotype B cells, while providing variable, inconclusive results, did not indicate large 
differences in reactivity between the two subsets. In each case IgG transgenic MZ or FO 
phenotype cells produced more AFCs on adoptive transfer compared to IgM transgenic MZ 
or FO phenotype cells.
The finding that variations in the fraction of marginal zone and follicular HEL- 
binding peripheral B cell subsets between transgenic lines is not necessary to retain 
differential response to antigen is a surprising result, given the special qualities normally
Line to line variation does not explain B cell responses to antigen 171
attributed to marginal zone B cells. For example, they have been reported to have a pre­
activated phenotype as well as to rapidly migrate and differentiate upon antigen encounter 
(Liu, 1991; Liu, 1995; Arpin, 1997; Oliver, 1997a; Oliver, 1999; Martin, 2001). How can 
the findings presented in this thesis that a marginal zone phenotype does not necessarily 
correlate with antigen reactivity be reconciled with these observations? Firstly it may be 
inappropriate to compare many of these reports with the current study, given the 
heterogeneous makeup of the marginal zone B cell compartment in normal mice. Model 
systems demonstrating the rapid activation of memory B cells (Liu, 1991) or “polyreactive” 
B cells (Martin, 2001) may be measuring primarily the effects of prior antigen priming 
coupled with localisation to a key antigen-draining site. A significant population of “naive” 
B cells that accumulate in the marginal zone of normal rats show no signs of somatic 
mutation (Dämmers, 1999a; Dammers, 2000), and yet studies of the rate of replacement of 
the marginal zone pool and Vh gene useage suggest that selective forces among these cells 
are strong. By contrast, Ig transgenic mice that contain relatively high proportions of 
monoclonal B cells must disrupt the selective pressures existing in normal animals by 
decreasing the competition for entry into the marginal zone pool. The data presented in this 
thesis suggests that the level of clonal competition is one important determinant of the 
relative fraction of anti-HEL Ig transgenic cells that adopt a marginal zone phenotype (see 
Figure 5-5). It may be that the “space” normally reserved in the marginal zone for selected 
B cell clones can be filled by normally excluded clones in Ig transgenic mice as a default 
pathway, leading to marginal zone phenotype B cells that lack many of the functional 
properties derived from selection and antigen contact that are normally associated with 
those cells.
One interesting factor contributing to reactivity to antigen may be variations in the 
expression of IgD amongst several anti-HEL transgenic lines. While lines expressing 
normally regulated IgM or IgD (MM4, MD4, M8E1, M8E2) make > 10-fold poorer 
responses to antigen compared to lines expressing the IgG membrane tail, lines carrying a 
dysregulated IgD transgene (DD6, MM4xDD6) make very robust responses. An 
explanation of the impact of higher IgD expression on B cell responses to antigen is 
difficult to reconcile with previous data, and is beyond the scope of this thesis to address.
To conclude, the data here exclude trivial explanations of line to line variation in the 
pattern of immune reactivity seen amongst the extensive panel of anti-HEL Ig transgenic 
mice used in this study. More surprisingly, data presented here shows that differences in 
the stage of B cell development or variations in marginal zone versus follicular phenotype 
amongst antigen-specific cells do not contribute to the observed differences in reactivity to 
antigen in vivo. Thus, expression of the IgG membrane tail on B cells that are
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developmentally matched in all other respects allows more robust responses to antigen 
compared to B cells expressing the naive IgM BCR isotype.
Section 6.6. Future work
In the future it would be useful to repeat the active sorting of marginal zone and 
follicular B cells from the IgM transgenic line and lines expressing the IgG membrane tail. 
By transferring a greater number of cells (at least 106) it may be possible to overcome the 
variable responses seen in this study. A comparison of the effects of CD21 ligation during 
sorting and adoptive transfer should also be carried out, to determine whether sorting MZ B 
cells using this parameter is overtly stimulatory. Alternative, potentially less stimulatory 
sorting parameters exist, such as CD Id (Roark, 1998).
Chapter 7. Biochemical analysis of early
signalling by IgG isotype 
receptors
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Section 7.1. Introduction
The previous chapters have established that the expression of the IgG membrane tail 
confers enhanced reactivity to antigen during an immune response in vivo. The membrane 
tail acts by protecting B cells from loss during the process of clonal expansion, although the 
biochemical mechanism behind this protective effect is currently unknown.
This short chapter describes preliminary biochemistry experiments designed to test 
whether there are early BCR signalling differences between IgG, IgM/G and IgM isotype 
anti-HEL transgenic B cells. This is an important line of investigation that aims to combine 
the cellular observations of heightened reactivity to antigen during an immune response 
with isotype-specific biochemical pathways operating in B cells bearing the IgG membrane 
tail.
Several previous lines of evidence have suggested that BCR signalling via anti-HEL 
receptors bearing the membrane tail of IgG is qualitatively different compared to lines 
expressing combinations of IgM and IgD. For example, despite expressing equivalent 
levels of transgenic receptors on pro-B bone marrow lineage cells compared to transgenic 
lines expressing IgM and IgD, lines expressing the IgG membrane tail accumulate “edited” 
B cells in the periphery that have lost the ability to bind HEL (Pogue, 2000). As well, 
peripheral HEL-binding B cells in the IgG and IgM/G lines express lower receptor levels 
(80 % and 40 % lower respectively) compared to the IgM-only line (Pogue, 1996). This is 
reminiscent of the receptor modulation made by MD4 anti-HEL B cells deficient in SHP-1 
(Cyster, 1995), CD22 (Comall, 1998), Lyn kinase (Comall, 1998) or overexpressing CD 19 
(Inaoki, 1997), and suggests that IgG membrane tail signalling may be of a different 
quality, leading to compensatory mechanisms such as receptor editing and receptor down- 
modulation.
In vitro experiments with IgG, IgM/G and IgM transgenic anti-HEL lines have 
focussed on early signal transduction events surrounding BCR stimulation, using cross- 
linking antibodies or the cognate antigen HEL in either monomeric or multimeric form 
(Pogue, 1996). Some signalling pathways were more active in transgenic B cells 
expressing the IgG membrane tail. For example, elevated basal intracellular calcium was 
observed in IgG and IgM/G mature transgenic B cells compared to the IgM transgenic B 
cells. In addition, the IgG and IgM/G transgenic B cells made a more robust calcium flux 
to multimeric HEL-dextran and anti-kappa antibodies. However, some signalling pathways 
were less active in transgenic B cells expressing the IgG membrane tail. For example, the 
induction of tyrosine phosphorylation of intracellular cytoplasmic proteins was poor in IgG
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and IgM/G transgenic B cells by either HEL or anti-kappa stimulation. These in vitro 
observations suggested that the IgG isotype BCR coupled more efficiently to some 
downstream signalling pathways, as the poor induction of tyrosine phosphorylation was 
still accompanied by a robust calcium response. These observations also suggested that 
signalling via the IgG or IgM isotypes in this system diverge very soon after antigen 
receptor engagement.
The movement of both B and T cell antigen receptors into detergent-insoluble, 
cytoskeleton-associated membrane microdomains (lipid rafts) has been proposed as a very 
early step required for proper antigen receptor signalling in mature, naive lymphocytes 
(Cheng, 1999; Viola, 1999; Weintraub, 2000; Cherukuri, 2001). It was reasoned that IgG 
and IgM/G BCR receptors might signal more efficiently due to constitutive association 
with lipid rafts that are rich in positive signalling molecules such as Src family kinases and 
Syk, while excluding negative regulators of signalling such as the protein tyrosine 
phosphatase CD45 (Weintraub, 2000; Cherukuri, 2001). In this study the partitioning of 
IgG, IgM/G and IgM BCRs into cytoskeleton-associated lipid rafts was investigated to 
determine whether the IgG and IgM/G isotype receptors were arranged differently at the 
cell surface.
Section 7.2. IgG transgenic B cells show a different
pattern of early activation compared to IgM 
transgenic B cells
All of the experiments described in this chapter were performed with primary splenic 
B cells from Ig transgenic lines on the RAGT' background, allowing the isolation of a pure 
population of HEL-binding B cells.
In agreement with the findings of Pogue (Pogue, 1996), the induction of tyrosine 
phosphorylation on bulk cytoplasmic proteins was consistently lower upon antigen receptor 
stimulation in IgG transgenic B cells compared to IgM transgenic B cells. A representative 
experiment is shown in Figure 7-1 where detergent lysates and the detergent-insoluble 
fraction from resting or HEL-stimulated IgG:RAGT ' and IgM:RAGT ' primary B cells 
were analysed by Western Blot. Panel A shows the blot probed for anti-phosphotyrosine. 
While there was little induced tyrosine phosphorylation in the IgG detergent-soluble 
fraction, the IgG detergent-insoluble fraction contained several proteins that became 
phosphorylated on stimulation. The opposite was seen in the IgM samples, as there were 
several proteins that were inducibly phosphorylated in the detergent-soluble fraction upon
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stimulation, but there were few phosphorylation changes in proteins associated with the 
IgM detergent-insoluble pellet.
An interesting observation was made with respect to the isoforms of Igaß that 
associate with the IgG or IgM isotype antigen receptors. Panel B shows the blot in panel A 
re-probed with anti-sera against Lyn, Iga and Igß. There are distinct molecular mass 
isoforms of Iga associated with the detergent soluble and detergent-insoluble fractions in 
both IgM and IgG transgenic B cells. This heterogeneity in Iga molecular mass has been 
observed previously, for example between IgD and IgM-associated molecules, and reflects 
differential N-glycosylation (Campbell, 1991; Pogue, 1994). The IgG transgenic B cells 
lack the lower -30 kDa molecular mass isoform indicated by the star. In addition, there is a 
mobility shift of the intermediate Iga species between the detergent-soluble (-32-33 kDa) 
and insoluble (~ 34 kDa) fractions in both IgG and IgM transgenic cells. It is tempting to 
speculate that this mobility shift reflects phosphorylation and that a large fraction of the 
active, phosphorylated IgM and IgG receptors are present in the detergent-insoluble 
material.
Section 7.3. The IgG BCR may constitutively associate 
with lipid rafts
Cytoskeleton-associated membrane rafts were investigated next, as the movement of 
the BCR into these membrane domains upon receptor cross-linking is one of the earliest 
events in antigen receptor signalling in B cells, and is a step that is uncoupled in B cell 
anergy (Weintraub, 2000). An isolation procedure using high salt washes of detergent- 
insoluble material that has been previously validated in primary naive and anergic B cells 
(Weintraub, 2000) was used to test whether the IgG isotype BCR associates more readily 
with cytoskeleton-associated membrane rafts, either constitutively or after in vitro 
stimulation. This technique was first applied to the association of the activated TCR with 
the T cell cytoskeleton (Marano, 1997) and the method involves extracting cells with non­
ionic detergent in a buffer that stabilises the cytoskeleton. Most of the plasma membrane is 
dissolved into the supernatant by the detergent, but a small fraction of the membrane 
remains detergent insoluble and attached to the cytoskeleton. When the NaCl concentration 
is increased, attached membrane fragments are released into the supernatant. Figure 7-2 
shows results from RAG 1-deficient IgG, IgM/G and IgM transgenic B cells that were 
stimulated in vitro with HEL, then low salt detergent and high salt detergent fractions were 
prepared under non-reducing conditions and analysed by Western blot. The BCR complex 
was detected by probing for kappa light chain under non-reducing conditions, which 
allowed IgG, IgM and IgM/G isotypes to be distinguished on the basis of molecular mass.
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These data are in accordance with previous studies using the MD4 anti-HEL line 
(Weintraub, 2000), and show the movement of the IgM isotype BCR from MM4:RAGr7' B 
cells into the salt extractable cytoskeleton-associated membrane raft fraction after 
stimulation. This has been a consistent observation in four out of four experiments 
performed using this system. These data also show the constitutive presence of the IgG 
isotype BCR in the membrane raft fraction from GG4:RAGr7' B cells, with little 
enrichment after stimulation. The same pattern has also been observed with IgM/G isotype 
MG2:RAGr/_ B cells. However, for both IgG and IgM/G transgenic B cells the 
constitutive association with membrane rafts was not consistent, being observed in only 
two out of three experiments.
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Figure 7-1. TX-100 lysis of stimulated IgGiRAGT'" and lgM:RAG1'/_ 
transgenic B cells showing differences in tyrosine 
phosphorylation and Igotß isoforms
Results from a representative experiment in which 107 IgGiRAGl'7* or 107 IgMiRAGl'7' 
transgenic B cells were stimulated ± HEL (10 p-g/ml) for 3 minutes at 37 °C. After 
stimulation, cells were lysed in buffer containing 1 % (v/v) TX-100 with protease and 
phosphatase inhibitors (see materials and methods Section 2.12). 1.5 x 106 cell equivalents 
of soluble lysate and 0.75 x 106 cell equivalents extracted from the insoluble lysate using 
sample buffer were run on a 10 % reducing polyacrylamide gel and transferred to a PVDF 
membrane for Western blotting.
A. Western blot probed with anti-phosphotyrosine mAb (clone 4G10) followed by goat 
anti-mouse IgG F(ab’)2 fragments conjugated to horse radish peroxidase (ICN). Molecular 
mass markers are shown at the left by bars.
B. The same blot as in (A), re-probed with a mixture of anti-Lyn, anti-Iga and anti-Igß 
antibodies (all rabbit anti-mouse polyclonal sera), followed by goat anti-rabbit HRP 
(Zymed). The position of the p53/p56 Lyn isoforms as well as Igß and Iga isoforms are 
shown. Stars indicate the low molecular mass -30 kDa Iga isoform present in the IgM 
samples and the intermediate molecular mass -32-33 kDa Iga isoform that shows a 
mobility shift in both samples between the two cellular fractions. Molecular mass markers 
are shown at the left by bars. The high background on this blot may reflect residual HRP 
activity from the blot in (A), as is was not stripped before re-probing. However, this has no 
stopped the unequivocal identification of the target proteins Lyn, Iga and Igß.
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Figure 7-2. The IgG isotype BCR may constitutiveiy associate with a salt- 
extractable cell compartment corresponding to cytoskeleton- 
associated membrane rafts
107 IgGiRAGl'7' or IgMiRAGl"7" transgenic B cells were stimulated ± HEL (10 Jig/ml) for 
3 minutes at 37 °C in the same experiment outlined in Figure 7-1. These samples were then 
lysed in low salt detergent containing 0.1 % Triton X-100 as well as protease and 
phosphatase inhibitors (see materials and methods). The detergent soluble “low salt” 
fraction corresponding to cytoplasmic material was collected. After washing, the 
detergent-insoluble pellet was resuspended in high salt CSB buffer to collect the high salt- 
extractable fraction enriched for cytoskeleton-associated membrane rafts. All samples were 
boiled in non-reducing sample buffer. 106 cell equivalents of low salt and 4x106 cell 
equivalents of high salt fractions were run under non-reducing conditions on 7.5 % 
polyacrylamide gels. Western blotting to PVDF membranes was performed as described in 
part 2.12 (b) of the materials and methods.
The Western blot was probed using biotinylated goat anti-mouse kappa light chain 
(Southern Biotechnology), followed by streptavidin/biotin-HRP conjugate (Amersham). 
The position of the IgG and IgM BCRs are indicated by the arrows. Molecular mass 
standards are indicated at the left by bars.
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Section 7.4. Chapter summary and future work
This short chapter has outlined preliminary biochemical evidence that IgG and IgM/G 
isotype BCRs may associate more readily than IgM BCRs with cytoskeleton-associated 
membrane rafts in resting primary B cells. It is tempting to speculate that BCRs bearing 
the IgG membrane tail preferentially associate with signalling complexes enriched in 
membrane rafts, which has the effect of focusing activation signals to those domains. This 
may explain the previously observed paradox of poor induced tyrosine phosphorylation of 
most cytoplasmic proteins but efficient signal transduction for subsequent calcium fluxes 
upon receptor cross-linking (Pogue, 1996). Also, this would be the opposite situation to B 
cell anergy where BCR partitioning into the membrane raft domains is uncoupled 
(Weintraub, 2000).
Despite these observations, there are many unanswered questions. For example, why 
was constitutive raft association not observed in one out of three experiments using IgG or 
IgM/G transgenic B cells? The association of these receptors with rafts in resting cells 
needs to be repeated to test reproducibility. Also, other biochemical and imaging 
techniques are available to assess association of the BCR with rafts. For example, the 
ability of rafts to sequester signalling complexes from phosphatases such as CD45 has been 
used to demonstrate movement of the TCR into these membrane domains (Viola, 1999).
As well, confocal microscopy detecting the co-localisation of the BCR and membrane rafts 
could provide corroboration for these findings.
Another significant issue is the interpretation of these biochemical studies relative to 
the cellular data presented in the rest of this thesis. At present it is not reasonable to 
extrapolate findings on the early signalling of primary transgenic B cells to explain the 
differential responses they make to antigen during an immune response. For example, the 
RAG 1-deficient IgG, IgM/G and IgM transgenic B cells used for these in vitro studies vary 
considerably in the fraction of HEL-binding B cells with a marginal zone or follicular 
surface phenotype (see Chapter 5). While studies in Chapter 6 have demonstrated that 
these variations play no role in the clonal expansion differences between these lines during 
an immune response in vivo, it is possible that the “pre-activated” biochemical pattern 
observed here in the IgG and IgM/G B cells simply reflects the greater fraction of marginal 
zone B cells in those lines. Marginal zone B cells in all anti-HEL transgenic lines are larger 
(see Figure 5-2), and in both IgG and IgM/G lines show compensatory down-modulation of 
surface BCR levels, suggesting a pre-activated state. To address this it may be possible to 
perform these experiments on lymph node B cells from Ig transgenic RAG 1-deficient mice, 
which show a uniform cell surface phenotype (Figure 6-3) and are more closely matched.
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Also, a biochemical explanation for the cell biology of this system must explain how 
differences between cells bearing the IgG membrane tail and those bearing IgM are not 
observed during the initial activation into cell cycle, but manifest between days 3 and 5 of 
an immune response in vivo (described in Chapter 4).
There are two possible scenarios by which the IgG membrane tail could mediate this 
effect. Firstly, signalling differences between IgG and IgM isotype receptors might occur 
throughout cell activation and cell division, but only affect cell biology in the system at 
later timepoints. In this case the IgG membrane tail might alter the relative balance of pro- 
and anti-apoptotic proteins in the cell, in a similar way to CD28 (Sperling, 1996; 
Gudmundsdottir, 1999) signalling during T cell clonal expansion. This may only affect the 
survival of cells expressing the IgG membrane tail at later timepoints, perhaps when 
antigen or T cell help becomes limiting, or when a cross-linking form of antigen is 
presented to the B cell. The relative levels of pro- and anti-apoptotic signalling pathways 
could be studied biochemically directly ex vivo, either during acute stimulation or after 
short-term culture.
Secondly, the relevant signalling differences may only be present at later timepoints. 
Perhaps differential signalling by the IgG membrane domain is only induced after some 
change in the immune response, such as antigen becoming limiting or the only available 
antigen being held in a highly cross-linking manner as immune complex. If this is the case, 
then the most useful approach may be to sort Ig transgenic cells from ongoing immune 
responses at relevant timepoints in order to conduct micro-array experiments. Once 
candidate genes have been identified that could be involved in the survival effect of the IgG 
membrane tail, a clear picture of signalling pathways affected by expression of the IgG 
membrane tail should emerge.
Chapter 8. General Discussion
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Section 8.1. Introductory comments
This thesis has investigated the role of BCR isotype in B cell responses to T- 
dependent antigens. The experimental system of naive Ig transgenic B cells bearing 
defined BCR isotypes was able to remove the other variables of frequency, priming status, 
location, surface phenotype and lifespan that often accompany isotype switching. In this 
way the contribution of BCR isotype to B cell responses could be studied in isolation.
This discussion will briefly summarise the findings of this study. Three key 
questions will then be addressed, (a) How does the current study add to the literature 
concerning the functional role of isotype-switched antigen receptors? (b) What are the 
possible biochemical mechanisms behind the protective action of the IgG membrane tail? 
(c) What is the importance of isotype-switched BCR expression for the features of the 
memory response? Finally, future work will be outlined to test some of the predictions 
made by this study.
Section 8.2. The role of BCR isotype in B cell 
responses to antigen
8.2 (a) Summary of the major findings:
The major finding of this study is that anti-HEL transgenic B cells expressing the 
unique membrane tail of IgGi make at least a 10-fold greater clonal expansion and AFC 
response compared to transgenic B cells expressing various combinations of IgM and IgD 
during a primary TD response in vivo. This is strong evidence for a distinct, functional role 
for BCR isotype during an immune response in vivo.
The increased clonal expansion of B cells bearing the IgG membrane tail is not due to 
greater initial activation, as an equivalent proportion of IgM, IgM/G and IgG transgenic 
cells enter cell division cycle on day 2 of this model immune response.
The IgG, IgM/G and IgM transgenic B cells appear to have similar rates of cell 
division, as assessed by CFSE dilution on day 3 and day 5 after immunisation and transfer, 
which reveals the mode of action of the IgG membrane tail. The IgG membrane tail acts to 
protect transgenic B cells from loss (most likely by cell death) during the process of clonal 
expansion.
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This is consistent with histological studies, where transgenic B cells expressing or 
lacking the IgG membrane tail are found in similar extrafollicular sites near the junctional 
zones of the spleen on days 3 and 4 after transfer. By day 5, however, a large accumulation 
of syndecan-binding transgenic B cells in the junctional zones is apparent in mice bearing 
the IgG membrane tail, while few of the IgM transgenic B cells make this transition.
Transgenic B cells in this system, regardless of isotype, apparently modulate BCR 
levels strongly on day 4 after immunisation and transfer during a primary response to HEL 
in the presence of TCR transgenic helpers. This is hypothesised to be the result of contact 
with a highly cross-linking form of HEL, and only transgenic cells expressing the IgG 
membrane tail survive the encounter to make the transition to extrafollicular plasma cells 
with the recovery of surface Ig expression. Most transgenic B cells expressing IgM or IgD 
receptors do not survive.
Cell death induced by FasL expression on transferred transgenic helper T cells is not 
responsible for the loss of transgenic cells expressing IgM and IgD isotype receptors, 
although a role for FasL expressed by endogenous recipient T cells or dendritic cells is still 
possible. The role of the Fas/FasL death pathway in limiting IgM transgenic cell clonal 
expansion could be more thoroughly ruled out by transfers into FasLgld recipient mice. 
Apoptotic cell death remains the hypothesised pathway of IgM transgenic cell loss, and 
possibly involves encounter with an immuno-modulatory form of HEL as discussed above.
Two other interesting preliminary findings have also been made:
Firstly, the expression of IgD along with IgM seems to decrease the sensitivity of 
transgenic B cells to cell loss. The MD4 line (IgM and IgD), for example, consistently 
made a more robust clonal expansion and AFC response than the MM4 line (IgM-only).
The nature of the protective effect is unknown and is difficult to reconcile with previous 
data that has shown no functional differences between IgM and IgD (Roes, 1991; Brink, 
1992; Roes, 1993; Lutz, 1998). The most extreme example of this effect is in lines carrying 
an IgD transgene that is independently expressed (DD6 and MM4xDD6). These lines made 
responses comparable to lines expressing the IgG membrane tail. The strong in vivo anti- 
HEL response of the IgD-only line is certainly consistent with previous observations of 
reactivity between IgM-only, IgM/IgD and IgD-only lines to HEL-SRBC (Brink, 1992). 
Several differences, including a combination of higher surface receptor expression and the 
dysregulation of normal IgD expression, especially with respect to early expression in the 
bone marrow as well as the development of IgD-secreting plasma cells (Brink, 1992), make 
results using these lines difficult to interpret.
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Secondly, transgenic B cells expressing the IgG membrane tail and transgenic B cells 
expressing IgM can both participate in both follicular and germinal centre pathways during 
an immune response. After seeding into short-term primed recipients, both IgM and IgM/G 
transgenic B cells participated in follicular clonal expansion, and by day 5 some transgenic 
B cells of each type had entered germinal centres. Interestingly, this method of priming 
completely abolished the dominant extrafollicular response seen in the anti-lysozyme 
response in unprimed mice in the presence of TCR transgenic helpers, providing a useful 
system for the future to dissect the possible role of helper T cells in driving germinal centre 
versus extrafollicular focus responses.
8.2 (b) Validation of the experimental model
The experiments in this thesis compared many different anti-HEL Ig transgenic lines 
expressing different isotype BCRs. In order to make valid conclusions about the role of 
BCR isotype in B cell responses it was important to ensure that line-to-line construct and 
phenotypic differences would not complicate the analysis.
Several issues needed to be addressed. The transgenic lines were created using 
constructs that differ in switch region sequences and which potentially integrated in a 
variety of sites and might affect line-to-line comparison. Also, previously documented 
differences in splenic B cell phenotype existed between the three principal lines (GG4,
MG2 and MM4) used in this study. This included varying expression of CD21 and BCR 
on mature B cells, as well as varying degrees of receptor editing away from the transgene 
specificity (Pogue, 1996; Pogue, 2000). In fact, this thesis has extended the analysis of 
these differences, by showing that the increased fraction of CD21hl HEL-binding cells in 
the IgG and IgM/G lines compared to the IgM-only line is due to a greater fraction of HEL- 
binding cells with a marginal zone location and CD21hl CD23' surface phenotype. When 
many transgenic lines were analysed there was wide variation in the fraction of marginal 
zone and follicular phenotype HEL-binding cells, probably due to a complicated 
combination of clonal competition for marginal zone entry as well as BCR isotype effects.
The issue of line-to-line variation was discounted as an explanation for differential 
responses of transgenic B cells to antigen, as lines made with the same construct gave 
consistent responses, and variations in transgene switch region did not correlate with 
variations in reactivity to antigen. Even though an extensive panel of transgenic lines was 
used, heightened reactivity to antigen in vivo only correlated with the expression of the IgG 
membrane tail (or a dysregulated form of IgD). In a similar way, the effect of edited B 
cells in IgG and IgM/G lines that no longer bound antigen was discounted, as transgenic B 
cells from RAGE7' or RAG1+/+ mice had the same pattern of reactivity to antigen in vivo.
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Surprisingly, the variable proportion of marginal zone and follicular phenotype HEL- 
binding B cells in each line was also discounted as a factor in differential responses to 
antigen. Firstly, some lines with a relatively low fraction of HEL-binding marginal zone 
phenotype cells still make a similar clonal expansion response compared to lines with many 
HEL-binding marginal zone phenotype cells. Secondly, two experiments using matched 
immature bone marrow or mature lymph node B cells recapitulated the differential 
responses to antigen, even though there was no evidence of cell surface phenotypic 
heterogeneity in the B cells used.
The validation of this experimental system was crucial to the conclusions that can be 
drawn from it. Despite every effort to test the effect of line-to-line heterogeneity as a cause 
of the different responses to antigen, BCR isotype is the only factor that predicts the 
magnitude of the transgenic B cell response to antigen. The IgG membrane tail 
consistently protects B cells from loss during a primary immune response in vivo and 
allows a greater net clonal expansion compared to B cells expressing normally-regulated 
combinations of IgM and IgD.
8.2 (c) Integration of these findings with other studies of
switched isotype BCR function
The study outlined in this thesis provides a potential mechanism to bring together 
many previous observations about the role of isotype-switched B cells during an immune 
response. This section will review how this study encompasses previous work and will 
highlight several uncertainties that still need to be addressed.
A series of early papers concerned with the relationship of BCR isotype and B cell 
function showed a strong correlation between memory B cells and the expression of 
isotype-switched receptors, in particular IgG. It was shown that depletion of IgG+ cells 
from primed lymphocyte mixtures, either by radioactive antigen (Coffman, 1977) or 
complement-mediated lysis (Yuan, 1977) decreased the adoptively transferable memory 
response. In addition, later studies using primed, antigen-specific B cells isolated by a 
rosetting method (Yefenof, 1986) or by cell sorting (Hayakawa, 1987) showed that in vitro 
memory responses by these cells were mostly due to IgG+ B cells. Interestingly, the study 
of Yefenof and colleagues (Yefenof, 1986) demonstrated, using limiting dilution assays, 
that IgG+ memory cells had a much larger “clone size” of plaque-forming cells compared to 
the IgG* memory cell fraction. From the results presented in this thesis, it is tempting to 
speculate that the dominance of IgG+ B cells in driving memory responses in vivo or during 
culture in vitro is due to IgG membrane tail expression, which allows a robust clonal burst 
by protecting B cells from loss during clonal expansion.
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The early work presented above provided only correlative evidence that expression of 
IgG was a component of the heightened responses of memory B cells. The contribution of 
BCR isotype was masked in those studies by the other changes that accompany memory 
cell formation. They were useful in defining the phenotypes of memory B cells and 
showing that memory B cells had decreased activation requirements compare to naive B 
cells, but gave no way of assessing the contribution of IgG expression in isolation. In fact, 
aside from in vitro biochemical experiments into the mechanisms of isotype-specific BCR 
surface expression (Venkitaraman, 1991; Weiser, 1994; Knight, 1997), BCR signalling 
(Leca, 1991; Dorseuil, 1992; Kim, 1993; Eray, 1998) and antigen presentation (Patel, 1993; 
Weiser, 1994; Knight, 1997), there have been very few studies to directly assess the 
functional role of isotype-switched receptors.
With the results presented in this thesis as well as the elegant studies of Kaisho et al. 
(Kaisho, 1997) and Achatz et al. (Achatz, 1997), two complementary experimental systems 
have now been used to isolate the role of isotype-switched IgG BCRs in B cell responses to 
antigen in vivo. These studies can now be compared and contrasted to reveal the relative 
strengths and weaknesses of each.
In the first approach, gene targeting technology was used to generate knockouts of 
membrane-bound IgGi (Kaisho, 1997) and IgE (Achatz, 1997), leading to profound defects 
in IgGi and IgE production in the knockout mice. This showed very convincingly that 
membrane expression of IgG and IgE were critical for the normal function of B cells 
expressing those isotypes. As well, tail-truncation mutants were generated lacking the 
putative extended cytoplasmic sequences of IgGi and IgE, which were replaced by the 3 aa 
sequence common to membrane-bound IgM and IgD (see Figure 1-3). These were 
constructed to investigate the role of the highly conserved extended cytoplasmic tail 
sequences of IgGi and IgE. Interestingly, these tail-truncation mutant mice showed an 
intermediate defect in IgGi and IgE responses, suggesting a critical function for the 
cytoplasmic tail domain. In the case of IgGi, Kaisho and colleagues showed that many 
fewer IgG+ antigen-specific cells accumulated at the peak of the anti-NP response in the 
tail-truncation animals, and they also showed profoundly decreased serum IgGi titres and 
affinity maturation (Kaisho, 1997). This study concluded that the cytoplasmic tail 
sequences of IgGi were critical for the function of IgG+ B cells, and it was also speculated 
on the basis of several in vitro observations (Weiser, 1994; Knight, 1997) that the IgGi 
cytoplasmic tail YXXM sequence might act as an antigen internalisation motif driving 
rapid B cell activation by the recruitment of T cell help.
The system outlined in this thesis took a complementary approach to the studies 
outlined above. To isolate the role of BCR isotype, this study used a panel of Ig transgenic
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mice sharing the same high-affinity antigen receptors but expressing different “naive”
(IgM, IgD) or “memory” (IgG) isotypes. The use of adoptive transfers allowed affinity, 
isotype and precursor frequency to remain constant. This is in contrast to the study of 
Kaisho et al., in which clear differences in affinity maturation and precursor frequency after 
the primary response were apparent in comparisons of tail-truncation and wild-type mice 
(Kaisho, 1997). Also, all of the transgenic B cells in this study were naive, removing the 
difficulty of interpreting the responses of antigen-experienced versus naive cells. It was 
found that transgenic B cells bearing IgG made a more robust response to antigen in vivo 
compared to transgenic B cells bearing IgM or IgD, due to a protective effect from cell loss 
during clonal expansion. To isolate the role of the unique membrane tail domain of IgG, 
the study in this thesis performed the “add-back” experiment of grafting the complete 
membrane tail (extracellular spacer, transmembrane and cytoplasmic sequences) of IgG 
onto IgM to see if it conferred any novel functions. Chimeric IgM/G transgenic B cells 
showed the same robust response to antigen as IgG transgenic B cells, demonstrating that 
the IgG membrane tail was the molecular determinant of increased clonal expansion and 
AFC production in this system. This finding does not support the conclusions of Kaisho 
and colleagues regarding the cellular mechanism behind the action of the IgGi cyoplasmic 
tail sequences. In the system outlined in this thesis transgenic B cells bearing the IgGi 
membrane tail were not activated more quickly than IgM transgenic B cells. Rather than 
impacting on cell activation or cell division, the IgG membrane tail instead seems to protect 
B cells from loss during clonal expansion.
While each study had produced different interpretations for the cellular mechanism 
behind the action of the IgG membrane tail, the two experimental approaches seemed to 
reach very similar conclusions about the critical role of this unit in determining the 
response of IgG+ B cells to antigen in vivo. In complementary findings, ablation of the 
cytoplasmic sequences of the membrane tail reduces IgG+ B cell responses, and the 
addition of the entire membrane tail domain onto IgM produces a full IgG-like cellular 
response. The advantage of the Kaisho study is that it narrows down the loss-of-function 
effect in the tail-truncation mutants to the cytoplasmic tail sequences of IgGi, while the 
work presented in this thesis has only localised the gain-of-function effect using IgM/G 
chimeric mice to the entire membrane domain of IgGi. If it is assumed that the deletion of 
the IgG cytoplasmic tail sequence in the tail-truncation mutants disrupted the protective 
effect of the IgG membrane tail domain, then it may be that the cytoplasmic tail of IgG is 
the key section of the IgG membran tail that mediates this effect.
How confident can we be in merging these two approaches to conclude that the IgG 
cytoplasmic tail sequences are responsible for the protective effects of IgG expression 
outlined in this thesis? While this is an attractive hypothesis, several questions remain,
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especially concerning the interpretation of the loss-of-fimction tail truncation mutants. The 
study of Kaisho et al. relied on the surface expression of mutant IgG molecules carrying a 
disrupted, evolutionarily conserved domain. The study showed that there was a lower IgG 
Atail level on LPS/IL-4 stimulated cells compared to wild-type B cells, suggesting a 
problem in the cell surface expression of the mutant IgG molecule. In addition, there was a 
profoundly lower IgG serum level in the pre-immune tail-truncation mice, which could be 
interpreted as a problem in IgG production even before immunisation. Taken together, an 
alternative interpretation for that study is that the truncation of the IgG cytoplasmic tail 
sequence led to poor or unstable IgG membrane expression, with the consequence of a 
lower IgG immune response.
This highlights the difficulties in dissecting the IgG membrane tail domain by 
deletional strategies. By including the entire conserved membrane tail domain of IgG in 
the IgM/G chimeric construct, Pogue and Goodnow were able to ensure equivalent surface 
expression amongst bone marrow B cells in IgM/G and IgM transgenic lines (Pogue, 2000), 
demonstrating that the gain-of-function findings presented here are not clouded by the same 
issues as the deletional study. A limitation of the work outlined in this thesis, however, is 
that it cannot isolate the relevant, minimal sequences within the IgG membrane tail domain 
that mediate the protective effects described here. It remains possible that the extracellular 
membrane-proximal region of IgG i, which is also highly conserved amongst the IgG 
subclasses (see Figure 1-3) may be the key section of the membrane tail mediating 
biological effects, perhaps through isotype-specific interactions with the Igaß heterodimer. 
This is speculation that cannot be presently resolved, however, and in the future mutational 
studies designed to dissect the IgG membrane tail domain will need to ensure correct 
membrane expression of the mutant molecules. It may be a more useful strategy to study 
IgG BCR signalling at a biochemical level, so that rational, minor mutational changes that 
minimise the possibility of disrupting Ig surface expression can be made to test hypotheses 
about the key sequences within the IgG membrane tail that mediate biological function.
8.2 (d) Candidate signalling pathways for the protective effect of
the IgG membrane tail
The hypothesis presented in this thesis is that signalling via the IgG membrane tail 
has a protective, anti-apoptotic effect that allows greater net clonal expansion during a TD 
immune response in vivo. This has striking parallels to the role of CD28 during the co­
stimulation of T cells, which has been shown to be a critical positive regulator of the size of 
the T cell clonal burst (Gudmundsdottir, 1999). One of the targets of CD28 signalling is 
Bcl-xL, and the induction of this anti-apoptotic protein is hypothesised to reduce the rate of 
T cell death over successive divisions during clonal expansion (Sperling, 1996). CD28
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signalling does not just act to decrease cell death, but also increases the production of IL-2 
and the rate of cell division (Gudmundsdottir, 1999), an effect not noticed during these 
studies of transgenic B cells expressing the IgG membrane tail. An important future 
experiment will be to test the role of apoptosis in limiting clonal expansion by transgenic B 
cells that do not express the IgG membrane tail. This could be done by over-expressing an 
anti-apoptotic protein such as Bcl-2 in the IgM transgenic line, to determine whether this 
rescues the clonal expansion response. This would provide good evidence that the relative 
balance of pro-apoptotic and anti-apoptotic factors is affected during antigen-driven 
expansion by the expression of the IgG membrane tail.
What candidate signalling pathways might the IgG membrane tail activate in order to 
shift the balance towards cell survival during clonal expansion?
Firstly, this thesis has presented preliminary evidence for differences in early 
signalling events in transgenic B cells bearing the IgG membrane tail. In particular, a 
consistent observation in this and previous work (Pogue, 1996) is a decreased induction of 
tyrosine phosphorylation of intracellular proteins in B ceils expressing IgG, despite normal 
calcium responses. In addition, this thesis has described possible differences in the 
partitioning of receptors carrying the IgG membrane tail into detergent-resistant lipid 
microdomains. It is tempting to speculate that the IgG antigen receptor is arranged 
differently in the membrane compared to IgM or IgD, and might associate more closely 
with signalling-rich areas of the cell, leading to qualitatively different signalling. It is not 
presently clear what segment of the IgG membrane tail might be responsible for these early 
signalling differences.
Downstream from the receptor, transcription factors of the NFkB family are 
candidate signalling molecules involved in the balance of survival and death in B cells that 
may be differentially regulated by the IgG membrane tail. The activation of transcription 
factors of the NFkB family plays an important role in the regulation of numerous genes in 
many cell types (Pahl, 1999), and in naive B cells NFkB induction is part of the spectrum 
of biochemical responses normally initiated by BCR signalling. By contrast, tolerant B 
cells with crippled BCR signalling only induce a subset of transcription factor responses, 
which do not include NFkB (Healy, 1997). The poor mitogenic responses in tolerant B 
cells correlated with a failure to up-regulate the anti-apoptotic protein A1 (Glynne, 2000), 
which has been shown to be induced by NFkB in B cells and to be essential for protection 
against BCR-induced apoptosis in vitro (Grumont, 1999). As B cells bearing the IgG 
membrane tail are even more resistant to cell loss, it will be interesting to determine if this 
is due to increased signalling via NFkB family members.
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A possible connection between the IgG BCR and increased NFkB signalling is also 
seen in the observation that even on the RAGT7' background a much greater fraction of IgG 
and IgM/G splenic transgenic B cells have a marginal zone phenotype compared to the IgM 
transgenic line. This may be due to an increased basal level of signalling via the NFkB 
pathway by the IgG BCR in resting B cells, as NFkB signalling has been implicated 
directly and indirectly in the control of marginal zone B cell numbers. Marginal zone B 
cells are absent from NFkB p50'A mice (Cariappa, 2000) and are present in increased 
numbers in mice that over-express BAFF (Mackay, 1999; Batten, 2000), a recently 
described NGF/TNF ligand family member that binds the BAFF receptor on B cells 
(Thompson, 2001), and which may signal via NFkB (Do, 2000). This suggests that 
marginal zone maintenance or recruitment could be a reflection of the quality or amount of 
NFkB signalling in B cells.
Section 8.3. A model of the role of BCR isotype during 
memory responses
How do the findings of this thesis integrate into the wider literature concerning the 
mechanisms and features of memory antibody responses? Because this system controlled 
for factors such as antigen experience by using naive transgenic B cells that only differed in 
BCR isotype, we do not know the role of BCR isotype on genuine memory B cells, which 
also have other unique characteristics. Nevertheless, the effect of the IgG membrane tail on 
clonal expansion by naive transgenic B cells was striking, and may well have an important 
effect on memory cells.
Traditionally, memory responses are thought to be due to the increased antigen- 
specific precursor frequency as well as the qualitiative changes that accompany memory 
cell formation. This section will present a model speculating that expression of an isotype- 
switched BCR may be critical component of the qualitative changes that allow memory 
cells to be more easily activated and produce greater magnitude immune responses.
8.3 (a) Quantitative and qualitative changes lead to the rapid
induction of the memory response
The rapid production and efficient triggering of the memory antibody response is 
explained by two key observations. Antigen-specific B and T cell precursor frequency is 
increased in immune animals relative to the naive repertoire. This is a direct prediction of 
the clonal selection theory (Burnet, 1959), and is often cited as being of fundamental 
importance for the rapid, high rise in antibody titre during the memory response (Ahmed,
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1996). In addition, recent work has shown that there are qualitative as well as quantitative 
differences between the memory and naive lymphocytes. These also seem to play a critical 
role in determining the rapid kinetics of the memory response.
Precursor frequency
There is no doubt that elevated frequencies of antigen-specific B (Hayakawa, 1987; 
Schittek, 1990; Ridderstad, 1996; Maruyama, 2000) and T cells (Flynn, 1998) can persist 
for long periods as the remnants of a primary immune response. Also, it has been observed 
that immunising Ig transgenic mice (Toellner, 1996), increasing the frequency of limiting T 
help by carrier-priming (Liu, 1991; Toellner, 1996) and transferring Ig (Adams, 1990; 
Erickson, 2000) or TCR transgenic cells (Freer, 1995; Rathmell, 1995), or both (Garside, 
1998), increases the magnitude of an immune response by providing many more antigen- 
specific precursor cells.
Is precursor frequency then the primary factor in determining the magnitude and 
kinetics of the normal memory response? While it makes intuitive sense, there are several 
pieces of evidence to suggest that memory responses might not rely on a large pool of 
antigen-specific cells, but rather on the qualitatively different properties of antigen-specific 
memory cells. For example, when the secondary B cell response to NP was analysed at the 
clonal level, it was estimated that only 18 genetically distinct B cell precursors were 
involved (Blier, 1987). In addition, Ridderstad et al. showed that mice carrying the Bt)?ld 
mutation, while producing 17-fold fewer NP-specific memory B cells still made normal 
secondary responses. One interpretation of this finding is that excess memory B cells are 
usually maintained in normal animals and not all are required for recall responses, at least 
up to 5 weeks after the primary response. It is tempting to speculate that the “excess” 
memory B cells provide a reservoir for continual low-level differentiation into plasma cells 
to maintain protective immunity. One caveat of the Ridderstad study is that only the B220+ 
memory population was enumerated, so it remains possible that the Bt\?ld mutation affected 
the relative production of B220+ and B220' memory cells (McHeyzer-Williams, 2000; 
Driver, 2001).
The study outlined in this thesis also suggests that differences other than precursor 
frequency affect the outcome of B cell responses to antigen. Transfer of as few as 104 IgG 
transgenic B cells augmented the endogenous primary response of C57BL/6 mice to TEL, 
while as many as 106 IgM transgenic B cells failed to increase the production of anti-TEL 
IgM (see Figure 3-1). This implies that the switch in isotype from IgM to IgG has a 
stronger effect on cell activation during an immune response than simply increasing the 
antigen-specific B cell frequency. Probably the immune system is aided by an elevated
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frequency of antigen-specific cells during a memory response, but does not absolutely 
require a vastly elevated frequency of those cells for effective memory. More important are 
the qualitative changes that accompany the memory state that lead to the rapid, vigorous 
activation, expansion and differentiation of memory cells.
Cell migration and location
Numerous qualitative changes in both memory B and memory CD4+ T cells 
potentially lead to their rapid activation on re-encounter with specific antigen. For antigen- 
specific memory B cells, this is partly due to increased BCR affinity allowing more 
efficient antigen capture, especially early during an infection when soluble antigen might 
be scarce. Also, the location of memory B cells near antigen-draining sites allows intimate 
contact with blood, lymph and mucosal environments (Spencer, 1985; Liu, 1988; Liu,
1991; Liu, 1995). The rapid, specific mobilisation of antigen-specific memory B ceils 
within hours from the marginal zone to the outer PALS in rodents (Liu, 1991; Toellner,
1996) is a good example of this principle in action.
In this migration, the activated memory B cell resembles a primed DC, rapidly 
homing to the site where antigen-specific T help can be engaged. This is a good analogy, 
as one striking difference between naive resting B cells and memory B cells is their ability 
to act as APCs. This reduces the requirement for DC priming of T cell help, as memory B 
cells can directly present antigen in a stimulatory form to antigen-specific T cells, many of 
which will be memory T cells with lower activation and co-stimulatory requirements 
(Byme, 1988; Rogers, 2000).
Pre-activated state
Studies in human memory B cells have demonstrated constitutive expression of co­
stimulatory B7 molecules (B7.1, B7.2), the rapid upregulation of those molecules after 
activation and the ability to activate T cells (Liu, 1995; Bar-Or, 2001). This a strong 
reciprocal collaboration, as memory helper T cells clonally expand, differentiate and 
secrete cytokines, which may then induce rapid isotype switching (Toellner, 1996), cell 
division and terminal differentiation in memory B cells. The lag period between the 
encounter of antigen and the production of antibody is therefore much shorter during the 
memory response compared to the primary (Liu, 1991; Toellner, 1996), because of rapid 
activation and expansion of memory B and T cells due to their pre-primed state.
The rapid production of plasma cells or effector T cells during the memory response 
may also indicate a different rate of differentiation for activated memory cells. The concept
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that memory cells are “biased” towards terminal differentiation is not a new one (Celada, 
1971), and it has received experimental support recently from a number of sources. For 
example, memory B cells isolated from human tonsil generated more AFCs than naive B 
cells in vitro, while undergoing a similar rate of cell division (Arpin, 1997). Also, memory 
T cells produce cytokine-secreting effector cells more rapidly (Rogers, 2000).
This simple concept of “bias” has become more complicated, however, with recent 
reports suggesting phenotypic heterogeneity in memory B and T cell subsets that correlates 
with effector production. For example, CD45RO+ CCR7+ “central memory” and CD45RO+ 
CCR7' “effector memory” T cells differ in their proliferative and differentiation capacity 
(Sallusto, 1999), as do B220' and B220+ memory B cell subsets in the mouse (McHeyzer- 
Williams, 2000) and the CD27+ CD80+ and CD27+ CD80‘ memory B cell subsets from 
human blood (Bar-Or, 2001). It may be that some memory cells are more “biased” towards 
effector production than others. A subset of memory cells making rapid effector responses 
in addition to a subset of memory cells able to make strong proliferative bursts before 
differentiation may be an ideal way of providing immediate protective immunity as well as 
ensuring the production of large numbers of effector cells.
8.3 (b) IgG expression as a component determining the
magnitude of the memory response
The rapid initiation of the memory response is due to increased antigen-specific 
precursor frequency, a reduced requirement for priming and the rapid differentiation of 
both memory B and T cells into effectors. A general feature of memory cells seems to be a 
“relaxation” of activation and expansion requirements compared to naive cells, and it may 
be that memory cells are equipped to overcome many of the normal limiting factors that are 
in place during the primary response. For example, there is evidence that memory CD8+ T 
cells are activated quicker than naive CD8+ T cells, require less antigen, and have a faster 
cycle time with less death, leading to greater expansion in vivo (Veiga-Femandes, 2000).
In the case of antibody responses, memory B cell responses can be induced by 
smaller amounts of antigen provided in the absence of adjuvant (Liu, 1991; McHeyzer- 
Williams, 1991; Kaisho, 1997), by-passing the requirement for the activation of innate 
mechanisms and DCs. This may be an example of a relaxation of the stringent rules that 
govern the differentiation and clonal burst of memory B cells relative to naive cells. One 
controlling factor limiting the production of plasma cells during the activation of naive B 
cells is associated with the splenic stroma (Sze, 2000) and may correspond to the number of 
CD1 lchl PDCs able to sustain extrafollicular foci (Garcia de Vinuesa, 1999). Given the 
consistent association of memory B cells with robust extrafollicular expansion (Liu, 1991;
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Toellner, 1996), it is tempting to speculate that memory B cells are less dependent on the 
putative survival signals provided by the splenic stroma or PDCs. Indeed, this study has 
shown that transgenic B cells expressing the IgG membrane tail make a more robust 
response in extrafollicular foci compare to transgenic B cells expressing IgM or IgD. 
Perhaps the protective, anti-apoptotic effect provided by the IgG membrane tail is the 
mechanism that reduces the dependence of IgG-expressing memory B cells on extrinsic 
survival signals during plasmablast expansion to lead to the production of many more 
effector plasma cells.
The hypothesis presented here for the role of IgG BCR expression in memory 
antibody responses can be summarised in the following way. For memory B cells, one of 
the key regulators of the clonal expansion process may be the expression of IgG, which has 
been shown in this study to protect B cells from death during clonal expansion. We know 
that TD memory responses to many protein and hapten antigens are dominated by IgG 
(Bauer, 1961; Nossal, 1989), and that this antibody is produced by memory B cells that 
express IgG (Okomura, 1976; Hayakawa, 1987; McHeyzer-Williams, 1991; Toellner,
1996), or switch to IgG rapidly after activation (Toellner, 1996). The protective effect of 
IgG during clonal expansion, in combination with other intrinsic changes in memory B 
cells such as higher affinity BCR (Eisen, 1964), location at antigen-draining sites (Spencer, 
1985; Liu, 1988; Liu, 1991; Liu, 1995), improved APC function (Liu, 1995; Bar-Or, 2001) 
and a bias towards plasma cell differentiation (Arpin, 1997; McHeyzer-Williams, 2000) 
synergise to provide rapid, robust clonal expansion and differentiation. This leads to the 
production of many antigen-specific plasma cells and high titres of antigen-specific IgG, 
which are the hallmarks of a TD memory response.
Section 8.4. Future directions
This study has demonstrated that BCR isotype can influence B cell responses to 
antigen during an immune response in vivo. The expression of the unique IgG membrane 
tail is sufficient to protect naive transgenic B cells from attrition during clonal expansion in 
vivo. This is a novel cellular mechanism not predicted by previous studies (Kaisho, 1997), 
and may play a critical role in the heightened antibody production seen during a memory 
antibody response.
An important question arising from this is the relative importance of BCR isotype in 
driving the memory response, compared to the changes in affinity, activation requirements 
and location that also occur. It will be an interesting extension of this work to compare 
memory transgenic B cells present after a normal primary response that express IgG or IgM 
BCRs, but are unable to switch BCR isotype. Do the protective effects of the IgG
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membrane tail still allow greater expansion and antibody production, or do the multiple 
other intrinsic changes in memory B cells allow robust memory responses even in the 
absence of the IgG membrane tail?
Another key unanswered question is the biochemical mechanism by which the IgG 
membrane tail mediates its protective effect. One candidate signalling pathway that may be 
regulated differently is the key transcription factor NFkB, which is accessible to 
biochemical analysis during short term stimulation in vitro. To gain an unbiased view of 
similarities and differences between IgM isotype and IgG isotype signalling, it may be 
more fruitful to perform global gene expression profiling using microarrays. This could be 
done on both acutely stimulated IgG and IgM B cells, as well as B cells sorted on days 3 
and 4 of an immune response, where the survival ability of IgG and IgM transgenic B cells 
seems to diverge.
The general relevance of the protective phenomenon reported in this study is also of 
interest. This study has shown that the IgG membrane tail mediates a protective effect 
during an immune response to the protein antigen HEL. To address whether IgG 
membrane tail expression allows more robust responses to other model antigens, the heavy 
chain-only MG line could be compared to the heavy chain-only MD line. In these lines, an 
elevated frequency of HEL-binding B cells is layered onto a more diverse repertoire. 
Lysozyme immunisation could then be directly compared to immunisation with other 
model antigens. If IgG membrane tail expression in non-lysozyme specific B cells allows 
more robust responses to other antigens, it would provide good evidence that the IgG 
membrane tail can augment clonal expansion as a general phenomenon.
Also, the role of the unique membrane tail domains of the other IgG subclasses as 
well as IgE and IgA remain to be resolved. Interestingly, Achatz and colleagues reported a 
reduction in IgE responses when the cytoplasmic sequences of that isotype were deleted by 
gene targeting (Achatz, 1997). They speculated that the IgE cytoplasmic sequence (which 
also contains a YXXM motif) acts in a similar way to IgGi by allowing more efficient 
antigen presentation. This thesis presents an alternative mechanism for the action of the 
IgG membrane tail and it is interesting to speculate that the IgE membrane tail may have a 
similar protective effect on IgE+ B cells. The extracellular spacer and cytoplasmic 
sequences of the membrane-bound IgG, IgE and IgA subclasses are sufficiently different 
from each other, however, that it is impossible to predict whether they will share common 
functions.
Chapter 9. Appendix
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Section 9.1. News and Views Article
The following section is reproduced by permission from Nature 407: 576-577 (2000), 
copyright (2000) Macmillan Magazines Ltd.
Memory needs no reminders
Stephen Martin and Chris Goodnow
Your body can ‘remember’ specific diseases and, decades later, protect you from 
reinfection. This principle has been known for centuries, but immunologists are still 
struggling with the cellular mechanisms that underlie its maintenance. Is this long-term 
immune ‘memory’ due to the formation of a special class of long-lived memory cells, or to 
occasional ‘reminders’ to the immune system from residual antigens — the invading agents 
that induced the response in the first place. On page 636 of this issue1 Maruyama and 
colleagues describe their use of an elegant genetic system to address the question. They 
suggest that B cells, the class of immune cell that makes antibodies, can persist as memory 
cells for long periods of time after immunization even in the total absence of specific 
stimulation by antigen.
To explain immune memory, Burnet and Talmage2 proposed that rare antigen- 
specific B-lymphocytes, which are precursors of antibody secreting cells, expand clonally 
when they encounter antigen. This clonal expansion results in an enlarged pool of antigen- 
specific B cells that produces a faster, larger response the next time the antigen is 
encountered — that is, they carry a memory of the original immunization. However, there 
was then a divergence of ideas about how the expanded pool of cells could persist, and this 
divide of opinion remains. One line of thought proposes that intermittent re-stimulation of 
the memory B-cell population by specific or cross-reactive antigen is required. In the late 
1960s it was discovered that intact protein antigen could exist in lymphoid tissues for 
months after immunization, in the form of antigen-antibody complexes on so-called 
follicular dendritic cells3,4. These immune complexes were thought to be an antigen depot 
for the continual stimulation of clonally expanded B cells5 and for helper T cells, which aid 
in priming the antigen-specific B cells to produce antibodies. In support of this view, cell- 
transfer experiments6 showed that functional B-cell memory declines rapidly with a half- 
life of around 3 weeks in the absence of antigen.
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The contrasting opinion holds that memory B cells represent a specialized state of 
long-lived quiescent cells that do not require further stimulation by antigen. Supporting 
evidence for this comes from the finding that B-cell memory can be maintained in mice that 
lack follicular dendritic cells7 and in mice deprived of helper T cells8. This shows that 
maintenance of memory B cells may not need antigen depots or signals from helper T cells. 
Moreover, immunological memory also occurs in the cytotoxic T that destroy virus- 
infected cells. Here,too, memory has been shown to persist under experimental conditions 
in which antigen is effectively absent9,10. This antigen-independent persistence of memory 
T cells may be a general theme of immunity and so apply to B cells too.
In their study, Maruyama et cd.1 used an inducible genetic switch to generate memory 
B cells in the absence of their specific antigen. The experiments involved genetically 
modifying mice to carry two different antibody genes specific for two structurally unrelated 
antigens. Antibody gene expression caused about 4% of the normal B cells in these mice to 
express specificity for the first antigen, nitrophenyl. However, although they had increased 
in frequency compared with an unmanipulated mouse, the nitrophenyl-specific B cells were 
still ‘naive’, having never encountered antigen before. The antibody gene specific for the 
second antigen, phycoerythrin, was held in an inactive form within each nitrophenyl- 
specific B cell. These two antibody genes were flanked by loxP sites, which allowed the 
genes to be modified by an enzyme called Cre recombinase. The recombinase gene itself 
was under inducible con-trol — Cre recombinase was made only when the mice were 
injected with the inducer, type-1 interferon.
Maruyama et al. immunized the mice with nitrophenyl to generate nitrophenyl- 
specific memory B cells. Memory B cells differ from naive B cells in that they are the 
‘antigen-experienced’ progeny of the original naive B cells and are thought to be 
responsible for immune memory. After 8 weeks, when a pool of nitrophenyl-specific 
memory B cells had been established, the mice were treated with interferon. This activated 
the Cre recombinase, which, in a small proportion of memory B cells, caused the 
irreversible loss of nitrophenyl specificity and a switch to phycoerythrin specificity (Fig. 1). 
The phycoerythrin-specific memory B cells were predicted to persist if antigen is not 
required for memory-cell maintenance, or to die if antigen is essential (Fig. 2). The upshot 
was that these cells were maintained just as well as the nitrophenyl-specific memory B cells 
for 15 weeks after treatment with interferon.
Do these results rule in favour of the antigen-independent camp? The answer depends 
on how quickly one would expect the phycoerythrin-specific memory cells to die off in the 
absence of antigen, if antigen is indeed required for memory-cell persistence. The rapid 
decline of memory in cell-transfer experiments6 suggests that memory cells would die off
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with a half-life of around 3 weeks. Maruyama and colleagues’ results clearly show that 
phycoerythrin-specific memory cells persist for much longer than that. But the apparent 
contradiction between the two sets of findings1,6 may have its roots in the unusual 
experimental design of the cell-transfer experiments — by sampling B cells from thoracic 
duct lymph, as opposed to sampling non-recirculating B cells from the spleen, the study 
may have measured the short lifespan of activated B cells rather than that of memory cells. 
The more relevant question for Maruyama et al. is whether or not the phycoerythrin- 
specific memory cells die off more slowly than the phycoerythrin-specific naive B cells in 
the absence of antigen. Naive B cells have been shown to have a wide variety of lifespans,
i i_1 •y
with an average half-life extrapolated to be at least 6-12 weeks , with many cells lasting 
for much longer. Given the potentially long lifespan of naive phycoerythrin-specific cells, a 
clear answer to whether antigen is needed to maintain pools of memory B cells must await 
experiments that monitor the decay of both naive and memory phycoerythrin-specific cells 
over longer periods, say 6-12 months.
The new findings1 raise a challenging question for immunologists. If memory B cells 
do not require persistent immunizing antigen to survive for months or years, what stops 
large numbers of memory cells accumulating over a lifetime of different infections?
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Figure 1. Does immune memory need reminders from antigen? This is the genetic 
switch used by Maruyama et al.1 to alter the specificity of memory B cells by genetic 
recombination. The antigens involved were nitrophenyl (NP) and phycoerythrin (PE). After 
the induction of nitrophenyl-specific memory B cells, treatment with interferon produced 
some phycoerythrin-specific memory B cells in the absence of their specific antigen. The 
lifespans of the nitrophenyl- and phycoerythrin-specific memory B cells were then 
compared.
' Naive nitrophenyt- 
specific ceil
Immunize with 
nitrophenyl
nitrophenyl-specific 
memory B cell
Cre-mediated 
changes in 
memory B cells
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Figure 2. The predicted experimental outcomes of Maruyama and colleagues 
experiments1. The only antigen used in this experiment was nitrophenyl; phycoerythrin 
was completely absent. It follows that if specific antigen is required for the maintenance of 
memory B cells, the phycoerythrin-specific memory B cells will die; if specific antigen is 
unnecessary for persistence, these cells will survive. The authors found that the 
phycoerythrin-specific memory B cells persist just as well as the nitrophenyl-specific cells, 
and conclude that specific antigen is not required for the maintenance of memory B cells.
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